10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period ended September 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to ________.

Commission File Number 001-35750 

First Internet Bancorp

(Exact Name of Registrant as Specified in Its Charter)

Indiana	20-3489991
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
8701 East 116th Street Fishers, IN	46038
(Address of Principal Executive Offices)	(Zip Code)

(317) 532-7900

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbols	Name of each exchange on which registered
Common Stock, without par value	INBK	The Nasdaq Stock Market LLC
6.0% Fixed to Floating Subordinated Notes due 2029	INBKZ	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ¨	Accelerated Filer þ
Non-accelerated Filer ¨	Smaller Reporting Company ☐
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of November 4, 2022, the registrant had 9,240,151 shares of common stock issued and outstanding.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. These statements are not historical facts, but rather statements based on the current expectations of First Internet Bancorp and its consolidated subsidiaries (the “Company,” “we,” “our,” or “us”) regarding our business strategies, intended results and future performance, including without limitation statements concerning the financial condition, results of operations, trends in lending policies and loan programs, plans and prospective business partnerships, objectives, future performance and business of the Company. Forward-looking statements are generally preceded by terms such as “anticipate,” “attempt,” “believe,” “can,” “continue,” “could,” “effort,” “estimate,” “expect,” “intend,” “likely,” “may,” “objective,” “optimistic,” “pending,” “plan,” “position,” “potential,” “preliminary,” “remain,” “should,” “will,” “would” or other similar expressions. Such statements are subject to certain risks and uncertainties including: the continued or potential effects of a global pandemic and related variants and mutations and other adverse public health developments on the economy, our business and operations and the business and operations of our vendors and customers; the conflict in Ukraine and potential adverse global economic effects; other general economic conditions, whether national or regional, and conditions in the lending markets in which we participate that may have an adverse effect on the demand for our loans and other products; our credit quality and related levels of nonperforming assets and loan losses, and the value and salability of the real estate that is the collateral for our loans; failures or breaches of or interruptions in the communication and information systems on which we rely to conduct our business that could reduce our revenues, increase our costs or lead to disruptions in our business; our plans to continue originating and growing loan portfolio, which may carry greater risks of non-payment or other unfavorable consequences; our dependence on capital distributions from First Internet Bank of Indiana (“the Bank”); results of examinations of us by our regulators, including the possibility that our regulators may, among other things, require us to increase our allowance for loan losses or to write-down assets; changing bank regulatory conditions, policies or programs, whether arising as new legislation or regulatory initiatives, that could lead to restrictions on activities of banks generally, or the Bank in particular; more restrictive regulatory capital requirements; increased costs, including deposit insurance premiums; regulation or prohibition of certain income producing activities or changes in the secondary market for loans and other products; changes in market rates and prices that may adversely impact the value of securities, loans, deposits and other financial instruments and the interest rate sensitivity of our balance sheet; our liquidity requirements being adversely affected by changes in our assets and liabilities; the effect of legislative or regulatory developments, including changes in laws concerning taxes, banking, securities, insurance and other aspects of the financial services industry; competitive factors among financial services organizations, including product and pricing pressures and our ability to attract, develop and retain qualified banking professionals; the growth and profitability of noninterest or fee income being less than expected; the loss of any key members of senior management; the effect of changes in accounting policies and practices, as may be adopted by the Financial Accounting Standards Board, the Securities and Exchange Commission (the “SEC”), the Public Company Accounting Oversight Board and other regulatory agencies; and the effect of fiscal and governmental policies of the United States federal government. Additional factors that may affect our results include those discussed in this Quarterly Report on Form 10-Q and our most recent Annual Report on Form 10-K under the heading “Risk Factors” and in other reports filed with the SEC. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The factors listed above could affect our financial performance and could cause our actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements.

Except as required by law, we do not undertake, and specifically disclaim any obligation, to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

i

PART I

ITEM 1.    FINANCIAL STATEMENTS 

First Internet Bancorp

Condensed Consolidated Balance Sheets

(Amounts in thousands except share data)

	September 30, 2022		December 31, 2021
	(Unaudited)
Assets
Cash and due from banks	$	14,743	$	7,492
Interest-bearing deposits	206,309		435,468
Total cash and cash equivalents	221,052		442,960
Securities available-for-sale, at fair value (amortized cost of $448,710 and $606,507 in 2022 and 2021, respectively)	393,565		603,044
Securities held-to-maturity, at amortized cost (fair value of $169,977 and $61,468 in 2022 and 2021, respectively)	191,057		59,565
Loans held-for-sale (includes $9,677 and $23,233 at fair value in 2022 and 2021, respectively)	23,103		47,745
Loans	3,255,906		2,887,662
Allowance for loan losses	(29,866)		(27,841)
Net loans	3,226,040		2,859,821
Accrued interest receivable	16,918		16,037
Federal Home Loan Bank of Indianapolis stock	28,350		25,650
Cash surrender value of bank-owned life insurance	39,612		38,900
Premises and equipment, net	70,747		59,842
Goodwill	4,687		4,687
Servicing asset, at fair value	5,795		4,702
Other real estate owned	—		1,188
Accrued income and other assets	43,498		46,853
Total assets	$	4,264,424	$	4,210,994
Liabilities and Shareholders’ Equity
Liabilities
Noninterest-bearing deposits	$	142,875	$	117,531
Interest-bearing deposits	3,049,769		3,061,428
Total deposits	3,192,644		3,178,959
Advances from Federal Home Loan Bank	589,926		514,922
Subordinated debt, net of unamortized debt issuance costs of $2,544 and $2,769 in 2022 and 2021, respectively	104,456		104,231
Accrued interest payable	1,887		2,018
Accrued expenses and other liabilities	14,654		30,526
Total liabilities	3,903,567		3,830,656
Commitments and Contingencies
Shareholders’ Equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	—		—
Voting common stock, no par value; 45,000,000 shares authorized; 9,290,885 and 9,754,455 shares issued and outstanding in 2022 and 2021, respectively	200,123		218,946
Nonvoting common stock, no par value; 86,221 shares authorized; issued and outstanding - none	—		—
Retained earnings	199,877		172,431
Accumulated other comprehensive loss	(39,143)		(11,039)
Total shareholders’ equity	360,857		380,338
Total liabilities and shareholders’ equity	$	4,264,424	$	4,210,994

See Notes to Condensed Consolidated Financial Statements

1

First Internet Bancorp

Condensed Consolidated Statements of Income – Unaudited

(Amounts in thousands except share and per share data)

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest Income
Loans	$	34,643	$	30,126	$	100,246	$	91,846
Securities – taxable	2,701		2,297		7,489		5,997
Securities – non-taxable	491		241		1,068		781
Other earning assets	1,264		370		2,436		1,067
Total interest income	39,099		33,034		111,239		99,691
Interest Expense
Deposits	10,520		7,090		23,025		23,423
Other borrowed funds	4,585		5,025		12,790		13,217
Total interest expense	15,105		12,115		35,815		36,640
Net Interest Income	23,994		20,919		75,424		63,051
Provision for Loan Losses	892		(29)		2,868		1,268
Net Interest Income After Provision for Loan Losses	23,102		20,948		72,556		61,783
Noninterest Income
Service charges and fees	248		276		845		822
Loan servicing revenue	653		511		1,858		1,390
Loan servicing asset revaluation	(333)		(274)		(1,100)		(669)
Mortgage banking activities	871		3,850		4,454		12,274
Gain on sale of loans	2,713		2,719		8,510		7,461
Gain on sale of premises and equipment	—		—		—		2,523
Other	164		731		883		1,349
Total noninterest income	4,316		7,813		15,450		25,150
Noninterest Expense
Salaries and employee benefits	10,439		9,316		31,149		28,040
Marketing, advertising and promotion	1,041		813		2,717		2,365
Consulting and professional services	790		728		3,912		2,792
Data processing	483		380		1,422		1,224
Loan expenses	1,142		383		3,417		1,458
Premises and equipment	2,808		1,687		7,767		4,875
Deposit insurance premium	229		230		797		930
Other	1,063		914		3,579		3,159
Total noninterest expense	17,995		14,451		54,760		44,843
Income Before Income Taxes	9,423		14,310		33,246		42,090
Income Tax Provision	987		2,220		4,056		6,454
Net Income	$	8,436	$	12,090	$	29,190	$	35,636
Income Per Share of Common Stock
Basic	$	0.89	$	1.22	$	3.04	$	3.59
Diluted	$	0.89	$	1.21	$	3.01	$	3.57
Weighted-Average Number of Common Shares Outstanding
Basic	9,458,259		9,936,237		9,615,039		9,922,877
Diluted	9,525,855		9,988,102		9,681,742		9,974,071
Dividends Declared Per Share	$	0.06	$	0.06	$	0.18	$	0.18

See Notes to Condensed Consolidated Financial Statements

2

First Internet Bancorp

Condensed Consolidated Statements of Comprehensive Income – Unaudited

(Amounts in thousands except per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Other comprehensive (loss) income
Securities available-for-sale
Net unrealized holding losses recorded within other comprehensive income before income tax	(18,406)		(1,789)		(51,682)		(2,596)
Income tax benefit	(5,121)		(441)		(13,384)		(616)
Net effect on other comprehensive (loss) income	(13,285)		(1,348)		(38,298)		(1,980)
Securities held-to-maturity
Reclassification of securities from available-for-sale to held-to-maturity	—		—		(5,402)		—
Amortization of net unrealized holding losses on securities transferred from available-for-sale to held-to-maturity	296		—		608		—
Income tax provision (benefit)	69		—		(1,203)		—
Net effect on other comprehensive (loss) income	227		—		(3,591)		—
Cash flow hedges
Net unrealized holding gains on cash flow hedging derivatives recorded within other comprehensive income before income tax	6,058		1,439		19,424		7,665
Income tax provision	1,393		348		5,639		1,657
Net effect on other comprehensive (loss) income	4,665		1,091		13,785		6,008
Total other comprehensive (loss) income	(8,393)		(257)		(28,104)		4,028
Comprehensive income	$	43	$	11,833	$	1,086	$	39,664

 See Notes to Condensed Consolidated Financial Statements

3

First Internet Bancorp

Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited

Nine Months Ended September 30, 2022 and 2021

(Amounts in thousands except per share data)

	Voting and Nonvoting Common Stock		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance, January 1, 2022	$	218,946	$	172,431	$	(11,039)	$	380,338
Net income	—		29,190		—		29,190
Other comprehensive loss	—		—		(28,104)		(28,104)
Dividends declared ($0.18 per share)	—		(1,744)		—		(1,744)
Recognition of the fair value of share-based compensation	1,967		—		—		1,967
Repurchased shares of common stock (518,167)	(20,626)		—		—		(20,626)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	15		—		—		15
Common stock redeemed for the net settlement of share-based awards	(179)		—		—		(179)
Balance, September 30, 2022	$	200,123	$	199,877	$	(39,143)	$	360,857
Balance, January 1, 2021	$	221,408	$	126,732	$	(17,196)	$	330,944
Net income	—		35,636		—		35,636
Other comprehensive income	—		—		4,028		4,028
Dividends declared ($0.18 per share)	—		(1,817)		—		(1,817)
Recognition of the fair value of share-based compensation	1,830		—		—		1,830
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	16		—		—		16
Common stock redeemed for the net settlement of share-based awards	(195)		—		—		(195)
Balance, September 30, 2021	$	223,059	$	160,551	$	(13,168)	$	370,442

See Notes to Condensed Consolidated Financial Statements

4

First Internet Bancorp

Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited

Three Months Ended September 30, 2022 and 2021

(Amounts in thousands except per share data)

	Voting and Nonvoting Common Stock		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance July 1, 2022	$	204,071	$	192,011	$	(30,750)	$	365,332
Net income	—		8,436		—		8,436
Other comprehensive loss	—		—		(8,393)		(8,393)
Dividends declared ($0.06 per share)	—		(570)		—		(570)
Recognition of the fair value of share-based compensation	434		—		—		434
Repurchased shares of common stock (120,000)	(4,387)		—		—		(4,387)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	5		—		—		5
Balance, September 30, 2022	$	200,123	$	199,877	$	(39,143)	$	360,857
Balance July 1, 2021	$	222,486	$	149,066	$	(12,911)	$	358,641
Net income	—		12,090		—		12,090
Other comprehensive loss	—		—		(257)		(257)
Dividends declared ($0.06 per share)	—		(605)		—		(605)
Recognition of the fair value of share-based compensation	568		—		—		568
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	5		—		—		5
Balance, September 30, 2021	$	223,059	$	160,551	$	(13,168)	$	370,442

See Notes to Condensed Consolidated Financial Statements

5

First Internet Bancorp

Condensed Consolidated Statements of Cash Flows – Unaudited

(Amounts in thousands except per share data)

	Nine Months Ended September 30,
	2022		2021
Operating Activities
Net income	$	29,190	$	35,636
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,745		6,649
Increase in cash surrender value of bank-owned life insurance	(712)		(708)
Provision for loan losses	2,868		1,268
Share-based compensation expense	1,967		1,830
Loans originated for sale	(431,053)		(645,620)
Proceeds from sale of loans	466,148		662,390
Gain on loans sold	(13,629)		(23,522)
Decrease in fair value of loans held-for-sale	599		854
(Gain) loss on derivatives	(3,625)		1,870
Settlement of derivatives	—		(1,859)
Loan servicing asset revaluation	1,100		669
Net change in accrued income and other assets	19,262		3,114
Net change in accrued expenses and other liabilities	(5,084)		372
Net cash provided by operating activities	73,776		42,943
Investing Activities
Net loan activity, excluding purchases	(87,883)		156,670
Proceeds from sale of other real estate owned	1,188		—
Maturities and calls of securities available-for-sale	69,798		129,183
Purchase of securities available-for-sale	(12,133)		(272,845)
Maturities and calls of securities held-to-maturity	5,927		6,000
Purchase of securities held-to-maturity	(41,246)		—
Redemption of Federal Home Loan Bank of Indianapolis stock	431		—
Purchase of Federal Home Loan Bank of Indianapolis stock	(3,131)		—
Net proceeds from sale of premises and equipment	—		8,116
Purchase of premises and equipment	(14,368)		(22,467)
Loans purchased	(295,254)		(37,527)
Net proceeds from sale of portfolio loans	14,466		—
Other investing activities	374		2,264
Net cash used in investing activities	(361,831)		(30,606)
Financing Activities
Net increase (decrease) in deposits	13,685		(46,290)
Cash dividends paid	(1,733)		(1,802)
Repayment of subordinated debt	—		(35,000)
Net proceeds from issuance of subordinated debt	—		58,658
Repurchase of common stock	(20,626)		—
Proceeds from advances from Federal Home Loan Bank	455,000		110,000
Repayment of advances from Federal Home Loan Bank	(380,000)		(110,000)
Other, net	(179)		(194)
Net cash provided by (used in) financing activities	66,147		(24,628)
Net Decrease in Cash and Cash Equivalents	(221,908)		(12,291)
Cash and Cash Equivalents, Beginning of Period	442,960		419,806
Cash and Cash Equivalents, End of Period	$	221,052	$	407,515
Supplemental Disclosures
Cash paid during the period for interest	35,946		36,511
Cash paid during the period for taxes	1,893		4,995
Loans transferred to other real estate owned	—		1,188
Loans transferred to held-for-sale from portfolio	14,049		—
Cash dividends declared, paid in subsequent period	557		591
Securities purchased during the period, settled in subsequent period	2,997		—
Transfer of available-for-sale mortgage-backed securities to held-to-maturity mortgage-backed securities at fair value	96,220		—

See Notes to Condensed Consolidated Financial Statements

6

First Internet Bancorp

Notes to Condensed Consolidated Financial Statements – Unaudited

(Table amounts in thousands except share and per share data)

Note 1:        Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results expected for the year ending December 31, 2022 or any other period. The September 30, 2022 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2021.

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, valuation of the servicing asset and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements.

The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.

Certain reclassifications have been made to the 2021 financial statements to conform to the presentation of the 2022 financial statements. These reclassifications had no effect on net income.

7

Note 2:        Earnings Per Share

Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and nine months ended September 30, 2022 and 2021. 

(dollars in thousands, except per share data)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Basic earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Basic earnings per common share	$	0.89	$	1.22	$	3.04	$	3.59
Diluted earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Dilutive effect of equity compensation	67,596		51,865		66,703		51,194
Weighted-average common and incremental shares	9,525,855		9,988,102		9,681,742		9,974,071
Diluted earnings per common share (1)	$	0.89	$	1.21	$	3.01	$	3.57

(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 426 and 1,616 for the three and nine months ended September 30, 2022, respectively. There were 0 and 28 weighted-average antidilutive shares for the three and nine months ended September 30, 2021, respectively.

Note 3:         Securities

The following tables summarize securities available-for-sale and securities held-to-maturity as of September 30, 2022 and December 31, 2021.

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	38,197	$	—	$	(1,868)	$	36,329
Municipal securities	71,156		181		(7,800)		63,537
Agency mortgage-backed securities - residential	259,568		—		(40,377)		219,191
Agency mortgage-backed securities - commercial	17,825		—		(1,303)		16,522
Private label mortgage-backed securities - residential	12,320		—		(1,279)		11,041
Asset-backed securities	5,000		—		(116)		4,884
Corporate securities	44,644		25		(2,608)		42,061
Total available-for-sale	$	448,710	$	206	$	(55,351)	$	393,565

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,957	$	—	$	(1,289)	$	12,668
Mortgage-backed securities - residential	123,718		—		(16,148)		107,570
Mortgage-backed securities - commercial	5,828		—		(1,142)		4,686
Corporate securities	47,554		9		(2,510)		45,053
Total held-to-maturity	$	191,057	$	9	$	(21,089)	$	169,977

8

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	50,013	$	164	$	(1,137)	$	49,040
Municipal securities	75,158		1,940		(65)		77,033
Agency mortgage-backed securities - residential	377,928		960		(5,652)		373,236
Agency mortgage-backed securities - commercial	36,024		441		(139)		36,326
Private label mortgage-backed securities - residential	15,902		122		(3)		16,021
Asset-backed securities	5,000		4		—		5,004
Corporate securities	46,482		597		(695)		46,384
Total available-for-sale	$	606,507	$	4,228	$	(7,691)	$	603,044

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,992	$	717	$	—	$	14,709
Corporate securities	45,573		1,186		—		46,759
Total held-to-maturity	$	59,565	$	1,903	$	—	$	61,468

The carrying value of securities at September 30, 2022 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
One to five years	$	32,743	$	31,812
Five to ten years	50,888		48,261
After ten years	70,366		61,854
	153,997		141,927
Agency mortgage-backed securities - residential	259,568		219,191
Agency mortgage-backed securities - commercial	17,825		16,522
Private label mortgage-backed securities - residential	12,320		11,041
Asset-backed securities	5,000		4,884
Total	$	448,710	$	393,565

	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value
One to five years	$	11,163	$	10,915
Five to ten years	44,865		42,091
After ten years	5,483		4,715
	61,511		57,721
Agency mortgage-backed securities - residential	123,718		107,570
Agency mortgage-backed securities - commercial	5,828		4,686
Total	$	191,057	$	169,977

There were no gross gains or losses resulting from the sale of available-for-sale securities during the three and nine months ended September 30, 2022 and September 30, 2021, respectively.

9

Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at September 30, 2022 and December 31, 2021 was $541.0 million and $403.2 million, which was approximately 96% and 61%, respectively, of the Company’s AFS and HTM securities portfolios. As of September 30, 2022, the Company’s security portfolio consisted of 447 securities, of which 438 were in an unrealized loss position. The unrealized losses are related to the categories noted below.

These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced, with the resulting loss recognized in net income in the period the other-than-temporary impairment (“OTTI”) is identified.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at September 30, 2022.

Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities

The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the terms of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at September 30, 2022.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at September 30, 2022 and December 31, 2021.

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	33,956	$	(1,092)	$	2,223	$	(776)	$	36,179	$	(1,868)
Municipal securities	52,815		(7,800)		—		—		52,815		(7,800)
Agency mortgage-backed securities- residential	186,134		(34,577)		30,061		(5,800)		216,195		(40,377)
Agency mortgage-backed securities- commercial	11,072		(849)		5,442		(454)		16,514		(1,303)
Private label mortgage-backed securities - residential	3,352		(418)		7,689		(861)		11,041		(1,279)
Asset-backed securities	4,884		(116)		—		—		4,884		(116)
Corporate securities	27,595		(1,478)		11,376		(1,130)		38,971		(2,608)
Total	$	319,808	$	(46,330)	$	56,791	$	(9,021)	$	376,599	$	(55,351)

10

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity
Municipal securities	$	12,167	$	(1,256)	$	388	$	(33)	$	12,555	$	(1,289)
Agency mortgage-backed securities - residential	75,251		(10,583)		32,319		(5,565)		107,570		(16,148)
Agency mortgage-backed securities - commercial	4,686		(1,142)		—		—		4,686		(1,142)
Corporate securities	33,712		(2,342)		5,831		(168)		39,543		(2,510)
Total	$	125,816	$	(15,323)	$	38,538	$	(5,766)	$	164,354	$	(21,089)

	December 31, 2021
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	2,921	$	(79)	$	40,305	$	(1,058)	$	43,226	$	(1,137)
Municipal securities	5,721		(65)		—		—		5,721		(65)
Agency mortgage-backed securities - residential	287,820		(3,694)		40,840		(1,958)		328,660		(5,652)
Agency mortgage-backed securities - commercial	3,944		(139)		—		—		3,944		(139)
Private label mortgage-backed securities	374		(3)		—		—		374		(3)
Asset-backed securities	—		—		—		—		—		—
Corporate securities	11,813		(187)		9,491		(508)		21,304		(695)
Total	$	312,593	$	(4,167)	$	90,636	$	(3,524)	$	403,229	$	(7,691)

There were no amounts reclassified from accumulated other comprehensive loss to the condensed consolidated statements of income during the three and nine months ended September 30, 2022 and September 30, 2021, respectively.

11

Note 4:        Loans

Loan balances as of September 30, 2022 and December 31, 2021 are summarized in the table below. Categories of loans include:

(in thousands)	September 30, 2022		December 31, 2021
Commercial loans
Commercial and industrial	$	104,780	$	96,008
Owner-occupied commercial real estate	58,615		66,732
Investor commercial real estate	91,021		28,019
Construction	139,509		136,619
Single tenant lease financing	895,302		865,854
Public finance	614,139		592,665
Healthcare finance	293,686		387,852
Small business lending	113,001		108,666
Franchise finance	225,012		81,448
Total commercial loans	2,535,065		2,363,863
Consumer loans
Residential mortgage	337,565		186,770
Home equity	22,114		17,665
Other consumer loans	312,512		265,478
Total consumer loans	672,191		469,913
Total commercial and consumer loans	3,207,256		2,833,776
Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other(1)	48,650		53,886
Total loans	3,255,906		2,887,662
Allowance for loan losses	(29,866)		(27,841)
Net loans	$	3,226,040	$	2,859,821

(1) Includes carrying value adjustments of $33.9 million and $37.5 million related to terminated interest rate swaps associated with public finance loans as of September 30, 2022 and December 31, 2021, respectively. 

Risk characteristics of each loan portfolio segment are as follows:

Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States.

Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States and its loans are often secured by manufacturing and service facilities, as well as office buildings.

12

Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the Midwest and Southwest regions of the United States. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects unless other underwriting factors are present to mitigate these additional risks.

Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, and multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States.

Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.

Public Finance: These loans are made on a nationwide basis to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; renewable energy projects; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment.

Healthcare Finance: These loans were made on a nationwide basis to healthcare providers, primarily dentists, for practice acquisition financing or refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the underlying collateral provided by the borrower.

Small Business Lending: These loans are made on a nationwide basis to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration (“SBA”) under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. These loans also include loans originated by the Bank under the SBA’s Paycheck Protection Program, which are fully guaranteed by the SBA.

Franchise Finance: These loans are made on a nationwide basis through our partnership with ApplePie Capital, which, through their deep relationships with franchise brands provides franchisees with financing options for new franchise units, recapitalization, expansion, equipment and working capital. The sources of repayment are either based on identified cash flows from existing operations of the borrower or pro forma cash flow for new franchise locations.

13

Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market.

Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Allowance for Loan Losses Methodology

Company policy is designed to maintain an adequate allowance for loan losses (“ALLL”). The portfolio is segmented by loan type, and the required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on average historical losses, adjusted for current economic factors and portfolio trends. Management adds qualitative factors for observable trends, changes in internal practices, changes in delinquencies and impairments, and external factors. Observable factors include changes in the composition and size of portfolios, as well as loan terms or concentration levels. The Company evaluates the impact of internal changes such as management and staff experience levels or modification to loan underwriting processes. Delinquency trends are scrutinized for both volume and severity of past due, nonaccrual, or classified loans, as well as any changes in the value of underlying collateral. Finally, the Company considers the effect of other external factors such as national, regional, and local economic and business conditions, as well as competitive, legal, and regulatory requirements. Loans that are considered to be impaired are evaluated to determine the need for a specific allowance by applying at least one of three methodologies: present value of future cash flows; fair value of collateral less costs to sell; or the loan’s observable market price. All troubled debt restructurings (“TDR”) are considered impaired loans. Loans evaluated for impairment are removed from other pools to prevent double-counting. Accounting Standards Codification (“ASC”) Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral less costs to sell and allows existing methods for recognizing interest income.

Provision for Loan Losses

A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.

Policy for Charging Off Loans

The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.

14

The following tables present changes in the balance of the ALLL during the three and nine months ended September 30, 2022 and 2021. 

(in thousands)	Three Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	2,026	$	(301)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	703		(87)		—		—		616
Investor commercial real estate	621		453		—		—		1,074
Construction	1,707		(117)		—		—		1,590
Single tenant lease financing	9,712		315		—		—		10,027
Public finance	1,850		(61)		—		—		1,789
Healthcare finance	4,762		(1,150)		—		—		3,612
Small business lending	1,956		217		(130)		3		2,046
Franchise finance	2,281		734		—		—		3,015
Residential mortgage	1,138		231		—		1		1,370
Home equity	54		7		—		1		62
Other consumer loans	2,343		651		(106)		50		2,938
Total	$	29,153	$	892	$	(236)	$	57	$	29,866

	Nine Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,891	$	(166)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	742		(126)		—		—		616
Investor commercial real estate	328		746		—		—		1,074
Construction	1,612		(22)		—		—		1,590
Single tenant lease financing	10,385		(1,589)		—		1,231		10,027
Public finance	1,776		13		—		—		1,789
Healthcare finance	5,940		(2,328)		—		—		3,612
Small business lending	1,387		847		(210)		22		2,046
Franchise finance	1,083		1,932		—		—		3,015
Residential mortgage	643		724		—		3		1,370
Home equity	64		(139)		—		137		62
Other consumer loans	1,990		1,116		(397)		229		2,938
Tax refund advance loans	—		1,860		(1,860)		—		—
Total	$	27,841	$	2,868	$	(2,467)	$	1,624	$	29,866

15

(in thousands)	Three Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,902	$	122	$	—	$	2	$	2,026
Owner-occupied commercial real estate	1,021		(28)		—		—		993
Investor commercial real estate	329		(4)		—		—		325
Construction	1,357		(30)		—		—		1,327
Single tenant lease financing	11,205		(152)		—		—		11,053
Public finance	1,700		32		—		—		1,732
Healthcare finance	6,938		(584)		—		—		6,354
Small business lending	783		415		(10)		26		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	594		19		—		3		616
Home equity	63		—		—		2		65
Other consumer loans	2,174		(129)		(110)		50		1,985
Total	$	28,066	$	(29)	$	(120)	$	83	$	28,000

	Nine Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,146	$	823	$	(28)	$	85	$	2,026
Owner-occupied commercial real estate	1,082		(89)		—		—		993
Investor commercial real estate	155		170		—		—		325
Construction	1,192		135		—		—		1,327
Single tenant lease financing	12,990		454		(2,391)		—		11,053
Public finance	1,732		—		—		—		1,732
Healthcare finance	7,485		(1,131)		—		—		6,354
Small business lending	628		776		(222)		32		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	519		91		(6)		12		616
Home equity	48		63		(51)		5		65
Other consumer loans	2,507		(334)		(423)		235		1,985
Total	$	29,484	$	1,268	$	(3,121)	$	369	$	28,000

16

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of September 30, 2022 and December 31, 2021. 

(in thousands)	Loans						Allowance for Loan Losses
September 30, 2022	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	94,617	$	10,163	$	104,780	$	1,377	$	350	$	1,727
Owner-occupied commercial real estate	56,993		1,622		58,615		616		—		616
Investor commercial real estate	91,021		—		91,021		1,074		—		1,074
Construction	139,509		—		139,509		1,590		—		1,590
Single tenant lease financing	895,302		—		895,302		10,027		—		10,027
Public finance	614,139		—		614,139		1,789		—		1,789
Healthcare finance	293,686		—		293,686		3,612		—		3,612
Small business lending(1)	105,129		7,872		113,001		1,368		678		2,046
Franchise finance	225,012		—		225,012		3,015		—		3,015
Residential mortgage	334,082		3,483		337,565		1,370		—		1,370
Home equity	22,114		—		22,114		62		—		62
Other consumer	312,509		3		312,512		2,938		—		2,938
Total	$	3,184,113	$	23,143	$	3,207,256	$	28,838	$	1,028	$	29,866

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

(in thousands)	Loans						Allowance for Loan Losses
December 31, 2021	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	95,364	$	644	$	96,008	$	1,441	$	450	$	1,891
Owner-occupied commercial real estate	63,387		3,345		66,732		742		—		742
Investor commercial real estate	28,019		—		28,019		328		—		328
Construction	136,619		—		136,619		1,612		—		1,612
Single tenant lease financing	864,754		1,100		865,854		10,290		95		10,385
Public finance	592,665		—		592,665		1,776		—		1,776
Healthcare finance	386,926		926		387,852		5,417		523		5,940
Small business lending(1)	106,682		1,984		108,666		994		393		1,387
Franchise finance	81,448		—		81,448		1,083		—		1,083
Residential mortgage	183,852		2,918		186,770		643		—		643
Home equity	17,651		14		17,665		64		—		64
Other consumer	265,469		9		265,478		1,990		—		1,990
Total	$	2,822,836	$	10,940	$	2,833,776	$	26,380	$	1,461	$	27,841

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

17

The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:

•“Pass” - Higher quality loans that do not fit any of the other categories described below.

•“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

•“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.

•“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.

•“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans

Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.

18

The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	93,262	$	1,355	$	10,163	$	104,780
Owner-occupied commercial real estate	46,423		10,570		1,622		58,615
Investor commercial real estate	91,021		—		—		91,021
Construction	139,509		—		—		139,509
Single tenant lease financing	894,208		1,094		—		895,302
Public finance	611,709		2,430		—		614,139
Healthcare finance	292,280		1,406		—		293,686
Small business lending(1)	99,722		5,407		7,872		113,001
Franchise finance	224,721		291		—		225,012
Total commercial loans	$	2,492,855	$	22,553	$	19,657	$	2,535,065

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	September 30, 2022
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	336,492	$	1,073	$	337,565
Home equity	22,114		—		22,114
Other consumer	312,509		3		312,512
Total consumer loans	$	671,115	$	1,076	$	672,191

	December 31, 2021
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	82,412	$	12,952	$	644	$	96,008
Owner-occupied commercial real estate	59,369		4,018		3,345		66,732
Investor commercial real estate	28,019		—		—		28,019
Construction	124,578		12,041		—		136,619
Single tenant lease financing	859,612		5,142		1,100		865,854
Public finance	591,630		1,035		—		592,665
Healthcare finance	386,337		589		926		387,852
Small business lending(1)	99,250		7,433		1,983		108,666
Franchise finance	81,448		—		—		81,448
Total commercial loans	$	2,312,655	$	43,210	$	7,998	$	2,363,863

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	185,544	$	1,226	$	186,770
Home equity	17,651		14		17,665
Other consumer	265,469		9		265,478
Total consumer loans	$	468,664	$	1,249	$	469,913

19

The following tables present the Company’s loan portfolio delinquency analysis as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	350	$	350	$	104,430	$	104,780	$	350	$	—
Owner-occupied commercial real estate	—		—		—		—		58,615		58,615		1,622		—
Investor commercial real estate	—		—		—		—		91,021		91,021		—		—
Construction	—		—		—		—		139,509		139,509		—		—
Single tenant lease financing	—		—		—		—		895,302		895,302		—		—
Public finance	—		—		—		—		614,139		614,139		—		—
Healthcare finance	—		—		—		—		293,686		293,686		—		—
Small business lending(1)	—		356		488		844		112,157		113,001		2,958		—
Franchise finance	—		—		—		—		225,012		225,012		—		—
Residential mortgage	171		71		353		595		336,970		337,565		1,073		—
Home equity	—		—		—		—		22,114		22,114		—		—
Other consumer	30		20		—		50		312,462		312,512		3		—
Total	$	201	$	447	$	1,191	$	1,839	$	3,205,417	$	3,207,256	$	6,006	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	—	$	—	$	96,008	$	96,008	$	674	$	—
Owner-occupied commercial real estate	—		—		—		—		66,732		66,732		—		—
Investor commercial real estate	—		—		—		—		28,019		28,019		3,419		—
Construction	—		—		—		—		136,619		136,619		—		—
Single tenant lease financing	—		—		—		—		865,854		865,854		1,100		—
Public finance	—		—		—		—		592,665		592,665		—		—
Healthcare finance	—		—		—		—		387,852		387,852		—		—
Small business lending(1)	—		—		657		657		108,009		108,666		959		—
Franchising Finance	—		—		—		—		81,448		81,448		—		—
Residential mortgage	51		226		106		383		186,387		186,770		1,226		—
Home equity	—		—		—		—		17,665		17,665		14		—
Other consumer	68		18		—		86		265,392		265,478		9		—
Total	$	119	$	244	$	763	$	1,126	$	2,832,650	$	2,833,776	$	7,401	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

20

Impaired Loans

A loan is designated as impaired, in accordance with the impairment accounting guidance, when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well-secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due.

Impaired loans include nonperforming loans as well as loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection.

ASC Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.

The following table presents the Company’s impaired loans as of September 30, 2022 and December 31, 2021. 

	September 30, 2022						December 31, 2021
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	9,813	$	9,813	$	—	$	—	$	—	$	—
Owner-occupied commercial real estate	—		—		—		3,345		3,466		—
Small business lending(1)	5,838		6,087		—		959		1,193		—
Residential mortgage	3,483		3,634		—		2,918		3,063		—
Home equity	—		—		—		14		15		—
Other consumer loans	3		29		—		9		44		—
Total	19,137		19,563		—		7,245		7,781		—
Loans with a specific valuation allowance
Commercial and industrial	350		350		350		644		677		450
Owner-occupied commercial real estate	1,622		1,779		—		—		—		—
Single tenant lease financing	—		—		—		1,100		1,123		95
Healthcare finance	—		—		—		926		926		523
Small business lending(1)	2,034		2,034		678		1,025		1,025		393
Total	4,006		4,163		1,028		3,695		3,751		1,461
Total impaired loans	$	23,143	$	23,726	$	1,028	$	10,940	$	11,532	$	1,461

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

21

The table below presents average balances and interest income recognized for impaired loans during the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended								Nine Months Ended
	September 30, 2022				September 30, 2021				September 30, 2022				September 30, 2021
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	4,906	$	—	$	—	$	—	$	1,636	$	—	$	259	$	9
Owner-occupied commercial real estate	1,645		—		3,457		—		2,471		—		3,297		—
Single tenant lease financing	—		—		1,315		—		—		—		100		5
Healthcare finance	—		—		—		—		—		—		336		—
Small business lending(1)	2,167		—		—		—		1,288		—		1,005		—
Residential mortgage	3,711		9		2,267		15		3,550		26		2,138		28
Home equity	15		—		14		—		14		—		13		—
Other consumer	8		—		23		—		9		—		27		—
Total	12,452		9		7,076		15		8,968		26		7,175		42
Loans with a specific valuation allowance
Commercial and industrial	350		—		690		—		456		—		677		—
Owner-occupied commercial real estate	—		—		—		—		—		—		473		—
Single tenant lease financing	—		—		2,048		—		547		—		4,875		—
Healthcare finance	660		—		956		37		826		45		809		73
Small business lending(1)	1,827		—		1,203		—		1,611		—		401		—
Other consumer	199		—		—		—		66		—		—		—
Total	3,036		—		4,897		37		3,506		45		7,235		73
Total impaired loans	$	15,488	$	9	$	11,973	$	52	$	12,474	$	71	$	14,410	$	115

1 Balance is partially guaranteed by the U.S. government.

The Company did not have any other real estate owned (“OREO”) as of September 30, 2022. The Company had $1.2 million in OREO as of December 31, 2021, which consisted of one commercial property. There were two loans totaling $0.2 million and one loan totaling $0.1 million in the process of foreclosure at September 30, 2022 and December 31, 2021, respectively.

Troubled Debt Restructurings

The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.

When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance.

In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to obtain additional collateral and/or guarantees to support the debt, or a combination of the two.

22

There were no loans classified as new TDRs during the three months ended September 30, 2022. There was one portfolio residential mortgage loan classified as a new TDR during the nine months ended September 30, 2022 with a pre-modification and post-modification outstanding recorded investment of $0.7 million. The Company did not allocate a specific allowance for that loan as of September 30, 2022. The modifications consisted of interest-only payments for a period of time. There was one portfolio residential mortgage loan classified as a new TDR during the three and nine months ended September 30, 2021 with a pre-modification and post-modification outstanding recorded investment of $0.8 million. The Company did not allocate a specific allowance for that loan as of September 30, 2021. The modifications consisted of interest-only payments for a period of time. There were no performing TDRs that had payment defaults within the twelve months following modification during the three and nine months ended September 30, 2022 and 2021, respectively.

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encouraged financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief were in effect from the period beginning March 1, 2020 until the earlier of January 1, 2022 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. As of September 30, 2022, the Company had no loans as non-TDR loan modifications due to COVID-19.

Note 5:        Premises and Equipment

The following table summarizes premises and equipment at September 30, 2022 and December 31, 2021.

(in thousands)	September 30, 2022		December 31, 2021
Land	$	5,598	$	—
Construction in process	5		57,469
Right of use leased asset	244		208
Building and improvements	55,226		1,090
Furniture and equipment	19,424		7,800
Less: accumulated depreciation	(9,750)		(6,725)
Total	$	70,747	$	59,842

  

On February 16, 2021, the Company entered into an agreement to sell its then headquarters (the “Prior Headquarters”) and certain equipment located in the Prior Headquarters to a third party. The sale was completed on April 16, 2021, and the Company recorded a gain on sale of $2.5 million. As a part of the sale agreement, the buyer agreed to lease the Prior Headquarters back to the Company through December 31, 2021. The Company vacated the Prior Headquarters at the end of the lease, on or prior to December 31, 2021.

Note 6:        Goodwill        

As of September 30, 2022 and December 31, 2021, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three and nine months ended September 30, 2022. Goodwill is assessed for impairment annually as of August 31, or more frequently if events occur or circumstances change that indicate an impairment may exist. When assessing goodwill for impairment, first, a qualitative assessment can be made to determine whether it is more likely than not that the estimated fair value of a reporting unit is less than its estimated carrying value. If the results of the qualitative assessment are not conclusive, a quantitative goodwill test is performed. Alternatively, a quantitative goodwill test can be performed without performing a qualitative assessment.

23

Goodwill was assessed for impairment using a qualitative test performed as of August 31, 2022. The estimated fair value of the reporting unit exceeded the net carrying value, and therefore no goodwill impairment existed as of that date.

Note 7:        Servicing Asset

Activity for the servicing asset and the related changes in fair value for the three and nine months ended September 30, 2022 and 2021 are shown in the table below.

	Three Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	5,345	$	4,120
Additions:
Originated and purchased servicing	783		566
Subtractions
Paydowns:	(279)		(176)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(54)		(98)
Loan servicing asset revaluation	$	(333)	$	(274)
Balance, end of period	$	5,795	$	4,412

	Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	4,702	$	3,569
Additions:
Originated and purchased servicing	2,193		1,512
Subtractions
Paydowns:	(888)		(500)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(212)		(169)
Loan servicing asset revaluation	$	(1,100)	$	(669)
Balance, end of period	$	5,795	$	4,412

Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of September 30, 2022 and December 31, 2021 are shown in the table below.

(in thousands)	September 30, 2022		December 31, 2021
Loan portfolios serviced for:
SBA guaranteed loans	$	285,736	$	230,514
Total	$	285,736	$	230,514

Loan servicing revenue totaled $0.7 million and $1.9 million for the three and nine months ended September 30, 2022 and $0.5 million and $1.4 million for the three and nine months ended September 30, 2021, respectively. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.3 million and $1.1 million downward valuation for the three and nine months ended September 30, 2022, respectively, and a $0.3 million and $0.7 million downward valuation for the three and nine months ended September 30, 2021, respectively.

24

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 11 - Fair Value of Financial Instruments for further details.

Note 8:        Subordinated Debt

In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially had a fixed interest rate of 6.0% per year to, but excluding September 30, 2021, and thereafter a floating rate equal to the then-current three-month LIBOR rate plus 485 basis points. All interest on the 2026 Notes was payable quarterly. The 2026 Notes were scheduled to mature on September 30, 2026. The 2026 Notes were unsecured subordinated obligations of the Company eligible to be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes were intended to qualify as Tier 2 capital under regulatory guidelines. The Company redeemed the 2026 Notes in full on September 30, 2021.

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate plus 4.11%). All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

In October 2020, the Company entered into a term loan in the principal amount of $10.0 million evidenced by a term note due 2030 (the “2030 Note”). The 2030 Note initially bears a fixed interest rate of 6.0% per year to, but excluding, November 1, 2025 and thereafter at a floating rate equal to the then-current benchmark rate (initially the then current three-month term secured overnight financing rate (“Term SOFR”) plus 5.795%). The 2030 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after November 1, 2025. The 2030 Note is intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2030 Note to redeem a subordinated term note that had been entered into in October 2015.

In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes initially bear a fixed interest rate of 3.75% per year to, but excluding, September 1, 2026, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 3.11%). The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 1, 2026. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used a portion of the net proceeds from the issuance of the 2031 Notes to redeem the 2026 Notes. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. On December 30, 2021, we completed an exchange of $59.3 million principal amount of the unregistered 2031 Notes for registered 2031 Notes in satisfaction of our obligations under the registration rights agreement. Holders of $0.7 million of unregistered 2031 Notes did not participate in the exchange.

25

The following table presents the principal balance and unamortized debt issuance costs for the 2029 Notes, the 2030 Notes, and the 2031 Notes as of September 30, 2022 and December 31, 2021.

	September 30, 2022				December 31, 2021
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs
2029 Notes	$	37,000	$	(1,060)	$	37,000	$	(1,178)
2030 Notes	10,000		(190)		10,000		(208)
2031 Notes	60,000		(1,294)		60,000		(1,383)
Total	$	107,000	$	(2,544)	$	107,000	$	(2,769)

Note 9:        Benefit Plans

Employment Agreements

The Company is party to certain employment agreements with each of its Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer. The employment agreements each provide for annual base salaries and annual bonuses, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonuses are to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee. The agreements also provide that each of the Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer, may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.

The agreements also provide for the continuation of salary and certain other benefits for a specified period of time upon termination of employment under certain circumstances, including resignation for “good reason” or termination by the Company without “cause” at any time or any termination of employment within twelve months following a “change in control,” along with other specific conditions.

2022 Equity Incentive Plan

The First Internet Bancorp 2022 Equity Incentive Plan (the “2022 Plan”) was approved by our Board of Directors and ratified by our shareholders on May 16, 2022. The plan permits awards of incentive and non-statutory stock options, stock appreciation rights, restricted stock awards, stock unit awards, performance awards and other stock-based awards. All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2022 Plan. The 2022 Plan initially authorized the issuance of 400,000 new shares of the Company’s common stock plus all shares of common stock that remained available for future grants under the First Internet Bancorp 2013 Equity Incentive Plan (the “2013 Plan”).

Award Activity Under 2022 Plan

The Company recorded less than $0.1 million of share-based compensation expense for both the three and nine months ended September 30, 2022, related to stock-based awards under the 2022 Plan.

The following table summarizes the stock-based award activity under the 2022 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	—	$	—	—	$	—	—	$	—
Granted	—	—		4,151	36.84		—	—
Unvested at September 30, 2022	—	$	—	4,151	$	36.84	—	$	—

26

At September 30, 2022, the total unrecognized compensation cost related to unvested stock-based awards was 0.1 million with a weighted-average expense recognition period of 0.6 years.

2013 Equity Incentive Plan

The 2013 Plan authorized the issuance of 750,000 shares of the Company’s common stock in the form of stock-based awards to employees, directors, and other eligible persons. Although outstanding stock-based awards under the 2013 Plan remain in place according to their terms, our authority to grant new awards under the 2013 Plan terminated upon shareholder approval of the 2022 Plan.

Award Activity Under 2013 Plan

The Company recorded $0.4 million and $2.0 million of share-based compensation expense for the three and nine months ended September 30, 2022, respectively, related to stock-based awards under the 2013 Plan. The Company recorded $0.6 million and $1.8 million of share-based compensation expense for the three and nine months ended September 30, 2021, related to stock-based awards under the 2013 Plan.

The following table summarizes the stock-based award activity under the 2013 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	112,822	$	28.18	—	$	—	—	$	—
Granted	41,662	46.67		9,954	52.64		3	41.87
Cancelled/Forfeited	(5,441)	36.68		(644)	52.64		—	—
Vested	(23,256)	24.62		(7,378)	52.64		(3)	41.87
Unvested at September 30, 2022	125,787	$	34.59	1,932	$	52.64	—	$	—

At September 30, 2022, the total unrecognized compensation cost related to unvested stock-based awards was $2.1 million with a weighted-average expense recognition period of 1.8 years.

Directors Deferred Stock Plan

Until January 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The Directors Deferred Stock Plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right.

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the nine months ended September 30, 2022.

	Deferred Stock Rights
Outstanding, beginning of period	84,536
Granted	322
Exercised	—
Outstanding, end of period	84,858

All deferred stock rights granted during the 2022 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.

27

Note 10:        Commitments and Credit Risk

In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At September 30, 2022 and December 31, 2021, the Company had outstanding loan commitments totaling approximately $508.6 million and $324.3 million, respectively.

Capital Commitments

Capital expenditures contracted for at the balance sheet date but not yet recognized in the financial statements are associated with the construction of the building where our corporate headquarters is located, along with an attached parking garage. The Company has entered into construction-related contracts in the amount of $69.2 million. As of September 30, 2022, $6.1 million of such contract commitments had not yet been incurred. These commitments are due within one year.

Note 11:        Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1    Quoted prices in active markets for identical assets or liabilities

Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.

Available-for-Sale Securities

Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.

Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage- and asset-backed securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.

In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2022 or December 31, 2021.

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).

28

Servicing Asset

Fair value is based on a loan-by-loan basis taking into consideration the original maturity of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing assets begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).

Interest Rate Swap Agreements

The fair value of interest rate swap agreements is estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data (Level 2).

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).

Interest Rate Lock Commitments

The fair values of interest rate lock commitments (“IRLCs”) are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3).

The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at September 30, 2022 and December 31, 2021.

			September 30, 2022  Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	36,329	$	—	$	36,329	$	—
Municipal securities	63,537		—		63,537		—
Agency mortgage-backed securities - residential	219,191		—		219,191		—
Agency mortgage-backed securities - commercial	16,522		—		16,522		—
Private label mortgage-backed securities - residential	11,041		—		11,041		—
Asset-backed securities	4,884		—		4,884		—
Corporate securities	42,061		—		42,061		—
Total available-for-sale securities	$	393,565	$	—	$	393,565	$	—
Loans held-for-sale (mandatory pricing agreements)	9,677		—		9,677		—
Servicing asset	5,795		—		—		5,795
Interest rate swap assets	8,978		—		8,978		—
Forward contracts	1,006		1,006		—		—
IRLCs	(388)		—		—		(388)

29

			December 31, 2021 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	49,040	$	—	$	49,040	$	—
Municipal securities	77,033		—		77,033		—
Agency mortgage-backed securities - residential	373,236		—		373,236		—
Agency mortgage-backed securities - commercial	36,326		—		36,326		—
Private label mortgage-backed securities - residential	16,021		—		16,021		—
Asset-backed securities	5,004		—		5,004		—
Corporate securities	46,384		—		46,384		—
Total available-for-sale securities	$	603,044	$	—	$	603,044	$	—
Loans held-for-sale (mandatory pricing agreements)	23,233		—		23,233		—
Servicing asset	4,702		—		—		4,702
Interest rate swap agreements	(14,271)		—		(14,271)		—
Forward contracts	(30)		(30)		—		—
IRLCs	718		—		—		718

The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, July 1, 2022	$	5,345	$	462
Total realized gains
Additions:
Originated and purchased servicing	783		—
Subtractions:
Paydowns	(279)		—
Change in fair value	(54)		(850)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of July 1, 2021	$	4,120	$	818
Total realized gains
Additions:
Originated and purchased servicing	566		—
Subtractions:
Paydowns	(176)		—
Change in fair value	(98)		22
Balance, September 30, 2021	$	4,412	$	840

30

	Nine Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, January 1, 2022	$	4,702	$	718
Total realized gains
Additions:
Originated and purchased servicing	2,193		—
Subtractions:
Paydowns	(888)		—
Change in fair value	(212)		(1,106)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of January 1, 2021	$	3,569	$	3,361
Total realized gains
Additions:
Originated and purchased servicing	1,512		—
Subtractions:
Paydowns	(500)		—
Change in fair value	(169)		(2,521)
Balance, September 30, 2021	$	4,412	$	840

The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.

Impaired Loans (Collateral Dependent)

Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price.

If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment.

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at September 30, 2022 and December 31, 2021.

			September 30, 2022
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,134	$	—	$	—	$	1,134

31

			December 31, 2021
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,228	$	—	$	—	$	1,228

 Significant Unobservable (Level 3) Inputs

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)	Fair Value at September 30, 2022		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,134	Fair value of collateral	Discount for type of property and current market conditions	10%	10%
IRLCs	(388)		Discounted cash flow	Loan closing rates	25% - 100%	81%
Servicing asset	5,795		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 12%	14.6% 12%

(dollars in thousands)	Fair Value at December 31, 2021		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,228	Fair value of collateral	Discount for type of property and current market conditions	0% - 35%	10.1%
IRLCs	718		Discounted cash flow	Loan closing rates	42% - 100%	89%
Servicing asset	4,702		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 10%	12.5% 10%

The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.

Cash and Cash Equivalents

For these instruments, the carrying amount is a reasonable estimate of fair value.

Securities Held-to-Maturity

Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.

Level 2 securities include municipal securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for

32

specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.

In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2022 or December 31, 2021.

Loans Held-for-Sale (best efforts pricing agreements)

The fair value of these loans approximates carrying value.

Loans

The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.

Accrued Interest Receivable

The fair value of these financial instruments approximates carrying value.

Federal Home Loan Bank of Indianapolis Stock

The fair value approximates carrying value.

Deposits 

The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.

Advances from Federal Home Loan Bank

The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.

Subordinated Debt

The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.

 Accrued Interest Payable

The fair value of these financial instruments approximates carrying value.

Commitments

The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of September 30, 2022 and December 31, 2021.

33

The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021.

	September 30, 2022 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	221,052	$	221,052	$	221,052	$	—	$	—
Securities held-to-maturity	191,057		169,977		—		169,977		—
Loans held-for-sale (best efforts pricing agreements)	13,426		13,426		—		13,426		—
Net loans	3,226,040		3,027,916		—		—		3,027,916
Accrued interest receivable	16,918		16,918		16,918		—		—
Federal Home Loan Bank of Indianapolis stock	28,350		28,350		—		28,350		—
Deposits	3,192,644		3,056,730		1,910,715		—		1,146,015
Advances from Federal Home Loan Bank	589,926		545,824		—		545,824		—
Subordinated debt	104,456		104,544		34,425		70,119		—
Accrued interest payable	1,887		1,887		1,887		—		—

	December 31, 2021 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	442,960	$	442,960	$	442,960	$	—	$	—
Securities held-to-maturity	59,565		61,468		—		61,468		—
Loans held-for-sale (best efforts pricing agreements)	24,512		24,512		—		24,512		—
Net loans	2,859,821		2,880,024		—		—		2,880,024
Accrued interest receivable	16,037		16,037		16,037		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,178,959		3,190,000		1,909,432		—		1,280,568
Advances from Federal Home Loan Bank	514,922		526,143		—		526,143		—
Subordinated debt	104,231		108,788		38,643		70,145		—
Accrued interest payable	2,018		2,018		2,018		—		—

Note 12:        Mortgage Banking Activities

The Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 13 for further information on derivative financial instruments. 

34

During the three months ended September 30, 2022 and 2021, the Company originated mortgage loans held-for-sale of $85.1 million and $198.3 million, respectively, and sold $95.0 million and $186.1 million of mortgage loans, respectively, into the secondary market. During the nine months ended September 30, 2022 and 2021, the Company originated mortgage loans held-for-sale of $343.3 million and $585.5 million, respectively, and sold $365.3 million and $579.2 million of mortgage loans, respectively, into the secondary market.

The following table presents the components of income from mortgage banking activities for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Gain on loans sold	$	1,178	$	3,244	$	5,119	$	14,550
Gain (loss) resulting from the change in fair value of loans held-for-sale	(450)		110		(599)		(854)
Gain (loss) resulting from the change in fair value of derivatives	143		496		(66)		(1,422)
Net revenue from mortgage banking activities	$	871	$	3,850	$	4,454	$	12,274

Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.

Note 13:        Derivative Financial Instruments

The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.

The Company had various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of September 30, 2022 and December 31, 2021.  

35

(in thousands)	Carrying amount of the hedged asset				Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Securities available-for-sale (1)	$	69,050	$	75,156	$	(2,106)	$	1,729

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The designated hedged items were $50.0 million at both September 30, 2022 and December 31, 2021.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands) September 30, 2022	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%
Total at September 30, 2022	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%

(dollars in thousands) December 31, 2021	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%
Total at December 31, 2021	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%

In March 2021, the Company terminated the last layer of interest rate swaps associated with available-for-sale agency mortgage-backed securities - residential, which resulted in swap termination payments to counterparties totaling $1.9 million. The corresponding fair value hedging adjustment was allocated pro-rata to the underlying hedged securities and is being amortized over the remaining lives of the designated securities. During the three and nine months ended September 30, 2022, amortization expense totaling $0.1 million and $0.2 million, respectively, was recognized as a reduction to interest income on securities.

In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted average term to maturity of 11.5 years as of September 30, 2022. Amortization expense totaling $1.5 million and $3.6 million, for the three and nine months ended September 30 2022, respectively, and $1.5 million and $3.8 million, for the three and nine months ended September 30, 2021 respectively, related to these previously terminated fair value hedges was recognized as a reduction to interest income on loans.

The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021.

36

(dollars in thousands) September 30, 2022	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	4.34	$	5,242	3-month LIBOR	2.88	%
Interest rate swaps	60,000		0.89	730		1-month LIBOR	2.88	%
Interest rate swaps	40,000		1.67	912		Fed Funds Effective	2.78	%

(dollars in thousands) December 31, 2021	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	5.1	$	(8,560)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		2.0	(3,980)		1-month LIBOR	2.88	%

These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. As of September 30, 2022 the Company had no pledged cash collateral compared to $15.7 million, as of December 31, 2021. Cash collateral is pledged to counterparties on interest rate swap agreements as security for its obligations related to these agreements. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at September 30, 2022 and December 31, 2021.

	September 30, 2022				December 31, 2021
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	50,000	$	2,094	$	—	$	—
Interest rate swaps associated with variable-rate liabilities	210,000		6,884		—		—
Derivatives not designated as hedging instruments
IRLCs	—		—		62,789		718
Forward contracts	27,750		1,006		—		—
Total contracts	$	287,750	$	9,984	$	62,789	$	718
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	—	$	—	$	50,000	$	(1,731)
Interest rate swaps associated with variable-rate liabilities	—		—		210,000		(12,540)
Derivatives not designated as hedging instruments
Forward contracts	—		—		72,750		(30)
IRLCs	31,202		(388)		—		—
Total contracts	$	31,202	$	(388)	$	332,750	$	(14,301)

The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three and nine months ended September 30, 2022 and 2021.

37

	Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Three Months Ended				Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest rate swap agreements	$	6,058	$	1,439	$	19,424	$	7,665

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three and nine ended September 30, 2022 and 2021.

	Amount of Gain / (Loss) Recognized in the Three Months Ended				Amount of Gain / (Loss) Recognized in the Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	—	$	—	$	—	$	(2,519)
Forward contracts	993		—		1,036		—
Liability Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(850)	$	22	$	(1,102)	$	—
Forward contracts	—		474		—		1,097

The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three and nine months ended September 30, 2022 and 2021.

(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest income
Securities - taxable	$	—	$	—	$	—	$	(253)
Securities - non-taxable	(7)		(280)		(442)		(817)
Total interest income	(7)		(280)		(442)		(1,070)
Interest expense
Deposits	159		702		1,338		2,072
Other borrowed funds	168		774		1,355		2,258
Total interest expense	327		1,476		2,693		4,330
Net interest income	$	(334)	$	(1,756)	$	(3,135)	$	(5,400)

Note 14:     Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, included in shareholders' equity, for the nine months ended September 30, 2022 and 2021, respectively, are presented in the table below.

38

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, January 1, 2022	$	(2,555)	$	—	$	(8,484)	$	(11,039)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(51,682)		(5,402)		19,424		(37,660)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		608		—		608
Other comprehensive (loss) gain before tax	(51,682)		(4,794)		19,424		(37,052)
Income tax (benefit) provision	(13,384)		(1,203)		5,639		(8,948)
Other comprehensive (loss) income - net of tax	(38,298)		(3,591)		13,785		(28,104)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, January 1, 2021	$	468	$	—	$	(17,664)	$	(17,196)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(2,596)		—		7,665		5,069
Other comprehensive (loss) gain before tax	(2,596)		—		7,665		5,069
Income tax (benefit) provision	(616)		—		1,657		1,041
Other comprehensive (loss) income - net of tax	(1,980)		—		6,008		4,028
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, July 1, 2022	$	(27,568)	$	(3,818)	$	636	$	(30,750)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(18,406)		—		6,058		(12,348)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		296		—		296
Other comprehensive (loss) gain before tax	(18,406)		296		6,058		(12,052)
Income tax (benefit) provision	(5,121)		69		1,393		(3,659)
Other comprehensive (loss) income - net of tax	(13,285)		227		4,665		(8,393)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, July 1, 2021	$	(164)	$	—	$	(12,747)	$	(12,911)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(1,789)		—		1,439		(350)
Other comprehensive gain (loss) before tax	(1,789)		—		1,439		(350)
Income tax (benefit) provision	(441)		—		348		(93)
Other comprehensive income (loss) - net of tax	(1,348)		—		1,091		(257)
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

39

Details About Accumulated Other Comprehensive Income (Loss) Components	Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Affected Line Item in the Statements of Income
	Three Months Ended September 30, 2022		Three Months Ended September 30, 2021		Nine Months Ended September 30, 2022		Nine Months Ended September 30, 2021
Reclassifications from accumulated other comprehensive loss to earnings before tax	$	(296)	—		$	(608)	$	—	Interest income
Total amount reclassified before tax	(296)		—		(608)		—		Income before income taxes
Tax benefit	(68)		—		(139)		—		Income tax provision
Total reclassifications from accumulated other comprehensive loss	$	(228)	$	—	$	(469)	$	—	Net income

40

Note 15:     Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

•Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

•Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

•In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

The Company expects to adopt this guidance on January 1, 2023 and is currently evaluating the impact of the amendments on the Company’s consolidated financial statements. The Company has a current expected credit losses (“CECL”) working group that has been meeting to discuss implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. Specific to the model, the CECL working group has discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation is expected to be completed in the fourth quarter 2022.

41

The Company expects to record a one-time cumulative effect adjustment to the ALLL in retained earnings on the consolidated balance sheet as of the beginning of the first reporting period in which the new standard is effective, as is required in the guidance. The Company believes there will be an increase in the ALLL as a result of the adoption of this new standard; however, it is waiting to provide an estimate until the completion of the model validation and analysis by the CECL working group. The Company will continue to evaluate and refine the ALLL throughout the remainder of 2022, considering changes in portfolio composition, economic conditions and the results from the model validation.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company adopted the temporary relief issued under the CARES Act, thereby suspending the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act specifies that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of January 1, 2022 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on     Financial Reporting (March 2020)

In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBORon financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2022. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the separate recognition and measurement guidance for Troubled Debt Restructurings ("TDRs") by creditors. The elimination of the TDR guidance may be adopted prospectively for loan modifications after adoption or on a modified retrospective basis, which would also apply to loans previously modified, resulting in a cumulative effect adjustment to retained earnings in the period of adoption for changes in the allowance for credit losses. The ASU requires an entity to disclose current-period gross write-offs by year of origination for financing receivables within the scope of Subtopic 326-20. This guidance is effective on January 1, 2023, with early adoption permitted. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this report. This discussion and analysis includes certain forward-looking statements that involve risks, uncertainties, and assumptions. You should review the “Risk Factors” sections of this report and our Annual Report on Form 10-K for the year ended December 31, 2021 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by such forward-looking statements. See also “Cautionary Note Regarding Forward-Looking Statements” at the beginning of this report.

42

Overview

    First Internet Bancorp (“we,” “our,” “us,” or the “Company”) is a financial holding company with $4.3 billion in total assets as of September 30, 2022, that conducts its primary business activities through its wholly owned subsidiary, First Internet Bank of Indiana, an Indiana chartered bank (the “Bank”). The Bank was the first state-chartered, Federal Deposit Insurance Corporation (“FDIC”) insured Internet bank and commenced banking operations in 1999. The Company was incorporated under the laws of the State of Indiana on September 15, 2005. On March 21, 2006, we consummated a plan of exchange by which we acquired all of the outstanding shares of the Bank.

    The Bank has three wholly-owned subsidiaries: First Internet Public Finance Corp., an Indiana corporation that provides a range of public and municipal finance lending and leasing products to governmental entities throughout the United States and acquires securities issued by state and local governments and other municipalities; JKH Realty Services, LLC, a Delaware limited liability company that manages other real estate owned (“OREO”) properties as needed; and SPF15, Inc., an Indiana corporation that owns real estate used primarily for the Bank’s principal office.

We offer a wide range of commercial, small business, consumer and municipal banking products and services. We conduct our consumer and small business deposit operations primarily through digital channels on a nationwide basis and have no traditional branch offices. Our residential mortgage products are offered nationwide primarily through a digital direct-to-consumer platform and are supplemented with Central Indiana-based mortgage and construction lending. Our consumer lending products are primarily originated on a nationwide basis through relationships with dealerships and financing partners.

Our commercial banking products and services are delivered through a relationship banking model and include commercial and industrial (“C&I”), construction and investor commercial real estate, single tenant lease financing, public finance, healthcare finance, small business lending, franchise finance and commercial deposits and treasury management. Our C&I team provides credit solutions such as lines of credit, term loans, owner-occupied commercial real estate loans and corporate credit cards on a regional basis to commercial borrowers primarily in the Midwest and Southwest regions of the United States. We primarily offer construction and investor commercial real estate loans within Central Indiana or on a regional basis and single tenant lease financing on a nationwide basis. Our public finance team provides a range of public and municipal lending and leasing products to government entities on a nationwide basis. Our healthcare finance team was established in conjunction with our strategic partnership with Provide, Inc. (formerly known as Lendeavor, Inc.), a San Francisco-based technology-enabled lender to healthcare practices, which provided lending on a nationwide basis for healthcare practice finance or acquisition, acquisition or refinancing of owner-occupied commercial real estate and equipment purchases. In the third quarter 2021, Provide was acquired by a super-regional financial institution. Subsequent to Provide being acquired, the acquiring institution has retained most, if not all, of Provide’s loan origination activity and our healthcare finance loan balances have declined. Our franchise finance business was established in July 2021 in conjunction with our business relationship with ApplePie Capital, a financial technology (“fintech”) company that specializes in providing financing to franchisees in various industry segments. Our commercial deposits and treasury management team works with the other commercial teams to provide deposit products and treasury management services to our commercial and municipal lending customers as well as pursues commercial deposit opportunities in business segments where we have no credit relationships.

We believe that we can differentiate ourselves from larger financial institutions by providing a full suite of services to emerging small businesses and entrepreneurs on a nationwide basis. We have recruited experienced small business sales, credit and operations personnel to expand our capabilities in small business lending and U.S. government guaranteed lending programs. We continue to scale up this business with the goal of driving increased earnings and profitability in future periods.

We plan to expand our fintech partnerships. With the rapid evolution of technology that enables consumers and small businesses to manage their finances digitally, fintechs are addressing a significantly growing marketplace. Fintechs have created robust digital offerings, unburdened by legacy technology architecture, to address growing customer expectations. Through partnerships with selected fintechs, we believe our ability to win and retain consumer and small business relationships will be significantly enhanced. Furthermore, we believe partnering with select fintechs will allow us to further diversify our revenue sources, acquire lower-cost deposits and pursue additional asset generation capabilities.

43

Results of Operations

During the third quarter 2022, net income was $8.4 million, or $0.89 per diluted share, compared to third quarter 2021 net income of $12.1 million, or $1.21 per diluted share, representing a decrease in net income of $3.7 million, or 30.2%, and a decrease in diluted earnings per share of $0.32, or 26.4%. During the nine months ended September 30, 2022, net income was $29.2 million, or $3.01 per diluted share, compared to the nine months ended September 30, 2021 net income of $35.6 million, or $3.57 per diluted share, resulting in a decrease in net income of $6.4 million, or 18.1%, and a decrease in diluted earnings per share of $0.56, or 15.7%.

The $3.7 million decrease in net income for the third quarter 2022 compared to the third quarter 2021 was due primarily to a decrease of $3.5 million, or 44.8%, in noninterest income, an increase of $3.5 million, or 24.5%, in noninterest expense and an increase of $0.9 million, in provision for loan losses, partially offset by an increase of $3.1 million, or 14.7%, in net interest income, and a decrease of $1.2 million, or 55.5%, in income tax expense.

The $6.4 million decrease in net income for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021 was due primarily to an increase of $9.9 million, or 22.1% in noninterest expense, a decrease of $9.7 million, or 38.6%, in noninterest income and an increase of $1.6 million, or 126.2%, in provision for loan losses, partially offset by an increase of $12.4 million, or 19.6%, in net interest income and a decrease of $2.4 million, or 37.2%, in income tax expense.

During the third quarter 2022, return on average assets (“ROAA”), return on average shareholders’ equity (“ROAE”), and return on average tangible common equity (“ROATCE”) were 0.82%, 9.01%, and 9.13%, respectively, compared to 1.12%, 13.10%, and 13.27%, respectively, for the third quarter 2021. During the nine months ended September 30, 2022, ROAA, ROAE and ROATCE were 0.94%, 10.40%, and 10.53%, respectively, compared to 1.13%, 13.54%, and 13.73%, respectively, for the nine months ended September 30, 2021.

During the third quarter 2022, the Company had a $0.1 million write-down of software. Excluding this item, adjusted net income for the third quarter 2022 was $8.5 million and adjusted diluted earnings per share was $0.90. Additionally, for the third quarter 2022, adjusted ROAA, adjusted ROAE and adjusted ROATCE were 0.83%, 9.12% and 9.24%, respectively.

During the third quarter 2021, the Company fully redeemed its $25.0 million aggregate principal amount of 6.0%

fixed-to-floating rate subordinated notes due in 2026 and recognized $0.8 million of pre-tax costs related to this redemption.

Excluding this item, adjusted net income for the third quarter 2021 was $12.7 million and adjusted diluted earnings per share

was $1.27. Additionally, for the third quarter 2021, adjusted ROAA, adjusted ROAE and adjusted ROATCE were 1.18%, 13.79% and 13.97%, respectively.

During the nine months ended September 30, 2022, the Company recognized a nonrecurring consulting fee associated with a special project of $0.9 million, paid a $0.5 million discretionary inflation bonus to certain employees, recognized accelerated equity compensation expense of $0.3 million related to several retirements, incurred acquisition-related expenses of $0.3 million and expensed a write-down of software of $0.1 million. Excluding these items, adjusted net income for the nine months ended September 30, 2022 was $30.8 million and adjusted diluted earnings per share was $3.17. Additionally, for the nine months ended September 30, 2022, adjusted ROAA, adjusted ROAE and adjusted ROATCE were 0.99%, 11.00% and 11.13%, respectively.

During the nine months ended September 30, 2021, the Company recognized a $2.5 million pre-tax gain on sale of its corporate headquarters and recognized $0.8 million of pre-tax costs related to the redemption of its $25.0 million aggregate principal amount of 6.0% fixed-to-floating rate subordinated notes due in 2026. Excluding these items, adjusted net income for the nine months ended September 30, 2021 was $34.3 million, or $3.44 per diluted share. Additionally, for the nine months ended September 30, 2021, adjusted ROAA, adjusted ROAE and adjusted ROATCE were 1.09%, 13.03% and 13.21%, respectively.

Refer to the “Reconciliation of Non-GAAP Financial Measures” section of Part I, Item 2 of this report, Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information.

44

Consolidated Average Balance Sheets and Net Interest Income Analyses

For the periods presented, the following tables provide the average balances of interest-earning assets and interest-bearing liabilities and the related yields and cost of funds. The tables do not reflect any effect of income taxes except for net interest margin - FTE, as discussed below. Balances are based on the average of daily balances. Nonaccrual loans are included in average loan balances.

	Three Months Ended
	September 30, 2022						June 30, 2022						September 30, 2021
(in thousands)	Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost
Assets
Interest-earning assets
Loans, including loans held-for-sale	$	3,175,854	$	34,643	4.33	%	$	3,019,891	$	32,415	4.31	%	$	2,956,333	$	30,126	4.04	%
Securities - taxable	532,470		2,701		2.01	%	543,422		2,567		1.89	%	629,101		2,297		1.45	%
Securities - non-taxable	73,859		491		2.64	%	76,974		328		1.71	%	84,241		241		1.14	%
Other earning assets	188,467		1,264		2.66	%	322,302		796		0.99	%	479,051		370		0.31	%
Total interest-earning assets	3,970,650		39,099		3.91	%	3,962,589		36,106		3.65	%	4,148,726		33,034		3.16	%
Allowance for loan losses	(29,423)						(28,599)						(28,127)
Noninterest-earning assets	164,461						163,875						144,590
Total assets	$	4,105,688					$	4,097,865					$	4,265,189
Liabilities
Interest-bearing liabilities
Interest-bearing demand deposits	$	342,116	$	551	0.64	%	$	348,274	$	466	0.54	%	$	198,637	$	150	0.30	%
Savings accounts	57,700		111		0.76	%	66,657		68		0.41	%	62,195		56		0.36	%
Money market accounts	1,369,783		4,581		1.33	%	1,427,665		1,921		0.54	%	1,498,218		1,532		0.41	%
BaaS - brokered deposits	153,936		859		2.21	%	71,234		154		0.87	%	—		—		0.00	%
Certificates and brokered deposits	1,037,792		4,418		1.69	%	1,104,592		3,799		1.38	%	1,378,678		5,352		1.54	%
Total interest-bearing deposits	2,961,327		10,520		1.41	%	3,018,422		6,408		0.85	%	3,137,728		7,090		0.90	%
Other borrowed funds	637,877		4,585		2.85	%	583,553		4,018		2.76	%	611,975		5,025		3.26	%
Total interest-bearing liabilities	3,599,204		15,105		1.67	%	3,601,975		10,426		1.16	%	3,749,703		12,115		1.28	%
Noninterest-bearing deposits	124,067						108,980						104,161
Other noninterest-bearing liabilities	11,114						12,636						45,138
Total liabilities	3,734,385						3,723,591						3,899,002
Shareholders’ equity	371,303						374,274						366,187
Total liabilities and shareholders’ equity	$	4,105,688					$	4,097,865					$	4,265,189
Net interest income			$	23,994					$	25,680					$	20,919
Interest rate spread 1					2.24%						2.49%						1.88	%
Net interest margin 2					2.40%						2.60%						2.00	%
Net interest margin - FTE 3					2.53%						2.74%						2.13	%

1 Yield on total interest-earning assets minus cost of total interest-bearing liabilities.

2 Net interest income divided by total average interest-earning assets (annualized).

3 On an FTE basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes. This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets. The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons. Net interest margin - FTE represents a non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this measure to its most directly comparable GAAP measure.

45

	Nine Months Ended
	September 30, 2022						September 30, 2021
(in thousands)	Average Balance		Interest /Dividends		Yield /Cost		Average Balance		Interest /Dividends		Yield /Cost
Assets
Interest-earning assets
Loans, including loans held-for-sale	$	3,057,768	$	100,246	4.38	%	$	3,016,817	$	91,846	4.07	%
Securities - taxable	547,759		7,489		1.83	%	527,625		5,997		1.52	%
Securities - non-taxable	77,236		1,068		1.85	%	85,130		781		1.23	%
Other earning assets	321,262		2,436		1.01	%	478,399		1,067		0.30	%
Total interest-earning assets	4,004,025		111,239		3.71	%	4,107,971		99,691		3.24	%
Allowance for loan losses	(28,671)						(29,446)
Noninterest-earning assets	163,512						136,954
Total assets	$	4,138,866					$	4,215,479
Liabilities
Interest-bearing liabilities
Interest-bearing demand deposits	$	336,311	$	1,429	0.57	%	$	190,785	$	425	0.30	%
Savings accounts	61,647		232		0.50	%	$	54,740	145		0.35	%
Money market accounts	1,416,984		8,006		0.76	%	1,428,554		4,385		0.41	%
BaaS - brokered deposits	79,613		1,019		1.71	%	—		—		0.00	%
Certificates and brokered deposits	1,122,097		12,339		1.47	%	1,446,960		18,468		1.71	%
Total interest-bearing deposits	3,016,652		23,025		1.02	%	3,121,039		23,423		1.00	%
Other borrowed funds	613,609		12,790		2.79	%	593,605		13,217		2.98	%
Total interest-bearing liabilities	3,630,261		35,815		1.32	%	3,714,644		36,640		1.32	%
Noninterest-bearing deposits	115,142						97,760
Other noninterest-bearing liabilities	18,273						51,281
Total liabilities	3,763,676						3,863,685
Shareholders’ equity	375,190						351,794
Total liabilities and shareholders’ equity	$	4,138,866					$	4,215,479
Net interest income			$	75,424					$	63,051
Interest rate spread 1					2.39%						1.92%
Net interest margin 2					2.52%						2.05%
Net interest margin - FTE 3					2.65%						2.19%

1 Yield on total interest-earning assets minus cost of total interest-bearing liabilities.

2 Net interest income divided by total average interest-earning assets (annualized).

3 On an FTE basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes. This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets. The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons. Net interest margin - FTE represents a non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of this measure to its most directly comparable GAAP measure.

46

Rate/Volume Analysis 

The following table illustrates the impact of changes in the volume of interest-earning assets and interest-bearing liabilities and interest rates on net interest income for the periods indicated. The change in interest not due solely to volume or rate has been allocated in proportion to the absolute dollar amounts of the change in each. 

	Three Months Ended September 30, 2022 vs. June 30, 2022 Due to Changes in						Three Months Ended September 30, 2022 vs. September 30, 2021 Due to Changes in						Nine Months Ended September 30, 2022 vs. September 30, 2021 Due to Changes in
(in thousands)	Volume		Rate		Net		Volume		Rate		Net		Volume		Rate		Net
Interest income
Loans, including loans held-for-sale	$	2,044	$	184	$	2,228	$	2,297	$	2,220	$	4,517	$	1,271	$	7,129	$	8,400
Securities – taxable	(282)		416		134		(1,890)		2,294		404		235		1,257		1,492
Securities – non-taxable	(87)		250		163		(195)		445		250		(119)		406		287
Other earning assets	(2,034)		2,502		468		(1,602)		2,496		894		(661)		2,030		1,369
Total	(359)		3,352		2,993		(1,390)		7,455		6,065		726		10,822		11,548
Interest expense
Interest-bearing deposits	(828)		4,940		4,112		(2,580)		6,010		3,430		(1,030)		632		(398)
Other borrowed funds	420		147		567		1,152		(1,592)		(440)		632		(1,059)		(427)
Total	(408)		5,087		4,679		(1,428)		4,418		2,990		(398)		(427)		(825)
Increase (decrease) in net interest income	$	49	$	(1,735)	$	(1,686)	$	38	$	3,037	$	3,075	$	1,124	$	11,249	$	12,373

Net interest income for the third quarter 2022 was $24.0 million, an increase of $3.1 million, or 14.7%, compared to $20.9 million for the third quarter 2021. The increase in net interest income was the result of a $6.1 million, or 18.4% increase in total interest income to $39.1 million for the third quarter 2022 from $33.0 million for the third quarter 2021, partially offset by a $3.0 million, or 24.7%, increase in total interest expense to $15.1 million for the third quarter 2022 from $12.1 million for the third quarter 2021.

Net interest income for the nine months ended September 30, 2022 was $75.4 million, an increase of $12.4 million, or 19.6%, compared to $63.1 million for the nine months ended September 30, 2021. The increase in net interest income was the result of an $11.5 million, or 11.6%, increase in total interest income to $111.2 million for the nine months ended September 30, 2022 from $99.7 million for the nine months ended September 30, 2021, as well as a $0.8 million, or 2.3%, decrease in total interest expense to $35.8 million for the nine months ended September 30, 2022 from $36.6 million for the nine months ended September 30, 2021.

The increase in total interest income for the third quarter 2022 compared to third quarter 2021 was due primarily to a $4.5 million, or 15.0%, increase in interest earned on loans, $0.9 million, or 241.6%, increase in income from other earning assets and a $0.7 million, or 25.8%, increase in interest earned on securities. The increase in income from loans was due primarily to a 29 bp increase in the yield earned on loans, as well as an increase of $219.5 million, or 7.4%, in the average balance of loans compared to the third quarter 2021. The yield earned on other earning assets increased 235 bps, partially offset by a decrease in the average balance of other earning assets of $290.6 million, or 60.7%. The decrease in the average balance of other earning assets was due primarily to lower cash balances. The average balance of securities decreased $107.0 million, or 15.0%, while the yield earned on the securities portfolio increased 68 bps for the third quarter 2022 compared to the third quarter 2021. The increase in the yields earned on loans, other earning assets and securities was due to the rise in interest rates throughout 2022.

47

The increase in total interest income for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021 was due primarily to an $8.4 million, or 9.2%, increase in interest earned on loans, a $1.8 million, or 26.3%, increase in interest earned on securities and a $1.4 million, or 128.3%, increase in income from other earning assets. The increase in income from loans was due primarily to a 31 bp increase in the yield earned on loans, as well as a $41.0 million, or 1.4%, increase in the average balance of loans. The average balance of securities increased $12.2 million, or 2.0%, and the yield earned on the securities portfolio increased 35 bps for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. In addition, the yield earned on other earning assets increased 71 bps, but was partially offset by a decrease in the average balance of other earning assets of $157.1 million, or 32.9%. The decrease in the average balance of other earning assets was due primarily to lower cash balances. The increase in the yields earned on loans, securities and other earning assets was due to the rise in interest rates throughout 2022.

The increase in total interest expense for the third quarter 2022 compared to the third quarter 2021 was due primarily to an increase of $3.0 million, or 199.0%, in interest expense associated with money market accounts and a $0.4 million, or 267.3%, increase in interest expense associated with interest-bearing demand deposits, partially offset by a $0.9 million, or 17.5%, decrease in interest expense related to certificates and brokered deposits. Additionally, the Company added Banking-as-a-Service (“BaaS”) deposits in 2022, which increased interest expense by $0.9 million. The increase in interest expense related to money market accounts was driven primarily by an increase of 92 bps in the cost of these deposits, partially offset by a decrease in the average balance of these deposits of $128.4 million, or 8.6%. The increase in interest expense related to interest-bearing demand deposits was due primarily to approximately $100.0 million in deposits with a contractual term of five years and a fixed rate of 1.15% pursuant to a new customer relationship in 2022. Interest expense on certificates and brokered deposits decreased due to a $340.9 million, or 24.7%, decrease in the average balance of these deposits, partially offset by an increase of 15 bps in the cost of these deposits. The decrease in certificates and brokered deposit balances was driven by the Company’s pricing strategy to reduce the level of these higher cost deposits. The increase in the cost of money market accounts and certificates and brokered deposits, as well as the cost of BaaS deposits, was due to the rise in interest rates throughout 2022.

The decrease in total interest expense for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021 was driven primarily by a $6.1 million, or 33.2%, decrease in interest expense related to certificates and brokered deposits, partially offset by a $3.6 million, or 82.6%, increase in interest expense associated with money market accounts and a $1.0 million, or 236.2%, increase in interest expense associated with interest-bearing demand deposits. Additionally, the Company added BaaS deposits in 2022, which increased interest expense by $1.0 million. Interest expense on certificates and brokered deposits decreased due to a decline of 24 bps in the cost of these deposits, as well as a $324.9 million, or 22.5%, decrease in average balance of these deposits. The decrease in certificates and brokered deposit balances was driven by the Company’s pricing strategy to reduce the level of these higher cost deposits. The increase in interest expense related to money market accounts was driven primarily by an increase of 35 bps in the cost of these deposits, partially offset by a decrease in the average balance of these deposits of $11.6 million, or 0.8%. The increase in interest expense related to interest-bearing demand deposits was due primarily to approximately $100.0 million in deposits with a contractual term of five years and a fixed rate of 1.15% pursuant to a new customer relationship in 2022. The increase in the cost of money market accounts, as well as the cost of BaaS deposits, reflects the increase in interest rates throughout 2022

Overall, the cost of total interest-bearing liabilities for the third quarter 2022 increased 39 bps to 1.67% from 1.28% for the third quarter 2021. The cost of total interest-bearing liabilities for the nine months ended September 30, 2022 remained flat with the nine months ended September 30, 2021 at 1.32%. The increase in the cost of funds for the third quarter 2022 reflects the rapid rise in interest rates throughout 2022.

Net interest margin (“NIM”) was 2.40% for the third quarter 2022 compared to 2.00% for the third quarter 2021, an increase of 40 bps. On a fully-taxable equivalent (“FTE”) basis, NIM was 2.53% for the third quarter 2022 compared to 2.13% for the third quarter 2021, an increase of 40 bps. The increase in third quarter 2022 NIM and FTE NIM compared to the third quarter 2021 reflects the increase in earning asset yields noted above, partially offset by the increase in the cost of interest-bearing liabilities.

NIM was 2.52% for the nine months ended September 30, 2022 compared to 2.05% for the nine months ended September 30, 2021, an increase of 47 bps. On a fully-taxable equivalent basis, NIM was 2.65% for the nine months ended September 30, 2022, compared to 2.19% for the nine months ended September 30, 2021, an increase of 46 bps. The increase in NIM for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021 reflects the increase in earning asset yields noted above, as the cost of interest-bearing liabilities remained stable.

48

Noninterest Income

The following table presents noninterest income for the last five completed fiscal quarters and the nine months ended September 30, 2022 and 2021.

	Three Months Ended										Nine Months Ended
(in thousands)	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021		September 30, 2022		September 30, 2021
Service charges and fees	$	248	$	281	$	316	$	292	$	276	$	845	$	822
Loan servicing revenue	653		620		585		544		511		1,858		1,390
Loan servicing asset revaluation	(333)		(470)		(297)		(400)		(274)		(1,100)		(669)
Mortgage banking activities	871		1,710		1,873		2,776		3,850		4,454		12,274
Gain on sale of loans	2,713		1,952		3,845		4,137		2,719		8,510		7,461
Gain on sale of premises and equipment	—		—		—		—		—		—		2,523
Other	164		221		498		345		731		883		1,349
Total noninterest income	$	4,316	$	4,314	$	6,820	$	7,694	$	7,813	$	15,450	$	25,150

During the third quarter 2022, noninterest income was $4.3 million, representing a decrease of $3.5 million, or 44.8%, compared to $7.8 million for the third quarter 2021. The decrease in noninterest income was due primarily to a decrease in revenue from mortgage banking activities and a decrease in other noninterest income, partially offset by an increase in loan servicing revenue. The decline in mortgage banking revenue was due primarily to decreases in interest rate locks, sold loan volumes and gain-on-sale margins driven by the increase in interest rates throughout 2022. The decrease in other noninterest income is due primarily to a distribution from the Company’s investment in a Small Business Investment Company fund that occurred during the three months ended September 30, 2021. The increase in loan servicing revenue was due to growth in the balance of the Company’s SBA 7(a) servicing portfolio.

During the nine months ended September 30, 2022, noninterest income was $15.5 million, representing a decrease of $9.7 million, or 38.6%, compared to $25.2 million for the nine months ended September 30, 2021. The decrease in noninterest income was due primarily to a decrease in revenue from mortgage banking activities and a decrease of $2.5 million from the gain on sale of premises and equipment resulting from the sale of the Company’s former headquarters that occurred in the second quarter 2021, partially offset by a $1.0 million, or 14.1%, increase in gain on sale of loans. The decrease in mortgage banking activities was due mainly to decreases in interest rate locks, sold loan volumes and gain-on-sale margins driven by the increase in interest rates throughout 2022. The increase in gain on sale of loans was due to an increase in the volume of U.S. SBA 7(a) guaranteed loan sales, as well as a gain on the sale of $14.4 million of single tenant lease financing loans in 2022.

Noninterest Expense

The following table presents noninterest expense for the last five completed fiscal quarters and the nine months ended September 30, 2022 and 2021.

	Three Months Ended										Nine Months Ended
(in thousands)	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021		September 30, 2022		September 30, 2021
Salaries and employee benefits	$	10,439	$	10,832	$	9,878	$	10,183	$	9,316	$	31,149	$	28,040
Marketing, advertising and promotion	1,041		920		756		896		813		2,717		2,365
Consulting and professional services	790		1,197		1,925		1,262		728		3,912		2,792
Data processing	483		490		449		425		380		1,422		1,224
Loan expenses	1,142		693		1,582		654		383		3,417		1,458
Premises and equipment	2,808		2,419		2,540		2,188		1,687		7,767		4,875
Deposit insurance premium	229		287		281		283		230		797		930
Other	1,063		1,147		1,369		1,064		914		3,579		3,159
Total noninterest expense	$	17,995	$	17,985	$	18,780	$	16,955	$	14,451	$	54,760	$	44,843

49

Noninterest expense for the third quarter 2022 was $18.0 million, compared to $14.5 million for the third quarter 2021. The increase of $3.5 million, or 24.5%, was due primarily to increases of $1.1 million, or 12.1%, in salaries and employee benefits, $1.1 million, or 2.9%, in premises and equipment, and $0.8 million, or 2.0%, in loan expenses. The higher salaries and employee benefits expense was due mainly to an increase in headcount as well as an increase in medical claims expense.The increase in premises and equipment was primarily related to costs associated with the Company’s new corporate headquarters, as well as investments in technology, software maintenance and a write-down of software. The increase in loan expenses was due mainly to servicing fees related to the growth in franchise finance loans.

Noninterest expense for the nine months ended September 30, 2022 was $54.8 million, compared to $44.8 million for the nine months ended September 30, 2021. The increase of $9.9 million, or 22.1%, was due primarily to increases of $3.1 million in salaries and employee benefits, $2.9 million in premises and equipment, $2.0 million in loan expenses and $1.1 million in consulting and professional fees. The higher salaries and employee benefits expense was due primarily to an increase in headcount, higher medical claims expense, a $0.5 million discretionary inflation bonus paid to certain employees and $0.3 million of accelerated equity compensation related to employees who retired during the year. The increase in premises and equipment was due mainly to costs associated with the Company’s new corporate headquarters, as well as investments in technology, software maintenance and a write-down of software. The increase in loan expenses was due primarily to servicing fees related to tax refund advance loans and franchise finance loans. The increase in consulting and professional fees was due primarily to a $0.9 million consulting fee associated with a special project.

Income tax provision was $1.0 million for the third quarter 2022, resulting in an effective tax rate of 10.5%, compared to a tax provision of $2.2 million for the third quarter 2021 and an effective tax rate of 15.5%. Income tax provision was $4.1 million for the nine months ended September 30, 2022, resulting in an effective tax rate of 12.2%, compared to an income tax provision of $6.5 million, or an effective tax rate of 15.3%, for the nine months ended September 30, 2021. The lower income tax provision and effective tax rate during the three and nine months ended September 30, 2022 is the result of the decline in noninterest income, resulting in a higher proportion of tax exempt income to total pre-tax income.

Financial Condition

The following table presents summary balance sheet data for the last five completed fiscal quarters.

(in thousands)
Balance Sheet Data:	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021
Total assets	$	4,264,424	$	4,099,806	$	4,225,397	$	4,210,994	$	4,252,292
Loans	3,255,906		3,082,127		2,880,780		2,887,662		2,936,148
Total securities	584,622		610,602		628,658		662,609		696,136
Loans held-for-sale	23,103		31,580		33,991		47,745		43,970
Noninterest-bearing deposits	142,875		126,153		119,196		117,531		110,117
Interest-bearing deposits	3,049,769		3,025,948		3,098,783		3,061,428		3,114,478
Total deposits	3,192,644		3,152,101		3,217,979		3,178,959		3,224,595
Advances from Federal Home Loan Bank	589,926		464,925		514,923		514,922		514,920
Total shareholders’ equity	360,857		365,332		374,655		380,338		370,442

Total assets increased $53.4 million, or 1.3%, to $4.3 billion at September 30, 2022 compared to $4.2 billion at December 31, 2021. The increase was due primarily to increases in loan balances, partially offset by decreases in total securities balances and cash balances.

As of September 30, 2022, total shareholders’ equity was $360.9 million, a decrease of $19.5 million, or 5.1%, compared to December 31, 2021, due primarily to stock repurchase activity and an increase in accumulated other comprehensive loss resulting from a decline in the value of the available-for-sale securities portfolio caused by the continued rise in interest rates during the year. This was partially offset by the net income earned during the year and an increase in the value of interest rate swaps classified as cash flow hedges. Tangible common equity totaled $356.2 million as of September 30, 2022, representing a decrease of $19.5 million, or 5.2%, compared to December 31, 2021. The ratio of total shareholders’ equity to total assets decreased to 8.46% as of September 30, 2022 from 9.03% as of December 31, 2021, and the ratio of tangible common equity to tangible assets decreased to 8.36% as of September 30, 2022 from 8.93% as of December 31, 2021.

Book value per common share decreased 0.4% to $38.84 as of September 30, 2022 from $38.99 as of December 31, 2021. Tangible book value per share decreased 0.4% to $38.34 as of September 30, 2022 from $38.51 as of December 31, 2021. The slight decline in both book value per common share and tangible book value per share reflects the declines in total

50

shareholders’ equity and tangible common equity, mostly offset by shares repurchased throughout the year. Refer to the “Reconciliation of Non-GAAP Financial Measures” section of Part I, Item 2 of this report, Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information.

Loan Portfolio Analysis

    The following table presents a summary of the Company’s loan portfolio for the last five completed fiscal quarters.

(dollars in thousands)	September 30, 2022				June 30, 2022				March 31, 2022				December 31, 2021				September 30, 2021
Commercial loans
Commercial and industrial	$	104,780	3.2	%	$	110,540	3.6	%	$	99,808	3.5	%	$	96,008	3.3	%	$	107,142	3.6	%
Owner-occupied commercial real estate	58,615		1.8	%	61,277		2.0	%	56,752		2.0	%	66,732		2.3	%	84,819		2.9	%
Investor commercial real estate	91,021		2.8	%	52,648		1.7	%	34,627		1.2	%	28,019		1.0	%	28,505		1.0	%
Construction	139,509		4.3	%	143,475		4.7	%	149,662		5.2	%	136,619		4.7	%	115,414		3.9	%
Single tenant lease financing	895,302		27.4	%	867,181		28.1	%	852,519		29.6	%	865,854		30.0	%	921,998		31.5	%
Public finance	614,139		18.9	%	613,759		19.9	%	587,817		20.4	%	592,665		20.5	%	601,738		20.5	%
Healthcare finance	293,686		9.0	%	317,180		10.3	%	354,574		12.3	%	387,852		13.4	%	417,388		14.2	%
Small business lending	113,001		3.5	%	102,724		3.3	%	97,040		3.4	%	108,666		3.8	%	102,889		3.5	%
Franchise finance	225,012		6.8	%	168,942		5.5	%	107,246		3.7	%	81,448		2.8	%	25,598		0.9	%
Total commercial loans	2,535,065		77.7	%	2,437,726		79.1	%	2,340,045		81.3	%	2,363,863		81.8	%	2,405,491		82.0	%
Consumer loans
Residential mortgage	337,565		10.4	%	281,124		9.1	%	191,153		6.6	%	186,770		6.5	%	188,750		6.4	%
Home equity	22,114		0.7	%	19,928		0.6	%	18,100		0.6	%	17,665		0.6	%	17,960		0.6	%
Other consumer	312,512		9.7	%	292,955		9.6	%	270,330		9.4	%	265,478		9.2	%	268,396		9.1	%
Tax refund advance loans	—		0.0	%	—		0.0	%	9,177		0.3	%	—		0.0	%	—		0.0	%
Total consumer loans	672,191		20.8	%	594,007		19.3	%	488,760		16.9	%	469,913		16.3	%	475,106		16.1	%
Net deferred loan origination costs, premiums and discounts on purchased loans and other (1)	48,650		1.5	%	50,394		1.6	%	51,975		1.8	%	53,886		1.9	%	55,551		1.9	%
Total loans	3,255,906		100.0	%	3,082,127		100.0	%	2,880,780		100.0	%	2,887,662		100.0	%	2,936,148		100.0	%
Allowance for loan losses	(29,866)				(29,153)				(28,251)				(27,841)				(28,000)
Net loans	$	3,226,040			$	3,052,974			$	2,852,529			$	2,859,821			$	2,908,148

(1) Includes carrying value adjustments of $33.9 million, $35.4 million, $36.4 million, $37.5 million and $38.9 million related to terminated interest rate swaps associated with public finance loans as of September 30, 2022, June 30, 2022, March 31, 2022, December 31, 2021, and September 30, 2021, respectively. 

Total loans were $3.3 billion as of September 30, 2022, an increase of $368.2 million, or 12.8%, compared to December 31, 2021. Total commercial loan balances were $2.5 billion as of September 30, 2022, up $171.2 million, or 7.2%, from December 31, 2021. Total consumer loan balances were $672.2 million as of September 30, 2022, an increase of $202.3 million, or 43.1%, compared to December 31, 2021. Compared to December 31, 2021, the increase in commercial loan balances was driven by growth in franchise finance, investor commercial real estate, single tenant lease financing, public finance, commercial and industrial and small business lending. The increase was partially offset by net payoffs in healthcare finance and owner-occupied commercial real estate loans. The increase in consumer loans was due to higher balances in the residential mortgage, home equity, trailers, recreational vehicles and other consumer loan portfolios.

Franchise finance was established in July 2021 in partnership with ApplePie Capital, a leading provider of growth financing to franchisees in various industry segments across the country. Through this relationship, we have funded $234.1 million in total originations since inception.

51

Asset Quality

Nonperforming loans are comprised of nonaccrual loans and loans 90 days past due and accruing. Nonperforming assets include nonperforming loans, other real estate owned and other nonperforming assets, which consist of repossessed assets. The following table provides a summary of the Company’s nonperforming assets for the last five completed fiscal quarters.

(dollars in thousands)	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021
Nonaccrual loans
Commercial loans:
Commercial and industrial	$	350		$	350		$	610		$	674		$	678
Owner-occupied commercial real estate	1,622			1,661			3,267			3,419			3,429
Single tenant lease financing	—			—			1,092			1,100			1,100
Small business lending (1)	2,958			1,297			881			959			1,351
Total commercial loans	4,930			3,308			5,850			6,152			6,558
Consumer loans:
Residential mortgage	1,073			1,201			1,207			1,226			1,253
Home equity	—			14			14			14			14
Other consumer	3			4			13			9			26
Total consumer loans	1,076			1,219			1,234			1,249			1,293
Total nonaccrual loans	6,006			4,527			7,084			7,401			7,851
Past Due 90 days and accruing loans
Total past due 90 days and accruing loans	—			—			—			—			—
Total nonperforming loans	6,006			4,527			7,084			7,401			7,851
Other real estate owned
Single tenant lease financing	—			—			—			1,188			1,188
Residential mortgage	—			—			—			—			—
Total other real estate owned	—			—			—			1,188			1,188
Other nonperforming assets	—			23			1			29			—
Total nonperforming assets	$	6,006		$	4,550		$	7,085		$	8,618		$	9,039
Total nonperforming loans to total loans(2)	0.18		%	0.15		%	0.25		%	0.26		%	0.27		%
Total nonperforming assets to total assets(2)	0.14		%	0.11		%	0.17		%	0.20		%	0.21		%
Allowance for loan losses to total loans	0.92		%	0.95		%	0.98		%	0.96		%	0.95		%
Nonaccrual loans to total loans	0.18		%	0.15		%	0.25		%	0.26		%	0.27		%
Allowance for loan losses to nonperforming loans(2)	497.3		%	644.0		%	398.8		%	376.2		%	356.6		%

1 Balance of loans are partially guaranteed by the U.S. government.

2 Includes the impact of nonperforming small business lending loans, which are guaranteed by the U.S. government.

Total nonperforming loans declined $1.4 million, or 18.9%, to $6.0 million as of September 30, 2022 compared to $7.4 million as of December 31, 2021 due primarily to upgrades and payoffs in the owner-occupied commercial real estate and commercial and industrial loan portfolios, partially offset by SBA loans placed on nonaccrual during 2022. Total nonperforming assets declined $2.6 million, or 30.3%, as of September 30, 2022, compared to December 31, 2021, due primarily to the upgrades and payoffs discussed above, as well as the decline in other real estate owned (“OREO”) discussed below.

52

Troubled Debt Restructurings

The following table provides a summary of troubled debt restructurings for the last five completed fiscal quarters.

(in thousands)	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021
Troubled debt restructurings – nonaccrual	$	2,342	$	2,389	$	2,440	$	2,492	$	2,550
Troubled debt restructurings – performing	2,410		2,425		2,418		1,693		843
Total troubled debt restructurings	$	4,752	$	4,814	$	4,858	$	4,185	$	3,393

Total TDRs as of September 30, 2022 were $4.8 million, up $0.6 million from December 31, 2021. The increase was driven by one residential mortgage loan that became a TDR in 2022.

     As of September 30, 2022, the Company did not own any OREO. As of December 31, 2021, the Company had one single tenant lease financing property in OREO with a carrying value of $1.2 million. During the first quarter 2022, the Company reached a settlement agreement with the guarantor, which resulted in the Company recovering $1.2 million in excess of the carrying value of OREO.

Non-TDR Loan Modifications due to COVID-19

    The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

    Additionally, Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief were in effect from the period beginning March 1, 2020 until January 1, 2022.

    In accordance with this guidance, the Company offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments.     As of September 30, 2022, the Company had no loans as non-TDR loan modifications due to COVID-19.

U.S. Small Business Administration Paycheck Protection Program

Section 1102 of the CARES Act created the PPP, which is jointly administered by the SBA and the Department of the Treasury. The PPP is designed to provide a direct incentive to small businesses to retain employees on their payroll during COVID-19 as well as to help cover certain utility costs and rent payments. These loans may be forgiven if certain conditions are satisfied and are fully guaranteed by the SBA. In 2020, as a preferred SBA lender, we assisted our clients in participating in the PPP to help them maintain their workforce in an uncertain and challenging environment. The loans originated in 2020 bear an interest rate of 1.00%, and we received gross origination fees of approximately $2.3 million. The Company received this fee revenue from the SBA in late June 2020, and it was deferred over the life of the PPP loans and recognized as interest income. The Company began processing applications for forgiveness from this round beginning in December 2020 and 100% of loan balances had been forgiven as of December 31, 2021.

On December 27, 2020, $285 billion in additional funding was allocated to the PPP through the passage of the Economic Aid to Hard-Hit Small Businesses, Nonprofits, and Venues Act. The Company began offering PPP loans again in 2021 and continued until the program’s funds were depleted. These loans may be forgiven if certain conditions are satisfied and are fully guaranteed by the SBA. The loans originated during 2021 bear an interest rate of 1.00% and the Company received gross origination fees of approximately $1.3 million. The Company received this fee revenue from the SBA during 2021, and it was deferred over the life of the PPP loans and recognized as interest income. The Company began processing applications for forgiveness from this round beginning in May 2021 and 100% of loan balances had been forgiven as of September 30, 2022.

53

The following table provides a rollforward of the activity of PPP loans through September 30, 2022.

(in thousands, except Number of Loans)	Number of Loans	Principal Balance		Net Deferred Fees
Originated	447	$	58,336	$	1,851
Principal repaid	(71)	(7,184)
Net deferred fees recognized				(1,253)
Balance, December 31, 2020	376	51,152		598
Originated	281	27,377		1,125
Principal repaid	(634)	(75,377)
Net deferred fees recognized				(1,624)
Balance, December 31, 2021	23	3,152		99
Originated	—	—		—
Principal repaid	(18)	(2,149)
Net deferred fees recognized				(75)
Balance, March 31, 2022	5	$	1,003	$	24
Originated	—	—		—
Principal repaid	(3)	(809)
Net deferred fees recognized				(19)
Balance, June 30, 2022	2	$	194	$	5
Originated	—	—		—
Principal repaid	(2)	(194)
Net deferred fees recognized				(5)
Balance, September 30, 2022	—	$	—	$	—

54

Allowance for Loan Losses 

The following table provides a rollforward of the allowance for loan losses for the last five completed fiscal quarters and the nine months ended September 30, 2022 and 2021.

	Three Months Ended															Nine Months Ended
(in thousands)	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021			September 30, 2022			September 30, 2021
Balance, beginning of period	$	29,153		$	28,251		$	27,841		$	28,000		$	28,066		$	27,841		$	29,484
Provision (credit) charged to expense	892			1,185			791			(238)			(29)			2,868			1,268
Losses charged off
Commercial and industrial	—			—			—			—			—			—			28
Single tenant lease financing	—			—			—			—			—			—			2,391
Small business lending	130			—			80			—			10			210			222
Residential mortgage	—			—			—			—			—			—			6
Home equity	—			—			—			—			—			—			51
Other consumer	106			128			163			106			110			397			423
Tax refund advance loans	—			372			1,488			—			—			1,860			—
Total losses charged off	236			500			1,731			106			120			2,467			3,121
Recoveries
Commercial and industrial	2			—			—			3			2			2			85
Single tenant lease financing	—			—			1,231			—			—			1,231			—
Small business lending	3			2			17			48			26			22			32
Residential mortgage	1			1			1			51			3			3			12
Home equity	1			134			2			2			2			137			5
Other consumer	50			80			99			81			50			229			235
Total losses charged off	57			217			1,350			185			83			1,624			369
Balance, end of period	$	29,866		$	29,153		$	28,251		$	27,841		$	28,000		$	29,866		$	28,000
Net charge-offs (recoveries)	$	179		$	283		$	381		$	(79)		$	37		$	843		$	2,752
Net charge-offs (recoveries) to average loans (annualized)
Commercial and industrial	0.00		%	0.00		%	0.00		%	(0.01		%)	(0.01		%)	0.00		%	(0.10		%)
Single tenant lease financing	0.00		%	0.00		%	(0.58		%)	0.00		%	0.00		%	(0.19		%)	0.34		%
Small business lending	0.14		%	0.00		%	0.23		%	(0.17		%)	(0.05		%)	0.22		%	0.20		%
Total commercial net charge-offs (recoveries)	0.01		%	0.00		%	(0.20		%)	(0.01		%)	0.00		%	(0.06		%)	0.14		%
Residential mortgage	0.00		%	0.00		%	0.00		%	(0.11		%)	(0.01		%)	0.00		%	0.00		%
Home equity	(0.01		%)	(1.42		%)	(0.04		%)	(0.04		%)	(0.05		%)	(0.94		%)	0.34		%
Other consumer	0.20		%	0.30		%	0.40		%	0.28		%	0.24		%	0.30		%	0.32		%
Tax refund advance loans	0.00		%	23.55		%	9.97		%	0.00		%	0.00		%	11.84		%	0.00		%
Total consumer net charge-offs (recoveries)	0.01		%	0.11		%	1.18		%	(0.02		%)	0.05		%	0.44		%	0.06		%
Total net charge-offs (recoveries) to average loans	0.02		%	0.04		%	0.05		%	(0.01)		%	0.01		%	0.04		%	0.12		%
Total net (recoveries) charge-offs, excluding tax refund advance loans	0.02		%	(0.01		%)	(0.16		%)	(0.01)		%	0.01		%	(0.05)		%	0.12		%

55

    The allowance for loan losses was $29.9 million as of September 30, 2022, compared to $27.8 million as of December 31, 2021. The allowance for loan losses as a percentage of total loans, including and excluding PPP loans, was 0.92% at September 30, 2022, compared to 0.96%, or 0.97% when excluding PPP loans, at December 31, 2021. The allowance for loan losses as a percentage of nonperforming loans increased to 497.3% as of September 30, 2022, compared to 376.2% as of December 31, 2021.

Net charge-offs of $0.2 million were recognized during the third quarter 2022, resulting in net charge-offs to average loans of 0.02%, compared to net recoveries to average loans of 0.01% for the third quarter 2021.

The provision for loan losses in the third quarter 2022 was $0.9 million, compared to a $29 thousand credit for the third quarter 2021. The provision for the third quarter 2022 was driven primarily by growth in the loan portfolio, partially offset by reductions in specific reserves due to positive developments on certain monitored loans.

Investment Securities Portfolio

The following tables present the amortized cost and approximate fair value of our investment portfolio by security type for the last five completed fiscal quarters.   

(in thousands)
Amortized Cost	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021
Securities available-for-sale
U.S. Government-sponsored agencies	$	38,197	$	41,542	$	45,335	$	50,013	$	53,380
Municipal securities	71,156		71,264		72,420		75,158		76,528
Agency mortgage-backed securities - residential	259,568		265,196		276,392		377,928		398,504
Agency mortgage-backed securities - commercial	17,825		23,312		24,815		36,024		34,109
Private label mortgage-backed securities - residential	12,320		13,259		15,090		15,902		19,997
Asset-backed securities	5,000		5,000		5,000		5,000		5,000
Corporate securities	44,644		42,655		47,580		46,482		48,460
Total available-for-sale	448,710		462,228		486,632		606,507		635,978
Securities held-to-maturity
Municipal securities	13,957		13,969		13,981		13,992		14,538
Agency mortgage-backed securities - residential	123,718		117,749		95,982		—		—
Agency mortgage-backed securities - commercial	5,828		5,838		5,847		—		—
Corporate securities	47,554		47,557		47,560		45,573		47,591
Total held-to-maturity	191,057		185,113		163,370		59,565		62,129
Total securities	$	639,767	$	647,341	$	650,002	$	666,072	$	698,107

56

(in thousands)
Approximate Fair Value	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021
Securities available-for-sale
U.S. Government-sponsored agencies	$	36,329	$	40,003	$	43,847	$	49,040	$	52,455
Municipal securities	63,537		67,923		72,804		77,033		77,450
Agency mortgage-backed securities - residential	219,191		237,546		257,682		373,236		395,105
Agency mortgage-backed securities - commercial	16,522		22,207		24,156		36,326		34,780
Private label mortgage-backed securities - residential	11,041		12,479		14,818		16,021		20,235
Asset-backed securities	4,884		4,897		4,986		5,004		5,005
Corporate securities	42,061		40,434		46,995		46,384		48,977
Total available-for-sale	393,565		425,489		465,288		603,044		634,007
Securities held-to-maturity
Municipal securities	12,668		13,356		14,093		14,709		15,319
Agency mortgage-backed securities - residential	107,570		109,054		92,939		—		—
Agency mortgage-backed securities - commercial	4,686		5,048		5,420		—		—
Corporate securities	45,053		46,561		47,519		46,759		49,018
Total held-to-maturity	169,977		174,019		159,971		61,468		64,337
Total securities	$	563,542	$	599,508	$	625,259	$	664,512	$	698,344

The approximate fair value of available-for-sale investment securities decreased $209.5 million, or 34.7%, to $393.6 million as of September 30, 2022, compared to $603.0 million as of December 31, 2021. The decrease was due primarily to decreases of $154.0 million in agency mortgage-backed securities - residential, $19.8 million in agency mortgage-backed securities - commercial, $13.5 million in municipal securities, and $12.7 million in U.S. Government-sponsored agencies. The decrease in agency mortgage-backed securities - residential and agency mortgage-backed securities - commercial was due primarily to the transfer of $96.2 million of these securities from available-for-sale to held-to-maturity in the first quarter 2022, as well as a decline in fair value resulting from the continued rise in interest rates. The decreases in other securities types were also driven by a decline in value resulting from the continued rise in interest rates, as well as net paydown activity.

Accrued Income and Other Assets

    Accrued income and other assets decreased $3.4 million, or 7.2%, to $43.5 million at September 30, 2022 compared to $46.9 million at December 31, 2021. The decrease was primarily related to a decrease of $15.7 million in cash pledged as collateral and $7.7 million in deferred tax assets, partially offset by increases of $9.3 million in derivative assets, $8.6 million in income tax receivable, and $2.1 million in investment fund partnerships. As of September 30, 2022 the Company had no pledged cash collateral compared to $15.7 million, as of December 31, 2021. Cash collateral is pledged to counterparties on interest rate swap agreements as security for its obligations related to these agreements. Collateral posted and received is dependent on the fair value of the underlying agreements as of the respective date.

Accrued Expenses and Other Liabilities

    Accrued expenses and other liabilities decreased $15.9 million, or 52.0%, to $14.7 million at September 30, 2022, compared to $30.5 million at December 31, 2021. The decrease in accrued expenses and other liabilities was due primarily to decreases of $13.9 million, or 97.3%, in derivative liabilities and $3.9 million in accrued taxes, partially offset by increases of $1.8 million, or 0.3%, in other liabilities and $0.1 million in accrued salary and benefits.

57

Deposits  

The following table presents the composition of the Company’s deposit base for the last five completed fiscal quarters.

(dollars in thousands)	September 30, 2022				June 30, 2022				March 31, 2022				December 31, 2021				September 30, 2021
Noninterest-bearing deposits	$	142,635	4.5	%	$	126,153	4.0	%	$	119,197	3.7	%	$	117,531	3.7	%	$	110,117	3.4	%
Interest-bearing demand deposits	337,765		10.6	%	350,551		11.1	%	334,723		10.4	%	247,967		7.8	%	201,557		6.3	%
Savings accounts	52,228		1.6	%	65,365		2.1	%	66,320		2.1	%	59,998		1.9	%	66,762		2.1	%
Money market accounts	1,378,087		43.2	%	1,363,424		43.3	%	1,475,857		45.8	%	1,483,936		46.7	%	1,479,358		45.8	%
BaaS - brokered deposits	96,287		3.0	%	194,133		6.2	%	50,006		1.6	%	—		0.0	%	—		0.0	%
Certificates of deposits	773,040		24.2	%	800,598		25.3	%	889,789		27.6	%	970,107		30.5	%	1,043,898		32.4	%
Brokered deposits	412,602		12.9	%	251,877		8.0	%	282,087		8.8	%	299,420		9.4	%	322,903		10.0	%
Total deposits	$	3,192,644	100.0	%	$	3,152,101	100.0	%	$	3,217,979	100.0	%	$	3,178,959	100.0	%	$	3,224,595	100.0	%

Total deposits increased $13.7 million, or 0.4%, to $3.2 billion as of September 30, 2022, compared to $3.2 billion as of December 31, 2021. This increase was due primarily to increases of $113.2 million, or 37.8%, in brokered deposits, $96.3 million in BaaS - brokered deposits, $89.8 million, or 36.2%, in interest-bearing demand deposits and $25.1 million, or 21.4%, in noninterest-bearing deposits, partially offset by decreases of $197.1 million, or 20.3%, in certificates of deposits, $105.8 million, or 7.1% in money market accounts and $7.8 million, or 13.0%, in savings accounts. The increase in brokered deposits was due to accessing certain deposit channels during the third quarter 2022 to support balance sheet liquidity and manage interest rate risk. The increase in BaaS brokered deposits was due to a relationship established in the first quarter 2022. The increase in the balance of interest-bearing demand deposits was due primarily to a new customer relationship from the first quarter of 2022 with approximately $100.0 million in deposits with a contractual term of five years and a fixed rate of 1.15%. The decrease in the balance of certificates of deposits was due to the maturity of higher-cost balances and reduced pricing strategies designed to limit the volume of new production. The decrease in money market accounts was due primarily to certain customer activity that can be periodically volatile.

Recent Debt Offerings

    In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes initially bear a fixed interest rate of 3.75% per year to, but excluding, September 1, 2026, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 3.11%). The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 1, 2026. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. On December 30, 2021, the Company completed an exchange of $59.3 million principal amount of the unregistered 2031 Notes for registered 2031 Notes in satisfaction of its obligations under the registration rights agreement. Holders of $0.7 million of unregistered 2031 Notes did not participate in the exchange.

Regulatory Capital Requirements

The Company and the Bank are subject to various regulatory capital requirements administered by state and federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities, and certain off-balance-sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators about components, risk weighting and other factors.

The Basel III Capital Rules became effective for the Company and the Bank on January 1, 2015, subject to a phase-in period for certain provisions. Quantitative measures established by the Basel III Capital Rules to ensure capital adequacy require the maintenance of minimum amounts and ratios of Common Equity Tier 1 capital, Tier 1 capital and Total capital, as defined in the regulations, to risk-weighted assets, and of Tier 1 capital to adjusted quarterly average assets (“Leverage Ratio”).

58

The Basel III Capital Rules were fully phased in on January 1, 2019 and require the Company and the Bank to maintain: 1) a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 4.5%, plus a 2.5% “capital conservation buffer” (resulting in a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 7.0%); 2) a minimum ratio of Tier 1 capital to risk-weighted assets of 6.0%, plus the capital conservation buffer (resulting in a minimum Tier 1 capital ratio of 8.5%); 3) a minimum ratio of Total capital to risk-weighted assets of 8.0%, plus the capital conservation buffer (resulting in a minimum Total capital ratio of 10.5%); and 4) a minimum Leverage Ratio of 4.0%.

The capital conservation buffer is designed to absorb losses during periods of economic stress. Failure to maintain the minimum Common Equity Tier 1 capital ratio plus the capital conservation buffer will result in potential restrictions on a banking institution’s ability to pay dividends, repurchase stock and/or pay discretionary compensation to its employees.

The following tables present actual and required capital ratios as of September 30, 2022 and December 31, 2021 for the Company and the Bank under the Basel III Capital Rules. The minimum required capital amounts presented include the minimum required capital levels as of September 30, 2022 and December 31, 2021, which are based on the Basel III Capital Rules. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules.

	Actual				Minimum Capital Required - Basel III				Minimum Required to be Considered Well Capitalized
(dollars in thousands)	Capital Amount		Ratio		Capital Amount		Ratio		Capital Amount		Ratio
As of September 30, 2022:
Common equity tier 1 capital to risk-weighted assets
Consolidated	$	392,281	11.72	%	$	234,271	7.00	%	N/A		N/A
Bank	462,999		13.87	%	233,603		7.00	%	$	216,917	6.50	%
Tier 1 capital to risk-weighted assets
Consolidated	392,281		11.72	%	284,472		8.50	%	N/A		N/A
Bank	462,999		13.87	%	283,661		8.50	%	266,975		8.00	%
Total capital to risk-weighted assets
Consolidated	526,603		15.73	%	351,406		10.50	%	N/A		N/A
Bank	492,865		14.77	%	350,404		10.50	%	333,719		10.00	%
Leverage ratio
Consolidated	392,281		9.49	%	165,323		4.00	%	N/A		N/A
Bank	462,999		11.22	%	165,096		4.00	%	206,370		5.00	%

	Actual				Minimum Capital Required - Basel III				Minimum Required to be Considered Well Capitalized
(dollars in thousands)	Capital Amount		Ratio		Capital Amount		Ratio		Capital Amount		Ratio
As of December 31, 2021:
Common equity tier 1 capital to risk-weighted assets
Consolidated	$	384,499	12.93	%	$	208,202	7.00	%	N/A		N/A
Bank	432,181		14.55	%	207,913		7.00	%	$	193,062	6.50	%
Tier 1 capital to risk-weighted assets
Consolidated	384,499		12.93	%	252,817		8.50	%	N/A		N/A
Bank	432,181		14.55	%	252,466		8.50	%	237,615		8.00	%
Total capital to risk-weighted assets
Consolidated	516,571		17.37	%	312,303		10.50	%	N/A		N/A
Bank	460,022		15.49	%	311,870		10.50	%	297,019		10.00	%
Leverage ratio
Consolidated	384,499		9.22	%	166,824		4.00	%	N/A		N/A
Bank	432,181		10.37	%	166,693		4.00	%	208,366		5.00	%

59

Shareholders’ Dividends

The Company’s Board of Directors declared a cash dividend of $0.06 per share of common stock payable October 17, 2022 to shareholders of record as of September 30, 2022. The Company expects to continue to pay cash dividends on a quarterly basis; however, the declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including the Company’s results of operations, financial condition, capital requirements, regulatory and contractual restrictions (including with respect to the Company’s outstanding subordinated debt), business strategy and other factors deemed relevant by the Board of Directors.

As of September 30, 2022, the Company had $107.0 million principal amount of subordinated debt outstanding evidenced by the 2029 Notes, 2030 Note and 2031 Notes. The agreements that govern our outstanding subordinated debt prohibit the Company from paying any dividends on its common stock or making any other distributions to shareholders at any time when there shall have occurred, and be continuing to occur, an event of default under the applicable agreement. If an event of default were to occur and the Company did not cure it, the Company would be prohibited from paying any dividends or making any other distributions to shareholders or from redeeming or repurchasing any common stock.

Capital Resources

The Company believes it has sufficient liquidity and capital resources to meet its cash and capital expenditure requirements for the next twelve months and longer. The Company may explore strategic alternatives, including additional asset, deposit or revenue generation channels that complement our commercial and consumer banking platforms, which may require additional capital. If the Company is unable to secure such capital at favorable terms, its ability to take advantage of such opportunities could be adversely affected.

On October 20, 2021, the Company’s Board of Directors approved a stock repurchase program authorizing the repurchase of up to $30.0 million of the Company’s outstanding common stock from time to time on the open market or in privately negotiated transactions. In October 2022, the Company’s Board of Directors increased the authorization to $35.0 million. Under this program, the Company repurchased 100,000 shares at a total cost of $4.4 million during 2021, 103,703 shares at a total cost of $5.1 million during the first quarter 2022, 294,464 shares at a total cost of $11.1 million during the second quarter 2022 and 120,000 shares at a total cost of $4.4 million during the third quarter 2022. The stock repurchase authorization is scheduled to expire on December 31, 2022. Various factors determine the amount and timing of our share repurchases, including our capital requirements, organic growth and other strategic opportunities, economic and market conditions (including the trading price of our stock), and regulatory and legal considerations. See Part II, Item 2, of this report for information regarding recent repurchase activity and our remaining authority under the program.

Liquidity

Liquidity management is the process used by the Company to manage the continuing flow of funds necessary to meet its financial commitments on a timely basis and at a reasonable cost while also maintaining safe and sound operations. Liquidity, represented by cash and investment securities, is a product of the Company’s operating, investing and financing activities. The primary sources of funds are deposits, principal and interest payments on loans and investment securities, maturing loans and investment securities, access to wholesale funding sources and collateralized borrowings. While scheduled payments and maturities of loans and investment securities are relatively predictable sources of funds, deposit flows are greatly influenced by interest rates, general economic conditions and competition. Therefore, the Company supplements deposit growth and enhances interest rate risk management through borrowings and wholesale funding, which are generally advances from the Federal Home Loan Bank (“FHLB”) and brokered deposits.

The Company holds cash and investment securities that qualify as liquid assets to maintain adequate liquidity to ensure safe and sound operations and meet its financial commitments. At September 30, 2022, on a consolidated basis, the Company had $614.6 million in cash and cash equivalents and investment securities available-for-sale and $23.1 million in loans held-for-sale that were generally available for its cash needs. The Company can also generate funds from wholesale funding sources and collateralized borrowings. At September 30, 2022, the Bank had the ability to borrow an additional $473.7 million from the FHLB, the Federal Reserve and correspondent bank Fed Funds lines of credit.

60

The Company is a separate legal entity from the Bank and must provide for its own liquidity. In addition to its operating expenses, the Company is responsible for paying any dividends declared to its common shareholders and interest and principal on outstanding debt. The Company’s primary sources of funds are cash maintained at the holding company level and dividends from the Bank, the payment of which is subject to regulatory limits. At September 30, 2022, the Company, on an unconsolidated basis, had $25.7 million in cash generally available for its cash needs, which is in excess of its current annual regular shareholder dividend and operating expenses.

The Company uses its sources of funds primarily to meet ongoing financial commitments, including withdrawals by depositors, credit commitments to borrowers, operating expenses and capital expenditures. At September 30, 2022, approved outstanding loan commitments, including unused lines of credit and standby letters of credit, amounted to $508.6 million. Certificates of deposits and brokered deposits scheduled to mature in one year or less at September 30, 2022 totaled $549.5 million.

Management is not aware of any other events or regulatory requirements that, if implemented, are likely to have a material effect on either the Company’s or the Bank’s liquidity.

61

Reconciliation of Non-GAAP Financial Measures

This Management’s Discussion and Analysis contains financial information determined by methods other than in accordance with GAAP. Non-GAAP financial measures, specifically tangible common equity, tangible assets, tangible book value per common share, tangible common equity to tangible assets, average tangible common equity, return on average tangible common equity, total interest income - FTE, adjusted total interest income - FTE, net interest income - FTE, adjusted net interest income, adjusted net interest income - FTE, net interest margin - FTE, adjusted net interest margin, adjusted net interest margin - FTE, provision (benefit) for loan losses, excluding tax refund advance loans, average loans, excluding tax refund advance loans, net (recoveries) charge-offs to average loans, excluding tax refund advance loans, loans, excluding PPP loans, allowance for loan losses to loans, excluding PPP loans, adjusted noninterest expense, adjusted income before income taxes, adjusted income tax provision, adjusted net income, adjusted diluted earnings per share, adjusted return on average assets, adjusted return on average shareholders’ equity, adjusted return on average tangible common equity, adjusted effective income tax rate, income before income taxes, excluding tax refund advance loans, income tax provision, excluding tax refund advance loans, and net income, excluding tax refund advance loans are used by the Company’s management to measure the strength of its capital and analyze profitability, including its ability to generate earnings on tangible capital invested by its shareholders. The Company also believes that it is a standard practice in the banking industry to present total interest income, net interest income and net interest margin on a fully-taxable equivalent basis, as those measures provide useful information for peer comparisons. Although the Company believes these non-GAAP financial measures provide a greater understanding of its business, they should not be considered a substitute for financial measures determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP financial measures that may be presented by other companies. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the following table for the last five completed fiscal quarters and the nine months ended September 30, 2022 and 2021.

62

(dollars in thousands, except share and per share data)	Three Months Ended															Nine Months Ended
	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021			September 30, 2022			September 30, 2021
Total equity - GAAP	$	360,857		$	365,332		$	374,655		$	380,338		$	370,442		$	360,857		$	370,442
Adjustments:
Goodwill	(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)
Tangible common equity	$	356,170		$	360,645		$	369,968		$	375,651		$	365,755		$	356,170		$	365,755
Total assets - GAAP	$	4,264,424		$	4,099,806		$	4,225,397		$	4,210,994		$	4,252,292		$	4,264,424		$	4,252,292
Adjustments:
Goodwill	(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)
Tangible assets	$	4,259,737		$	4,095,119		$	4,220,710		$	4,206,307		$	4,247,605		$	4,259,737		$	4,247,605
Common shares outstanding	9,290,885			9,404,000			9,683,727			9,754,455			9,854,153			9,290,885			9,854,153
Book value per common share	$	38.84		$	38.85		$	38.69		$	38.99		$	37.59		$	38.84		$	37.59
Effect of goodwill	(0.50)			(0.50)			(0.48)			(0.48)			(0.47)			(0.50)			(0.47)
Tangible book value per common share	$	38.34		$	38.35		$	38.21		$	38.51		$	37.12		$	38.34		$	37.12
Total shareholders’ equity to assets	8.46		%	8.91		%	8.87		%	9.03		%	8.71		%	8.46		%	8.71		%
Effect of goodwill	(0.10		%)	(0.10		%)	(0.10		%)	(0.10		%)	(0.10		%)	(0.10)		%	(0.10)		%
Tangible common equity to tangible assets	8.36		%	8.81		%	8.77		%	8.93		%	8.61		%	8.36		%	8.61		%
Total average equity - GAAP	$	371,303		$	374,274		$	380,767		$	376,832		$	366,187		$	375,190		$	351,794
Adjustments:
Average goodwill	(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)			(4,687)
Average tangible common equity	$	366,616		$	369,587		$	376,080		$	372,145		$	361,500		$	370,503		$	347,107
Return on average shareholders’ equity	9.01		%	10.23		%	11.94		%	13.14		%	13.10		%	10.40		%	13.54		%
Effect of goodwill	0.12		%	0.13		%	0.15		%	0.16		%	0.17		%	0.13		%	0.19		%
Return on average tangible common equity	9.13		%	10.36		%	12.09		%	13.30		%	13.27		%	10.53		%	13.73		%

63

(dollars in thousands)	Three Months Ended										Nine Months Ended
	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021		September 30, 2022		September 30, 2021
Total interest income	$	39,099	$	36,106	$	36,034	$	34,192	$	33,034	$	111,239	$	99,691
Adjustments:
Fully-taxable equivalent adjustments 1	1,280		1,377		1,314		1,348		1,356		3,971		4,105
Total interest income - FTE	$	40,379	$	37,483	$	37,348	$	35,540	$	34,390	$	115,210	$	103,796
Total interest income - FTE	$	40,379	$	37,483	$	37,348	$	35,540	$	34,390	$	115,210	$	103,796
Adjustments:
Income from tax refund advance loans	—		(149)		(2,864)		—		—		(3,013)		—
Adjusted total interest income - FTE	$	40,379	$	37,334	$	34,484	$	35,540	$	34,390	$	112,197	$	103,796
Net interest income	$	23,994	$	25,680	$	25,750	$	23,505	$	20,919	$	75,424	$	63,051
Adjustments:
Fully-taxable equivalent adjustments 1	1,280		1,377		1,314		1,348		1,356		3,971		4,105
Net interest income - FTE	$	25,274	$	27,057	$	27,064	$	24,853	$	22,275	$	79,395	$	67,156
Net interest income	$	23,994	$	25,680	$	25,750	$	23,505	$	20,919	$	75,424	$	63,051
Adjustments:
Subordinated debt redemption cost	—		—		—		—		810		—		810
Income from tax refund advance loans	—		(149)		(2,864)		—		—		(3,013)		—
Adjusted net interest income	$	23,994	$	25,531	$	22,886	$	23,505	$	21,729	$	72,411	$	63,861
Net interest income	$	23,994	$	25,680	$	25,750	$	23,505	$	20,919	$	75,424	$	63,051
Adjustments:
Fully-taxable equivalent adjustments 1	1,280		1,377		1,314		1,348		1,356		3,971		4,105
Subordinated debt redemption cost	—		—		—		—		810		—		810
Income from tax refund advance loans	—		(149)		(2,864)		—		—		(3,013)		—
Adjusted net interest income - FTE	$	25,274	$	26,908	$	24,200	$	24,853	$	23,085	$	76,382	$	67,966
1 Assuming a 21% tax rate

64

(dollars in thousands)	Three Months Ended															Nine Months Ended
	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021			September 30, 2022			September 30, 2021
Net interest margin	2.40		%	2.60		%	2.56		%	2.30		%	2.00		%	2.52		%	2.05		%
Effect of fully-taxable equivalent adjustments 1	0.13		%	0.14		%	0.13		%	0.13		%	0.13		%	0.13		%	0.14		%
Net interest margin - FTE	2.53		%	2.74		%	2.69		%	2.43		%	2.13		%	2.65		%	2.19		%
Net interest margin	2.40		%	2.60		%	2.56		%	2.30		%	2.00		%	2.52		%	2.05		%
Effect of subordinated debt redemption cost	0.00		%	0.00		%	0.00		%	0.00		%	0.08		%	0.00		%	0.02		%
Effect of income from tax refund advance loans	0.00		%	(0.02		%)	(0.28		%)	0.00		%	0.00		%	(0.10		%)	0.00		%
Adjusted net interest margin	2.40		%	2.58		%	2.28		%	2.30		%	2.08		%	2.42		%	2.07		%
Net interest margin	2.40		%	2.60		%	2.56		%	2.30		%	2.00		%	2.52		%	2.05		%
Effect of fully-taxable equivalent adjustments	0.13		%	0.14		%	0.13		%	0.13		%	0.13		%	0.13		%	0.14		%
Effect of subordinated debt redemption cost	0.00		%	0.00		%	0.00		%	0.00		%	0.08		%	0.00		%	0.02		%
Effect of income from tax refund advance loans	0.00		%	(0.02		%)	(0.28		%)	0.00		%	0.00		%	(0.10		%)	0.00		%
Adjusted net interest margin - FTE	2.53		%	2.72		%	2.41		%	2.43		%	2.21		%	2.55		%	2.21		%
Provision (benefit) for loan losses	$	892		$	1,185		$	791		$	(238)		$	(29)		$	2,868		$	1,268
Adjustments:
Provision for tax refund advance loans losses	—			(18)			(1,842)			—			—			(1,860)			—
Provision (benefit) for loan losses, excluding tax refund advance loans	$	892		$	1,167		$	(1,051)		$	(238)		$	(29)		$	1,008		$	1,268
Average loans	$	3,161,850		$	2,998,144		$	2,947,924		$	2,914,858		$	2,933,654		$	3,036,532		$	2,991,556
Adjustments:
Average tax refund advance loans	—			(3,185)			(60,499)			—			—			(20,996)			—
Average loans, excluding tax refund advance loans	$	3,161,850		$	2,994,959		$	2,887,425		$	2,914,858		$	2,933,654		$	3,015,536		$	2,991,556
Net charge-offs (recoveries) to average loans	0.02		%	0.04		%	0.05		%	(0.01		%)	0.01		%	0.04		%	0.12		%
Adjustments:
Effect of tax refund advance lending net charge-offs to average loans	0.00		%	(0.05		%)	(0.21		%)	0.00		%	0.00		%	(0.08		%)	0.00		%
Net (recoveries) charge-offs to average loans, excluding tax refund advance loans	0.02		%	(0.01		%)	(0.16		%)	(0.01		%)	0.01		%	(0.04		%)	0.12		%
Allowance for loan losses	$	29,866		$	29,153		$	28,251		$	27,841		$	28,000		$	29,866		$	28,000
Loans	$	3,255,906		$	3,082,127		$	2,880,780		$	2,887,662		$	2,936,148		$	3,255,906		$	2,936,148
Adjustments:
PPP loans	—			(194)			(1,003)			(3,152)			(14,981)			—			(14,981)
Loans, excluding PPP loans	$	3,255,906		$	3,081,933		$	2,879,777		$	2,884,510		$	2,921,167		$	3,255,906		$	2,921,167
Allowance for loan losses to loans	0.92		%	0.95		%	0.98		%	0.96		%	0.95		%	0.92		%	0.95		%
Effect of PPP loans	0.00		%	0.00		%	0.00		%	0.01		%	0.01		%	0.00		%	0.01		%
Allowance for loan losses to loans, excluding PPP loans	0.92		%	0.95		%	0.98		%	0.97		%	0.96		%	0.92		%	0.96		%

1 Assuming a 21% tax rate

65

(dollars in thousands, except share and per share data)	Three Months Ended										Nine Months Ended
	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021		September 30, 2022		September 30, 2021
Noninterest expense - GAAP	$	17,995	$	17,985	$	18,780	$	16,955	$	14,451	$	54,760	$	44,843
Adjustments:
Acquisition-related expenses	—		(103)		(170)		(163)		—		(273)		—
Nonrecurring consulting fee	—		—		(875)		—		—		(125)		—
Write-down of Software	(125)		—		—		(475)		—		(875)		—
Discretionary inflation bonus	—		(531)		—		—		—		(531)		—
Accelerated equity compensation	—		(289)		—		—		—		(289)		—
Adjusted noninterest expense	$	17,870	$	17,062	$	17,735	$	16,317	$	14,451	$	52,667	$	44,843
Income before income taxes - GAAP	$	9,423	$	10,824	$	12,999	$	14,482	$	14,310	$	33,246	$	42,090
Adjustments:
Gain on sale of premises and equipment	—		—		—		—		—		—		(2,523)
Acquisition-related expenses	—		103		170		163		—		273		—
Nonrecurring consulting fee	—		—		875		—		—		875		—
Write-down of Software	125		—		—		475		—		125		—
Subordinated debt redemption cost	—		—		—		—		810		—		810
Discretionary inflation bonus	—		531		—		—		—		531		—
Accelerated equity compensation	—		289		—		—		—		289		—
Adjusted income before income taxes	$	9,548	$	11,747	$	14,044	$	15,120	$	15,120	$	35,339	$	40,377
Income tax provision - GAAP	$	987	$	1,279	$	1,790	$	2,004	$	2,220	$	4,056	$	6,454
Adjustments:1
Gain on sale of premises and equipment	—		—		—		—		—		—		(530)
Acquisition-related expenses	—		21		36		34		—		57		—
Nonrecurring consulting fee	—		—		184		—		—		184		—
Write-down of Software	26		—		—		100		—		26		—
Subordinated debt redemption cost	—		—		—		—		170		—		170
Discretionary inflation bonus	—		112		—		—		—		112		—
Accelerated equity compensation	—		61		—		—		—		61		—
Adjusted income tax provision	$	1,013	$	1,473	$	2,010	$	2,138	$	2,390	$	4,496	$	6,094
Net income - GAAP	$	8,436	$	9,545	$	11,209	$	12,478	$	12,090	$	29,190	$	35,636
Adjustments:
Gain on sale of premises and equipment	—		—		—		—		—		—		(1,993)
Acquisition-related expenses	—		82		134		129		—		216		—
Nonrecurring consulting fee	—		—		691		—		—		691		—
Write-down of Software	99		—		—		375		—		99		—
Subordinated debt redemption cost	—		—		—		—		640		—		640
Discretionary inflation bonus	—		419		—		—		—		419		—
Accelerated equity compensation	—		228		—		—		—		228		—
Adjusted net income	$	8,535	$	10,274	$	12,034	$	12,982	$	12,730	$	30,843	$	34,283
1 Assuming a 21% tax rate

66

(dollars in thousands, except share and per share data)	Three Months Ended															Nine Months Ended
	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021			September 30, 2022			September 30, 2021
Diluted average common shares outstanding	9,525,855			9,658,689			9,870,394			9,989,951			9,988,102			9,681,742			9,974,071
Diluted earnings per share - GAAP	$	0.89		$	0.99		$	1.14		$	1.25		$	1.21		$	3.01		$	3.57
Adjustments:
Effect of gain on sale of premises and equipment	—			—			—			—			—			—			(0.19)
Effect of acquisition-related expenses	—			0.01			0.01			0.01			—			0.02			—
Effect of nonrecurring consulting fee	—			—			0.07			—			—			0.07			—
Effect of write-down of software	0.01			—			—			0.04			—			0.01			—
Effect of subordinated debt redemption cost	—			—			—			—			0.06			—			0.06
Effect of discretionary inflation bonus	—			0.04			—			—			—			0.04			—
Effect of accelerated equity compensation	—			0.02			—			—			—			0.02			—
Adjusted diluted earnings per share	$	0.90		$	1.06		$	1.22		$	1.30		$	1.27		$	3.17		$	3.44
Return on average assets	0.82		%	0.93		%	1.08		%	1.19		%	1.12		%	0.94		%	1.13		%
Effect of gain on sale of premises and equipment	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	(0.06		%)
Effect of acquisition-related expenses	0.00		%	0.01		%	0.01		%	0.01		%	0.00		%	0.01		%	0.00		%
Effect of nonrecurring consulting fee	0.00		%	0.00		%	0.07		%	0.00		%	0.00		%	0.02		%	0.00		%
Effect of write-down of software	0.01		%	0.00		%	0.00		%	0.04		%	0.00		%	0.00		%	0.00		%
Effect of subordinated debt redemption cost	0.00		%	0.00		%	0.00		%	0.00		%	0.06		%	0.00		%	0.02		%
Effect of discretionary inflation bonus	0.00		%	0.04		%	0.00		%	0.00		%	0.00		%	0.01		%	0.00		%
Effect of accelerated equity compensation	0.00		%	0.02		%	0.00		%	0.00		%	0.00		%	0.01		%	0.00		%
Adjusted return on average assets	0.83		%	1.00		%	1.16		%	1.24		%	1.18		%	0.99		%	1.09		%
Return on average shareholders' equity	9.01		%	10.23		%	11.94		%	13.14		%	13.10		%	10.40		%	13.54		%
Effect of gain on sale of premises and equipment	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	(0.75		%)
Effect of acquisition-related expenses	0.00		%	0.09		%	0.14		%	0.14		%	0.00		%	0.08		%	0.00		%
Effect of nonrecurring consulting fee	0.00		%	0.00		%	0.74		%	0.00		%	0.00		%	0.25		%	0.00		%
Effect of write-down of software	0.11		%	0.00		%	0.00		%	0.39		%	0.00		%	0.04		%	0.00		%
Effect of subordinated debt redemption cost	0.00		%	0.00		%	0.00		%	0.00		%	0.69		%	0.00		%	0.24		%
Effect of discretionary inflation bonus	0.00		%	0.45		%	0.00		%	0.00		%	0.00		%	0.15		%	0.00		%
Effect of accelerated equity compensation	0.00		%	0.24		%	0.00		%	0.00		%	0.00		%	0.08		%	0.00		%
Adjusted return on average shareholders' equity	9.12		%	11.01		%	12.82		%	13.67		%	13.79		%	11.00		%	13.03		%

67

(dollars in thousands, except share and per share data)	Three Months Ended															Nine Months Ended
	September 30, 2022			June 30, 2022			March 31, 2022			December 31, 2021			September 30, 2021			September 30, 2022			September 30, 2021
Return on average tangible common equity	9.13		%	10.36		%	12.09		%	13.30		%	13.27		%	10.53		%	13.73		%
Effect of gain on sale of premises and equipment	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	0.00		%	(0.77		%)
Effect of acquisition-related expenses	0.00		%	0.09		%	0.14		%	0.14		%	0.00		%	0.08		%	0.00		%
Effect of nonrecurring consulting fee	0.00		%	0.00		%	0.75		%	0.00		%	0.00		%	0.25		%	0.00		%
Effect of write-down of software	0.11		%	0.00		%	0.00		%	0.40		%	0.00		%	0.04		%	0.00		%
Effect of subordinated debt redemption cost	0.00		%	0.00		%	0.00		%	0.00		%	0.70		%	0.00		%	0.25		%
Effect of discretionary inflation bonus	0.00		%	0.45		%	0.00		%	0.00		%	0.00		%	0.15		%	0.00		%
Effect of accelerated equity compensation	0.00		%	0.25		%	0.00		%	0.00		%	0.00		%	0.08		%	0.00		%
Adjusted return on average tangible common equity	9.24		%	11.15		%	12.98		%	13.84		%	13.97		%	11.13		%	13.21		%
Effective income tax rate	10.5		%	11.8		%	13.8		%	13.8		%	15.5		%	12.2		%	15.3		%
Effect of gain on sale of premises and equipment	0.0		%	0.0		%	0.0		%	0.0		%	0.0		%	0.0		%	(0.6		%)
Effect of acquisition-related expenses	0.0		%	0.2		%	0.3		%	0.1		%	0.0		%	0.2		%	0.0		%
Effect of nonrecurring consulting fee	0.0		%	0.0		%	1.3		%	0.0		%	0.0		%	0.5		%	0.0		%
Effect of write-down of software	0.3		%	0.0		%	0.0		%	0.2		%	0.0		%	0.1		%	0.0		%
Effect of subordinated debt redemption cost	0.0		%	0.0		%	0.0		%	0.0		%	0.3		%	0.0		%	0.4		%
Effect of discretionary inflation bonus	0.0		%	1.0		%	0.0		%	0.0		%	0.0		%	0.3		%	0.0		%
Effect of accelerated equity compensation	0.0		%	0.6		%	0.0		%	0.0		%	0.0		%	0.2		%	0.0		%
Adjusted effective income tax rate	10.8		%	13.6		%	15.4		%	14.1		%	15.8		%	13.5		%	15.1		%
Income before income taxes - GAAP	$	9,423		$	10,824		$	12,999		$	14,482		$	14,310		$	33,246		$	42,090
Adjustments:
Income from tax refund advance lending	—			(149)			(2,864)			—			—			(3,013)			—
Provision for tax refund advance loans losses	—			18			1,842			—			—			1,860			—
Tax refund advance lending servicing fee	—			9			921			—			—			930			—
Income before income taxes, excluding tax refund advance loans	$	9,423		$	10,702		$	12,898		$	14,482		$	14,310		$	33,023		$	42,090
Income tax provision - GAAP	$	987		$	1,279		$	1,790		$	2,004		$	2,220		$	4,056		$	6,454
Adjustments:1
Income from tax refund advance lending	—			(31)			(601)			—			—			(632)			—
Provision for tax refund advance loans losses	—			4			387			—			—			391			—
Tax refund advance lending servicing fee	—			2			193			—			—			195			—
Income tax provision, excluding tax refund advance loans	$	987		$	1,254		$	1,769		$	2,004		$	2,220		$	4,010		$	6,454

68

(dollars in thousands, except share and per share data)	Three Months Ended										Nine Months Ended
	September 30, 2022		June 30, 2022		March 31, 2022		December 31, 2021		September 30, 2021		September 30, 2022		September 30, 2021
Net income - GAAP	$	8,436	$	9,545	$	11,209	$	12,478	$	12,090	$	29,190	$	35,636
Adjustments:
Income from tax refund advance lending	—		(118)		(2,263)		—		—		(2,381)		—
Provision for tax refund advance loans losses	—		14		1,455		—		—		1,469		—
Tax refund advance lending servicing fee	—		7		728		—		—		735		—
Net income, excluding tax refund advance loans	$	8,436	$	9,448	$	11,129	$	12,478	$	12,090	$	29,013	$	35,636

1 Assuming a 21% tax rate

Critical Accounting Policies and Estimates

There have been no material changes in the Company’s critical accounting policies or estimates from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021.

Recent Accounting Pronouncements

Refer to Note 15 to the condensed consolidated financial statements.

Off-Balance Sheet Arrangements

In the ordinary course of business, the Company enters into financial transactions to extend credit, interest rate swap agreements and forms of commitments that may be considered off-balance sheet arrangements. Interest rate swaps are arranged to receive hedge accounting treatment and are classified as either fair value or cash flow hedges. Fair value hedges are purchased to convert certain fixed rate assets to floating rate. Cash flow hedges are used to convert certain variable rate liabilities into fixed rate liabilities. At both September 30, 2022 and December 31, 2021, the Company had interest rate swaps with notional amounts of $260.0 million. Additionally, we enter into forward contracts related to our mortgage banking business to hedge the exposures we have from commitments to extend new residential mortgage loans to our customers and from our mortgage loans held-for-sale. At September 30, 2022 and December 31, 2021, the Company had commitments to sell residential real estate loans of $27.8 million and $72.8 million, respectively. These contracts mature in less than one year. Refer to Note 13 to the condensed consolidated financial statements for additional information about derivative financial instruments.

69

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Market risk is the risk of loss arising from adverse changes in the fair value of financial instruments due to changes in interest rates, foreign exchange rates and equity prices. The primary source of market risk for the Company is interest rate risk, which can be defined as the risk to earnings and the value of the Company’s equity resulting from changes in market interest rates. Interest rate risk arises in the normal course of business to the extent that there are timing and volume differences between the amount of interest-earning assets and the amount of interest-bearing liabilities that are prepaid, withdrawn, re-priced or mature in specified periods. The Company seeks to achieve consistent growth in net interest income and equity while managing volatility arising from shifts in market interest rates.

The Company monitors its interest rate risk position using income simulation models and economic value of equity (“EVE”) sensitivity analysis that capture both short-term and long-term interest rate risk exposure. Income simulation involves forecasting net interest income (“NII”) under a variety of interest rate scenarios. The Company uses EVE sensitivity analysis to understand the impact of changes in interest rates on long-term cash flows, income and capital. EVE is calculated by discounting the cash flows for all balance sheet instruments under different interest-rate scenarios. Modeling the sensitivity of NII and EVE to changes in market interest rates is highly dependent on the assumptions incorporated into the modeling process, especially those pertaining to non-maturity deposit accounts. In the Company’s standard model, it incorporates deposit betas ranging from 30% to 70% (100% for certain products) in up-rate scenarios related to its savings and money market non-maturity deposit products. These assumptions are reviewed and refined on an ongoing basis by the Company. The Company continually models its NII and EVE positions with various interest rate scenarios and assumptions of future balance sheet composition. The Company utilizes implied forward rates as its base case scenario which reflects market expectations for interest rates over the next 24 months. Presented below is the estimated impact on the Company’s NII and EVE position as of September 30, 2022, assuming a static balance sheet and instantaneous parallel shifts in interest rates:

	% Change from Base Case for Instantaneous Parallel Changes in Rates
	Implied Forward Curve -200 Basis Points		Implied Forward Curve -100 Basis Points		Base Implied Forward Curve		Implied Forward Curve +100 Basis Points		Implied Forward Curve +200 Basis Points
NII - Year 1	15.17	%	9.12	%	N/A		(6.61	%)	(13.46	%)
NII - Year 2	19.24	%	11.00	%	0.95	%	(6.65	%)	(14.96	%)
EVE	32.91	%	20.09	%	N/A		(18.06	%)	(35.55	%)

To supplement the instantaneous rate shocks required by regulatory guidance, the Company also calculates its interest rate risk position assuming a gradual change in market interest rates. This gradual change is commonly referred to as a “rate ramp” and evenly allocates a change in interest rates over a specified time period.

Presented below is the estimated impact on the Company’s NII and EVE position as of September 30, 2022, assuming a static balance sheet and gradual parallel shifts in interest rates:

	% Change from Base Case for Gradual Changes in Rates
	Implied Forward Curve -200 Basis Points		Implied Forward Curve -100 Basis Points		Base Implied Forward Curve		Implied Forward Curve +100 Basis Points		Implied Forward Curve +200 Basis Points
NII - Year 1	7.18	%	3.90	%	N/A		(3.03	%)	(6.10	%)
NII - Year 2	19.32	%	10.88	%	0.95	%	(7.05	%)	(15.45	%)
EVE	30.82	%	18.42	%	N/A		(17.13	%)	(33.68	%)

70

In the Company’s supplementary model, it incorporates deposit betas ranging from 12% to 94% in up-rate scenarios related to its savings and money market non-maturity deposit products, which approximates actual deposit pricing experience thus far in 2022. Presented below are the estimated impacts on the Company’s NII and EVE position as of September 30, 2022, assuming a static balance sheet and instantaneous and gradual parallel shifts in interest rates:

	% Change from Base Case for Instantaneous Parallel Changes in Rates
	Implied Forward Curve -200 Basis Points		Implied Forward Curve -100 Basis Points		Base Implied Forward Curve		Implied Forward Curve +100 Basis Points		Implied Forward Curve +200 Basis Points
NII - Year 1	14.64	%	8.87	%	N/A		(5.16	%)	(10.55	%)
NII - Year 2	19.23	%	11.38	%	1.76	%	(4.40	%)	(11.17	%)
EVE	30.04	%	18.93	%	N/A		(16.11	%)	(31.78	%)

	% Change from Base Case for Gradual Changes in Rates
	Implied Forward Curve -200 Basis Points		Implied Forward Curve -100 Basis Points		Base Implied Forward Curve		Implied Forward Curve +100 Basis Points		Implied Forward Curve +200 Basis Points
NII - Year 1	6.93	%	3.73	%	N/A		(2.45	%)	(4.93	%)
NII - Year 2	18.90	%	11.02	%	1.76	%	(4.83	%)	(11.82	%)
EVE	27.93	%	17.05	%	N/A		(15.37	%)	(30.32	%)

The NII and EVE figures presented in the tables above are reflective of a static balance sheet, and do not incorporate either balance sheet growth or strategies to increase net interest income while managing volatility arising from shifts in market interest rates. As such, it is likely that actual results will differ from what is presented in the tables above. Balance sheet strategies to achieve such objectives may include:

•Increasing the proportion of low-duration or variable-rate loans to total loans, including organic growth in SBA, construction or C&I lending

•Selling longer-term fixed rate loans

•Increasing the proportion of lower cost non-maturity deposits to total deposits

•Extending the duration of wholesale funding

•Executing derivative strategies to synthetically extend liabilities or shorten asset duration

•Repositioning the investment portfolio to manage its duration

ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. These controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating disclosure controls and procedures, the Company has recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Management is required to apply judgment in evaluating its controls and procedures.

The Company performed an evaluation under the supervision and with the participation of management, including the principal executive and principal financial officers, to assess the effectiveness of the design and operation of its disclosure controls and procedures under the Exchange Act. Based on that evaluation, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of September 30, 2022.

71

Changes in Internal Control over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the quarter ended September 30, 2022 that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

72

PART II

ITEM 1.    LEGAL PROCEEDINGS

Neither we nor any of our subsidiaries are party to any material legal proceedings. From time to time, the Bank is a party to legal actions arising from its normal business activities.

ITEM 1A.    RISK FACTORS

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Repurchases of Common Stock

On October 20, 2021, the Company's Board of Directors approved a stock repurchase program authorizing the repurchase of up to $30.0 million of our outstanding common stock from time to time on the open market or in privately negotiated transactions. In October 2022, the Company’s Board of Directors increased the authorization to $35.0 million. The stock repurchase authorization is scheduled to expire on December 31, 2022. Under this program, the Company repurchased 120,000 shares of common stock during the third quarter 2022 at an average price of $36.56 per share. The Company has repurchased a total of 618,167 shares at an average price of $40.54 per share under the program through September 30, 2022, leaving $9.9 million of remaining authority under the program.

The following table presents information with respect to purchases of the Company’s common stock made by or on behalf of the Company or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3), during the third quarter 2022.

	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased As Part of Publicly Announced Programs	Approximate Dollar Value Of Shares That May Yet Be Purchased Under The Program
July 1, 2022 - July 31, 2022	—	$	—	—	$	—
August 1, 2022 - August 31, 2022	44,533	$	37.92	44,533	$	12,636
September 1, 2022 - September 30, 2022	75,467	$	35.75	75,467	$	9,937
Total	120,000			120,000

Limitations on the Payment of Dividends

The ability of the Company to make capital distributions, including paying dividends and repurchasing shares, depends upon our receipt of dividends from the Bank. The ability of the Bank to pay dividends is limited by state and federal laws and regulations, including the requirement for the Bank to obtain the prior approval of the Indiana Department of Financial Institutions (“DFI”) before paying a dividend that, together with other dividends it has paid during a calendar year, would exceed the sum of its net income for the year to date combined with its retained net income for the previous two years. The ability of the Bank to pay dividends is further affected by the requirement to maintain adequate capital pursuant to applicable capital adequacy guidelines and regulations, and it is generally prohibited from paying any dividends if, following payment thereof, it would be undercapitalized. Notwithstanding the availability of funds for dividends, the FDIC and the DFI may prohibit the payment of dividends by the Bank if either or both determine such payment would constitute an unsafe or unsound practice. In addition, under the Basel III Capital Rules, institutions that seek the freedom to pay dividends have to maintain 2.5% in Common Equity Tier 1 Capital attributable to the capital conservation buffer.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

73

Not Applicable.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS 

Exhibit No.	Description	Method of Filing
3.1	Amended and Restated Articles of Incorporation of First Internet Bancorp (incorporated by reference to Exhibit 3.1 to current report on Form 8-K filed May 21, 2020)	Incorporated by Reference
3.2	Amended and Restated Bylaws of First Internet Bancorp (incorporated by reference to Exhibit 3.2 to current report on Form 8-K filed May 21, 2020)	Incorporated by Reference
31.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer	Filed Electronically
31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer	Filed Electronically
32.1	Section 1350 Certifications	Filed Electronically
101	Inline XBRL Instance Document (does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document)	Filed Electronically
101.SCH	Inline XBRL Taxonomy Extension Schema	Filed Electronically
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase	Filed Electronically
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase	Filed Electronically
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase	Filed Electronically
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase	Filed Electronically
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)	Filed Electronically

*Management contract, compensatory plan or arrangement required to be filed as an exhibit.

74

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		FIRST INTERNET BANCORP
11/9/2022	By	/s/ David B. Becker
		David B. Becker, Chairman and Chief Executive Officer (on behalf of Registrant)
11/9/2022	By	/s/ Kenneth J. Lovik
		Kenneth J. Lovik, Executive Vice President and Chief Financial Officer (principal financial officer)

75

EX-31.1

Exhibit 31.1

Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David B. Becker, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 9, 2022
		/s/ David B. Becker
		David B. Becker, Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kenneth J. Lovik, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 9, 2022
		/s/ Kenneth J. Lovik
		Kenneth J. Lovik, Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of First Internet Bancorp (the “Company") on Form 10-Q for the period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David B. Becker

David B. Becker

Chief Executive Officer

November 9, 2022

/s/ Kenneth J. Lovik

Kenneth J. Lovik

Chief Financial Officer

November 9, 2022

XML

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-35750
Entity Registrant Name	First Internet Bancorp
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	20-3489991
Entity Address, Address Line One	8701 East 116th Street
Entity Address, City or Town	Fishers
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46038
City Area Code	317
Local Phone Number	532-7900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,240,151
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Amendment Flag	false
Entity Central Index Key	0001562463
Current Fiscal Year End Date	--12-31
Common Stock
Class of Stock [Line Items]
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	INBK
Security Exchange Name	NASDAQ
6.0% Fixed to Floating Subordinated Notes due 2029
Class of Stock [Line Items]
Title of 12(b) Security	6.0% Fixed to Floating Subordinated Notes due 2029
Trading Symbol	INBKZ
Security Exchange Name	NASDAQ

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 14,743	$ 7,492
Interest-bearing deposits	206,309	435,468
Total cash and cash equivalents	221,052	442,960
Total available-for-sale securities	393,565	603,044
Securities held-to-maturity, at amortized cost (fair value of $169,977 and $61,468 in 2022 and 2021, respectively)	191,057	59,565
Loans held-for-sale (includes $9,677 and $23,233 at fair value in 2022 and 2021, respectively)	23,103	47,745
Loans	3,255,906	2,887,662
Allowance for loan losses	(29,866)	(27,841)
Net loans	3,226,040	2,859,821
Accrued interest receivable	16,918	16,037
Federal Home Loan Bank of Indianapolis stock	28,350	25,650
Cash surrender value of bank-owned life insurance	39,612	38,900
Premises and equipment, net	70,747	59,842
Goodwill	4,687	4,687
Servicing asset, at fair value	5,795	4,702
Other real estate owned	0	1,188
Accrued income and other assets	43,498	46,853
Total assets	4,264,424	4,210,994
Liabilities and Shareholders’ Equity
Noninterest-bearing deposits	142,875	117,531
Interest-bearing deposits	3,049,769	3,061,428
Total deposits	3,192,644	3,178,959
Advances from Federal Home Loan Bank	589,926	514,922
Subordinated debt, net of unamortized debt issuance costs of $2,544 and $2,769 in 2022 and 2021, respectively	104,456	104,231
Accrued interest payable	1,887	2,018
Accrued expenses and other liabilities	14,654	30,526
Total liabilities	3,903,567	3,830,656
Commitments and Contingencies
Shareholders’ Equity
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none	0	0
Retained earnings	199,877	172,431
Accumulated other comprehensive loss	(39,143)	(11,039)
Total shareholders’ equity	360,857	380,338
Total liabilities and shareholders’ equity	4,264,424	4,210,994
Voting Common Stock
Shareholders’ Equity
Common stock	200,123	218,946
Nonvoting Common Stock
Shareholders’ Equity
Common stock	$ 0	$ 0

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Amortized cost	$ 448,710	$ 606,507
Held-to-maturity, at fair value	169,977	61,468
Loans held-for-sale, at fair value	17,072	23,233
Unamortized discounts and debt issuance costs	$ 2,619	$ 2,769
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	4,913,779	4,913,779
Preferred stock, shares issued (in shares)	0	0
Preferred stock, share outstanding (in shares)	0	0
Voting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	45,000,000	45,000,000
Common stock, shares issued (in shares)	9,404,000	9,754,455
Common stock, shares outstanding (in shares)	9,404,000	9,754,455
Nonvoting Common Stock
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	86,221	86,221
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest Income
Loans	$ 34,643	$ 30,126	$ 100,246	$ 91,846
Securities – taxable	2,701	2,297	7,489	5,997
Securities – non-taxable	491	241	1,068	781
Other earning assets	1,264	370	2,436	1,067
Total interest income	39,099	33,034	111,239	99,691
Interest Expense
Deposits	10,520	7,090	23,025	23,423
Other borrowed funds	4,585	5,025	12,790	13,217
Total interest expense	15,105	12,115	35,815	36,640
Net Interest Income	23,994	20,919	75,424	63,051
Provision for Loan Losses	892	(29)	2,868	1,268
Net Interest Income After Provision for Loan Losses	23,102	20,948	72,556	61,783
Noninterest Income
Gain on sale of loans	2,713	2,719	8,510	7,461
Other	164	731	883	1,349
Total noninterest income	4,316	7,813	15,450	25,150
Noninterest Expense
Salaries and employee benefits	10,439	9,316	31,149	28,040
Marketing, advertising and promotion	1,041	813	2,717	2,365
Consulting and professional services	790	728	3,912	2,792
Data processing	483	380	1,422	1,224
Loan expenses	1,142	383	3,417	1,458
Premises and equipment	2,808	1,687	7,767	4,875
Deposit insurance premium	229	230	797	930
Other	1,063	914	3,579	3,159
Total noninterest expense	17,995	14,451	54,760	44,843
Income Before Income Taxes	9,423	14,310	33,246	42,090
Income Tax Provision	987	2,220	4,056	6,454
Net Income	$ 8,436	$ 12,090	$ 29,190	$ 35,636
Income Per Share of Common Stock
Basic (in dollars per share)	$ 0.89	$ 1.22	$ 3.04	$ 3.59
Diluted (in dollars per share)	$ 0.89	$ 1.21	$ 3.01	$ 3.57
Weighted-Average Number of Common Shares Outstanding
Basic (in shares)	9,458,259,000	9,936,237,000	9,615,039,000	9,922,877
Diluted (in shares)	9,525,855,000	9,988,102,000	9,681,742,000	9,974,071
Dividends Declared Per Share (in dollars per share)	$ 0.06	$ 0.06	$ 0.18	$ 0.18
Service charges and fees
Noninterest Income
Noninterest income	$ 248	$ 276	$ 845	$ 822
Loan servicing revenue
Noninterest Income
Noninterest income	653	511	1,858	1,390
Loan servicing asset revaluation
Noninterest Income
Noninterest income	(333)	(274)	(1,100)	(669)
Mortgage banking activities
Noninterest Income
Noninterest income	$ 871	$ 3,850	$ 4,454	$ 12,274

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Net income	$ 8,436	$ 12,090	$ 29,190	$ 35,636
Net unrealized holding losses recorded within other comprehensive income before income tax	(18,406)	(1,789)	(51,682)	(2,596)
Income tax benefit	(5,121)	(441)	(13,384)		$ (616)
Reclassification of securities from available-for-sale to held-to-maturity	0	0	(5,402)	0
Amortization of net unrealized holding losses on securities transferred from available-for-sale to held-to-maturity	296	0	608	0
Income tax provision (benefit)	69	0	(1,203)	0
Net effect on other comprehensive (loss) income	227	0	(3,591)	0
Net unrealized holding gains on cash flow hedging derivatives recorded within other comprehensive income before income tax	6,058	1,439	19,424		7,665
Income tax provision	1,393	348	5,639		$ 1,657
Net effect on other comprehensive (loss) income	4,665	1,091	13,785	6,008
Total other comprehensive (loss) income	(8,393)	(257)	(28,104)	4,028
Comprehensive income	43	11,833	1,086	39,664
Available-For-Sale Securities
Net effect on other comprehensive (loss) income	$ (13,285)	$ (1,348)	$ (38,298)	$ (1,980)

XML

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock Voting and Nonvoting Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance, beginning of period at Dec. 31, 2020	$ 330,944	$ 221,408	$ 126,732	$ (17,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	35,636		35,636
Other comprehensive income (loss)	4,028			4,028
Dividends declared	(1,817)		(1,817)
Recognition of the fair value of share-based compensation	1,830	1,830
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	16	16
Common stock redeemed for the net settlement of share-based awards	(195)	(195)
Balance, end of period at Sep. 30, 2021	370,442	223,059	160,551	(13,168)
Balance, beginning of period at Jun. 30, 2021	358,641	222,486	149,066	(12,911)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	12,090		12,090
Other comprehensive income (loss)	(257)			(257)
Dividends declared	(605)		(605)
Recognition of the fair value of share-based compensation	568	568
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	5	5
Balance, end of period at Sep. 30, 2021	370,442	223,059	160,551	(13,168)
Balance, beginning of period at Dec. 31, 2021	380,338	218,946	172,431	(11,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	29,190		29,190
Other comprehensive income (loss)	(28,104)			(28,104)
Dividends declared	(1,744)		(1,744)
Recognition of the fair value of share-based compensation	$ 1,967	1,967
Stock Repurchased During Period, Shares	(518,167)
Repurchased shares of common stock (518,167)	$ (20,626)	(20,626)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	15	15
Common stock redeemed for the net settlement of share-based awards	(179)	(179)
Balance, end of period at Sep. 30, 2022	360,857	200,123	199,877	(39,143)
Balance, beginning of period at Jun. 30, 2022	365,332	204,071	192,011	(30,750)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,436		8,436
Other comprehensive income (loss)	(8,393)			(8,393)
Dividends declared	(570)		(570)
Recognition of the fair value of share-based compensation	$ 434	434
Stock Repurchased During Period, Shares	(120,000)
Repurchased shares of common stock (518,167)	$ (4,387)	(4,387)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units	5	5
Balance, end of period at Sep. 30, 2022	$ 360,857	$ 200,123	$ 199,877	$ (39,143)

XML

Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.06	$ 0.06	$ 0.18	$ 0.18

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities
Net income	$ 29,190,000	$ 35,636,000
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,745,000	6,649,000
Increase in cash surrender value of bank-owned life insurance	(712,000)	(708,000)
Provision for loan losses	2,868,000	1,268,000
Share-based compensation expense	1,967,000	1,830,000
Loss on sale of available-for-sale securities	0
Loans originated for sale	(431,053,000)	(645,620,000)
Proceeds from sale of loans	466,148,000	662,390,000
Gain on loans sold	(13,629,000)	(23,522,000)
Decrease in fair value of loans held-for-sale	599,000	854,000
(Gain) loss on derivatives	(3,625,000)	1,870,000
Settlement of derivatives	0	(1,859,000)
Loan servicing asset revaluation	1,100,000	669,000
Net change in accrued income and other assets	19,262,000	3,114,000
Net change in accrued expenses and other liabilities	(5,084,000)	372,000
Net cash provided by operating activities	73,776,000	42,943,000
Investing Activities
Net loan activity, excluding purchases	(87,883,000)	156,670,000
Proceeds from sale of other real estate owned	1,188,000	0
Maturities and calls of securities available-for-sale	69,798,000	129,183,000
Purchase of securities available-for-sale	(12,133,000)	(272,845,000)
Maturities and calls of securities held-to-maturity	5,927,000	6,000,000
Purchase of securities held-to-maturity	(41,246,000)	0
Redemption of Federal Home Loan Bank of Indianapolis stock	431,000	0
Purchase of Federal Home Loan Bank of Indianapolis stock	(3,131,000)	0
Net proceeds from sale of premises and equipment	0	8,116,000
Purchase of premises and equipment	(14,368,000)	(22,467,000)
Loans purchased	(295,254,000)	(37,527,000)
Net proceeds from sale of portfolio loans	14,466,000	0
Other investing activities	374,000	2,264,000
Net cash used in investing activities	(361,831,000)	(30,606,000)
Financing Activities
Net increase (decrease) in deposits	13,685,000	(46,290,000)
Cash dividends paid	(1,733,000)	(1,802,000)
Repayment of subordinated debt	0	(35,000,000)
Net proceeds from issuance of subordinated debt	0	58,658,000
Repurchase of common stock	(20,626,000)	0
Proceeds from advances from Federal Home Loan Bank	455,000,000	110,000,000
Repayment of advances from Federal Home Loan Bank	(380,000,000)	(110,000,000)
Other, net	(179,000)	(194,000)
Net cash provided by (used in) financing activities	66,147,000	(24,628,000)
Net Decrease in Cash and Cash Equivalents	(221,908,000)	(12,291,000)
Cash and Cash Equivalents, Beginning of Period	442,960,000	419,806,000
Cash and Cash Equivalents, End of Period	221,052,000	407,515,000
Supplemental Disclosures
Cash paid during the period for interest	35,946,000	36,511,000
Income Taxes Paid, Net	1,893,000	4,995,000
Loans transferred to other real estate owned	0	1,188,000
Loans transferred to held-for-sale from portfolio	14,049,000	0
Cash dividends declared, paid in subsequent period	557,000	591,000
Securities purchased during the period, settled in subsequent period	2,997,000	0
Transfer of available-for-sale mortgage-backed securities to held-to-maturity mortgage-backed securities at fair value	$ 96,220,000	$ 0

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results expected for the year ending December 31, 2022 or any other period. The September 30, 2022 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2021.

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, valuation of the servicing asset and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements.

The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.

Certain reclassifications have been made to the 2021 financial statements to conform to the presentation of the 2022 financial statements. These reclassifications had no effect on net income.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and nine months ended September 30, 2022 and 2021. 

(dollars in thousands, except per share data)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Basic earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Basic earnings per common share	$	0.89	$	1.22	$	3.04	$	3.59
Diluted earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Dilutive effect of equity compensation	67,596		51,865		66,703		51,194
Weighted-average common and incremental shares	9,525,855		9,988,102		9,681,742		9,974,071
Diluted earnings per common share (1)	$	0.89	$	1.21	$	3.01	$	3.57

(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 426 and 1,616 for the three and nine months ended September 30, 2022, respectively. There were 0 and 28 weighted-average antidilutive shares for the three and nine months ended September 30, 2021, respectively.

XML

Securities

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Securities

Securities

The following tables summarize securities available-for-sale and securities held-to-maturity as of September 30, 2022 and December 31, 2021.

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	38,197	$	—	$	(1,868)	$	36,329
Municipal securities	71,156		181		(7,800)		63,537
Agency mortgage-backed securities - residential	259,568		—		(40,377)		219,191
Agency mortgage-backed securities - commercial	17,825		—		(1,303)		16,522
Private label mortgage-backed securities - residential	12,320		—		(1,279)		11,041
Asset-backed securities	5,000		—		(116)		4,884
Corporate securities	44,644		25		(2,608)		42,061
Total available-for-sale	$	448,710	$	206	$	(55,351)	$	393,565

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,957	$	—	$	(1,289)	$	12,668
Mortgage-backed securities - residential	123,718		—		(16,148)		107,570
Mortgage-backed securities - commercial	5,828		—		(1,142)		4,686
Corporate securities	47,554		9		(2,510)		45,053
Total held-to-maturity	$	191,057	$	9	$	(21,089)	$	169,977

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	50,013	$	164	$	(1,137)	$	49,040
Municipal securities	75,158		1,940		(65)		77,033
Agency mortgage-backed securities - residential	377,928		960		(5,652)		373,236
Agency mortgage-backed securities - commercial	36,024		441		(139)		36,326
Private label mortgage-backed securities - residential	15,902		122		(3)		16,021
Asset-backed securities	5,000		4		—		5,004
Corporate securities	46,482		597		(695)		46,384
Total available-for-sale	$	606,507	$	4,228	$	(7,691)	$	603,044

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,992	$	717	$	—	$	14,709
Corporate securities	45,573		1,186		—		46,759
Total held-to-maturity	$	59,565	$	1,903	$	—	$	61,468

The carrying value of securities at September 30, 2022 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
One to five years	$	32,743	$	31,812
Five to ten years	50,888		48,261
After ten years	70,366		61,854
	153,997		141,927
Agency mortgage-backed securities - residential	259,568		219,191
Agency mortgage-backed securities - commercial	17,825		16,522
Private label mortgage-backed securities - residential	12,320		11,041
Asset-backed securities	5,000		4,884
Total	$	448,710	$	393,565

	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value
One to five years	$	11,163	$	10,915
Five to ten years	44,865		42,091
After ten years	5,483		4,715
	61,511		57,721
Agency mortgage-backed securities - residential	123,718		107,570
Agency mortgage-backed securities - commercial	5,828		4,686
Total	$	191,057	$	169,977

There were no gross gains or losses resulting from the sale of available-for-sale securities during the three and nine months ended September 30, 2022 and September 30, 2021, respectively.

Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at September 30, 2022 and December 31, 2021 was $541.0 million and $403.2 million, which was approximately 96% and 61%, respectively, of the Company’s AFS and HTM securities portfolios. As of September 30, 2022, the Company’s security portfolio consisted of 447 securities, of which 438 were in an unrealized loss position. The unrealized losses are related to the categories noted below.

These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced, with the resulting loss recognized in net income in the period the other-than-temporary impairment (“OTTI”) is identified.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at September 30, 2022.

Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities

The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the terms of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at September 30, 2022.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at September 30, 2022 and December 31, 2021.

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	33,956	$	(1,092)	$	2,223	$	(776)	$	36,179	$	(1,868)
Municipal securities	52,815		(7,800)		—		—		52,815		(7,800)
Agency mortgage-backed securities- residential	186,134		(34,577)		30,061		(5,800)		216,195		(40,377)
Agency mortgage-backed securities- commercial	11,072		(849)		5,442		(454)		16,514		(1,303)
Private label mortgage-backed securities - residential	3,352		(418)		7,689		(861)		11,041		(1,279)
Asset-backed securities	4,884		(116)		—		—		4,884		(116)
Corporate securities	27,595		(1,478)		11,376		(1,130)		38,971		(2,608)
Total	$	319,808	$	(46,330)	$	56,791	$	(9,021)	$	376,599	$	(55,351)

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity
Municipal securities	$	12,167	$	(1,256)	$	388	$	(33)	$	12,555	$	(1,289)
Agency mortgage-backed securities - residential	75,251		(10,583)		32,319		(5,565)		107,570		(16,148)
Agency mortgage-backed securities - commercial	4,686		(1,142)		—		—		4,686		(1,142)
Corporate securities	33,712		(2,342)		5,831		(168)		39,543		(2,510)
Total	$	125,816	$	(15,323)	$	38,538	$	(5,766)	$	164,354	$	(21,089)

	December 31, 2021
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	2,921	$	(79)	$	40,305	$	(1,058)	$	43,226	$	(1,137)
Municipal securities	5,721		(65)		—		—		5,721		(65)
Agency mortgage-backed securities - residential	287,820		(3,694)		40,840		(1,958)		328,660		(5,652)
Agency mortgage-backed securities - commercial	3,944		(139)		—		—		3,944		(139)
Private label mortgage-backed securities	374		(3)		—		—		374		(3)
Asset-backed securities	—		—		—		—		—		—
Corporate securities	11,813		(187)		9,491		(508)		21,304		(695)
Total	$	312,593	$	(4,167)	$	90,636	$	(3,524)	$	403,229	$	(7,691)

There were no amounts reclassified from accumulated other comprehensive loss to the condensed consolidated statements of income during the three and nine months ended September 30, 2022 and September 30, 2021, respectively.

XML

Loans

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Loans

Loans

Loan balances as of September 30, 2022 and December 31, 2021 are summarized in the table below. Categories of loans include:

(in thousands)	September 30, 2022		December 31, 2021
Commercial loans
Commercial and industrial	$	104,780	$	96,008
Owner-occupied commercial real estate	58,615		66,732
Investor commercial real estate	91,021		28,019
Construction	139,509		136,619
Single tenant lease financing	895,302		865,854
Public finance	614,139		592,665
Healthcare finance	293,686		387,852
Small business lending	113,001		108,666
Franchise finance	225,012		81,448
Total commercial loans	2,535,065		2,363,863
Consumer loans
Residential mortgage	337,565		186,770
Home equity	22,114		17,665
Other consumer loans	312,512		265,478
Total consumer loans	672,191		469,913
Total commercial and consumer loans	3,207,256		2,833,776
Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other(1)	48,650		53,886
Total loans	3,255,906		2,887,662
Allowance for loan losses	(29,866)		(27,841)
Net loans	$	3,226,040	$	2,859,821

(1) Includes carrying value adjustments of $33.9 million and $37.5 million related to terminated interest rate swaps associated with public finance loans as of September 30, 2022 and December 31, 2021, respectively. 

Risk characteristics of each loan portfolio segment are as follows:

Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States.

Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States and its loans are often secured by manufacturing and service facilities, as well as office buildings.

Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the Midwest and Southwest regions of the United States. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects unless other underwriting factors are present to mitigate these additional risks.

Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, and multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States.

Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.

Public Finance: These loans are made on a nationwide basis to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; renewable energy projects; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment.

Healthcare Finance: These loans were made on a nationwide basis to healthcare providers, primarily dentists, for practice acquisition financing or refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the underlying collateral provided by the borrower.

Small Business Lending: These loans are made on a nationwide basis to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration (“SBA”) under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. These loans also include loans originated by the Bank under the SBA’s Paycheck Protection Program, which are fully guaranteed by the SBA.

Franchise Finance: These loans are made on a nationwide basis through our partnership with ApplePie Capital, which, through their deep relationships with franchise brands provides franchisees with financing options for new franchise units, recapitalization, expansion, equipment and working capital. The sources of repayment are either based on identified cash flows from existing operations of the borrower or pro forma cash flow for new franchise locations.

Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market.

Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.

Allowance for Loan Losses Methodology

Company policy is designed to maintain an adequate allowance for loan losses (“ALLL”). The portfolio is segmented by loan type, and the required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on average historical losses, adjusted for current economic factors and portfolio trends. Management adds qualitative factors for observable trends, changes in internal practices, changes in delinquencies and impairments, and external factors. Observable factors include changes in the composition and size of portfolios, as well as loan terms or concentration levels. The Company evaluates the impact of internal changes such as management and staff experience levels or modification to loan underwriting processes. Delinquency trends are scrutinized for both volume and severity of past due, nonaccrual, or classified loans, as well as any changes in the value of underlying collateral. Finally, the Company considers the effect of other external factors such as national, regional, and local economic and business conditions, as well as competitive, legal, and regulatory requirements. Loans that are considered to be impaired are evaluated to determine the need for a specific allowance by applying at least one of three methodologies: present value of future cash flows; fair value of collateral less costs to sell; or the loan’s observable market price. All troubled debt restructurings (“TDR”) are considered impaired loans. Loans evaluated for impairment are removed from other pools to prevent double-counting. Accounting Standards Codification (“ASC”) Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral less costs to sell and allows existing methods for recognizing interest income.

Provision for Loan Losses

A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.

Policy for Charging Off Loans

The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.

The following tables present changes in the balance of the ALLL during the three and nine months ended September 30, 2022 and 2021. 

(in thousands)	Three Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	2,026	$	(301)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	703		(87)		—		—		616
Investor commercial real estate	621		453		—		—		1,074
Construction	1,707		(117)		—		—		1,590
Single tenant lease financing	9,712		315		—		—		10,027
Public finance	1,850		(61)		—		—		1,789
Healthcare finance	4,762		(1,150)		—		—		3,612
Small business lending	1,956		217		(130)		3		2,046
Franchise finance	2,281		734		—		—		3,015
Residential mortgage	1,138		231		—		1		1,370
Home equity	54		7		—		1		62
Other consumer loans	2,343		651		(106)		50		2,938
Total	$	29,153	$	892	$	(236)	$	57	$	29,866

	Nine Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,891	$	(166)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	742		(126)		—		—		616
Investor commercial real estate	328		746		—		—		1,074
Construction	1,612		(22)		—		—		1,590
Single tenant lease financing	10,385		(1,589)		—		1,231		10,027
Public finance	1,776		13		—		—		1,789
Healthcare finance	5,940		(2,328)		—		—		3,612
Small business lending	1,387		847		(210)		22		2,046
Franchise finance	1,083		1,932		—		—		3,015
Residential mortgage	643		724		—		3		1,370
Home equity	64		(139)		—		137		62
Other consumer loans	1,990		1,116		(397)		229		2,938
Tax refund advance loans	—		1,860		(1,860)		—		—
Total	$	27,841	$	2,868	$	(2,467)	$	1,624	$	29,866

(in thousands)	Three Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,902	$	122	$	—	$	2	$	2,026
Owner-occupied commercial real estate	1,021		(28)		—		—		993
Investor commercial real estate	329		(4)		—		—		325
Construction	1,357		(30)		—		—		1,327
Single tenant lease financing	11,205		(152)		—		—		11,053
Public finance	1,700		32		—		—		1,732
Healthcare finance	6,938		(584)		—		—		6,354
Small business lending	783		415		(10)		26		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	594		19		—		3		616
Home equity	63		—		—		2		65
Other consumer loans	2,174		(129)		(110)		50		1,985
Total	$	28,066	$	(29)	$	(120)	$	83	$	28,000

	Nine Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,146	$	823	$	(28)	$	85	$	2,026
Owner-occupied commercial real estate	1,082		(89)		—		—		993
Investor commercial real estate	155		170		—		—		325
Construction	1,192		135		—		—		1,327
Single tenant lease financing	12,990		454		(2,391)		—		11,053
Public finance	1,732		—		—		—		1,732
Healthcare finance	7,485		(1,131)		—		—		6,354
Small business lending	628		776		(222)		32		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	519		91		(6)		12		616
Home equity	48		63		(51)		5		65
Other consumer loans	2,507		(334)		(423)		235		1,985
Total	$	29,484	$	1,268	$	(3,121)	$	369	$	28,000

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of September 30, 2022 and December 31, 2021. 

(in thousands)	Loans						Allowance for Loan Losses
September 30, 2022	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	94,617	$	10,163	$	104,780	$	1,377	$	350	$	1,727
Owner-occupied commercial real estate	56,993		1,622		58,615		616		—		616
Investor commercial real estate	91,021		—		91,021		1,074		—		1,074
Construction	139,509		—		139,509		1,590		—		1,590
Single tenant lease financing	895,302		—		895,302		10,027		—		10,027
Public finance	614,139		—		614,139		1,789		—		1,789
Healthcare finance	293,686		—		293,686		3,612		—		3,612
Small business lending(1)	105,129		7,872		113,001		1,368		678		2,046
Franchise finance	225,012		—		225,012		3,015		—		3,015
Residential mortgage	334,082		3,483		337,565		1,370		—		1,370
Home equity	22,114		—		22,114		62		—		62
Other consumer	312,509		3		312,512		2,938		—		2,938
Total	$	3,184,113	$	23,143	$	3,207,256	$	28,838	$	1,028	$	29,866

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

(in thousands)	Loans						Allowance for Loan Losses
December 31, 2021	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	95,364	$	644	$	96,008	$	1,441	$	450	$	1,891
Owner-occupied commercial real estate	63,387		3,345		66,732		742		—		742
Investor commercial real estate	28,019		—		28,019		328		—		328
Construction	136,619		—		136,619		1,612		—		1,612
Single tenant lease financing	864,754		1,100		865,854		10,290		95		10,385
Public finance	592,665		—		592,665		1,776		—		1,776
Healthcare finance	386,926		926		387,852		5,417		523		5,940
Small business lending(1)	106,682		1,984		108,666		994		393		1,387
Franchise finance	81,448		—		81,448		1,083		—		1,083
Residential mortgage	183,852		2,918		186,770		643		—		643
Home equity	17,651		14		17,665		64		—		64
Other consumer	265,469		9		265,478		1,990		—		1,990
Total	$	2,822,836	$	10,940	$	2,833,776	$	26,380	$	1,461	$	27,841

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:

•“Pass” - Higher quality loans that do not fit any of the other categories described below.

•“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

•“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.

•“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.

•“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans

Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.

The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	93,262	$	1,355	$	10,163	$	104,780
Owner-occupied commercial real estate	46,423		10,570		1,622		58,615
Investor commercial real estate	91,021		—		—		91,021
Construction	139,509		—		—		139,509
Single tenant lease financing	894,208		1,094		—		895,302
Public finance	611,709		2,430		—		614,139
Healthcare finance	292,280		1,406		—		293,686
Small business lending(1)	99,722		5,407		7,872		113,001
Franchise finance	224,721		291		—		225,012
Total commercial loans	$	2,492,855	$	22,553	$	19,657	$	2,535,065

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	September 30, 2022
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	336,492	$	1,073	$	337,565
Home equity	22,114		—		22,114
Other consumer	312,509		3		312,512
Total consumer loans	$	671,115	$	1,076	$	672,191

	December 31, 2021
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	82,412	$	12,952	$	644	$	96,008
Owner-occupied commercial real estate	59,369		4,018		3,345		66,732
Investor commercial real estate	28,019		—		—		28,019
Construction	124,578		12,041		—		136,619
Single tenant lease financing	859,612		5,142		1,100		865,854
Public finance	591,630		1,035		—		592,665
Healthcare finance	386,337		589		926		387,852
Small business lending(1)	99,250		7,433		1,983		108,666
Franchise finance	81,448		—		—		81,448
Total commercial loans	$	2,312,655	$	43,210	$	7,998	$	2,363,863

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	185,544	$	1,226	$	186,770
Home equity	17,651		14		17,665
Other consumer	265,469		9		265,478
Total consumer loans	$	468,664	$	1,249	$	469,913

The following tables present the Company’s loan portfolio delinquency analysis as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	350	$	350	$	104,430	$	104,780	$	350	$	—
Owner-occupied commercial real estate	—		—		—		—		58,615		58,615		1,622		—
Investor commercial real estate	—		—		—		—		91,021		91,021		—		—
Construction	—		—		—		—		139,509		139,509		—		—
Single tenant lease financing	—		—		—		—		895,302		895,302		—		—
Public finance	—		—		—		—		614,139		614,139		—		—
Healthcare finance	—		—		—		—		293,686		293,686		—		—
Small business lending(1)	—		356		488		844		112,157		113,001		2,958		—
Franchise finance	—		—		—		—		225,012		225,012		—		—
Residential mortgage	171		71		353		595		336,970		337,565		1,073		—
Home equity	—		—		—		—		22,114		22,114		—		—
Other consumer	30		20		—		50		312,462		312,512		3		—
Total	$	201	$	447	$	1,191	$	1,839	$	3,205,417	$	3,207,256	$	6,006	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	—	$	—	$	96,008	$	96,008	$	674	$	—
Owner-occupied commercial real estate	—		—		—		—		66,732		66,732		—		—
Investor commercial real estate	—		—		—		—		28,019		28,019		3,419		—
Construction	—		—		—		—		136,619		136,619		—		—
Single tenant lease financing	—		—		—		—		865,854		865,854		1,100		—
Public finance	—		—		—		—		592,665		592,665		—		—
Healthcare finance	—		—		—		—		387,852		387,852		—		—
Small business lending(1)	—		—		657		657		108,009		108,666		959		—
Franchising Finance	—		—		—		—		81,448		81,448		—		—
Residential mortgage	51		226		106		383		186,387		186,770		1,226		—
Home equity	—		—		—		—		17,665		17,665		14		—
Other consumer	68		18		—		86		265,392		265,478		9		—
Total	$	119	$	244	$	763	$	1,126	$	2,832,650	$	2,833,776	$	7,401	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

Impaired Loans

A loan is designated as impaired, in accordance with the impairment accounting guidance, when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well-secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due.

Impaired loans include nonperforming loans as well as loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection.

ASC Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.

The following table presents the Company’s impaired loans as of September 30, 2022 and December 31, 2021. 

	September 30, 2022						December 31, 2021
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	9,813	$	9,813	$	—	$	—	$	—	$	—
Owner-occupied commercial real estate	—		—		—		3,345		3,466		—
Small business lending(1)	5,838		6,087		—		959		1,193		—
Residential mortgage	3,483		3,634		—		2,918		3,063		—
Home equity	—		—		—		14		15		—
Other consumer loans	3		29		—		9		44		—
Total	19,137		19,563		—		7,245		7,781		—
Loans with a specific valuation allowance
Commercial and industrial	350		350		350		644		677		450
Owner-occupied commercial real estate	1,622		1,779		—		—		—		—
Single tenant lease financing	—		—		—		1,100		1,123		95
Healthcare finance	—		—		—		926		926		523
Small business lending(1)	2,034		2,034		678		1,025		1,025		393
Total	4,006		4,163		1,028		3,695		3,751		1,461
Total impaired loans	$	23,143	$	23,726	$	1,028	$	10,940	$	11,532	$	1,461

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

The table below presents average balances and interest income recognized for impaired loans during the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended								Nine Months Ended
	September 30, 2022				September 30, 2021				September 30, 2022				September 30, 2021
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	4,906	$	—	$	—	$	—	$	1,636	$	—	$	259	$	9
Owner-occupied commercial real estate	1,645		—		3,457		—		2,471		—		3,297		—
Single tenant lease financing	—		—		1,315		—		—		—		100		5
Healthcare finance	—		—		—		—		—		—		336		—
Small business lending(1)	2,167		—		—		—		1,288		—		1,005		—
Residential mortgage	3,711		9		2,267		15		3,550		26		2,138		28
Home equity	15		—		14		—		14		—		13		—
Other consumer	8		—		23		—		9		—		27		—
Total	12,452		9		7,076		15		8,968		26		7,175		42
Loans with a specific valuation allowance
Commercial and industrial	350		—		690		—		456		—		677		—
Owner-occupied commercial real estate	—		—		—		—		—		—		473		—
Single tenant lease financing	—		—		2,048		—		547		—		4,875		—
Healthcare finance	660		—		956		37		826		45		809		73
Small business lending(1)	1,827		—		1,203		—		1,611		—		401		—
Other consumer	199		—		—		—		66		—		—		—
Total	3,036		—		4,897		37		3,506		45		7,235		73
Total impaired loans	$	15,488	$	9	$	11,973	$	52	$	12,474	$	71	$	14,410	$	115

1 Balance is partially guaranteed by the U.S. government.

The Company did not have any other real estate owned (“OREO”) as of September 30, 2022. The Company had $1.2 million in OREO as of December 31, 2021, which consisted of one commercial property. There were two loans totaling $0.2 million and one loan totaling $0.1 million in the process of foreclosure at September 30, 2022 and December 31, 2021, respectively.

Troubled Debt Restructurings

The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.

When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance.

In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to obtain additional collateral and/or guarantees to support the debt, or a combination of the two.

There were no loans classified as new TDRs during the three months ended September 30, 2022. There was one portfolio residential mortgage loan classified as a new TDR during the nine months ended September 30, 2022 with a pre-modification and post-modification outstanding recorded investment of $0.7 million. The Company did not allocate a specific allowance for that loan as of September 30, 2022. The modifications consisted of interest-only payments for a period of time. There was one portfolio residential mortgage loan classified as a new TDR during the three and nine months ended September 30, 2021 with a pre-modification and post-modification outstanding recorded investment of $0.8 million. The Company did not allocate a specific allowance for that loan as of September 30, 2021. The modifications consisted of interest-only payments for a period of time. There were no performing TDRs that had payment defaults within the twelve months following modification during the three and nine months ended September 30, 2022 and 2021, respectively.

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encouraged financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief were in effect from the period beginning March 1, 2020 until the earlier of January 1, 2022 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. As of September 30, 2022, the Company had no loans as non-TDR loan modifications due to COVID-19.

XML

Premises and Equipment

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Premises and Equipment

Premises and Equipment

The following table summarizes premises and equipment at September 30, 2022 and December 31, 2021.

(in thousands)	September 30, 2022		December 31, 2021
Land	$	5,598	$	—
Construction in process	5		57,469
Right of use leased asset	244		208
Building and improvements	55,226		1,090
Furniture and equipment	19,424		7,800
Less: accumulated depreciation	(9,750)		(6,725)
Total	$	70,747	$	59,842

  

On February 16, 2021, the Company entered into an agreement to sell its then headquarters (the “Prior Headquarters”) and certain equipment located in the Prior Headquarters to a third party. The sale was completed on April 16, 2021, and the Company recorded a gain on sale of $2.5 million. As a part of the sale agreement, the buyer agreed to lease the Prior Headquarters back to the Company through December 31, 2021. The Company vacated the Prior Headquarters at the end of the lease, on or prior to December 31, 2021.

XML

Goodwill

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Goodwill        

As of September 30, 2022 and December 31, 2021, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three and nine months ended September 30, 2022. Goodwill is assessed for impairment annually as of August 31, or more frequently if events occur or circumstances change that indicate an impairment may exist. When assessing goodwill for impairment, first, a qualitative assessment can be made to determine whether it is more likely than not that the estimated fair value of a reporting unit is less than its estimated carrying value. If the results of the qualitative assessment are not conclusive, a quantitative goodwill test is performed. Alternatively, a quantitative goodwill test can be performed without performing a qualitative assessment.

Goodwill was assessed for impairment using a qualitative test performed as of August 31, 2022. The estimated fair value of the reporting unit exceeded the net carrying value, and therefore no goodwill impairment existed as of that date.

XML

Servicing Asset

9 Months Ended

Sep. 30, 2022

Transfers and Servicing [Abstract]

Servicing Asset

Servicing Asset

Activity for the servicing asset and the related changes in fair value for the three and nine months ended September 30, 2022 and 2021 are shown in the table below.

	Three Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	5,345	$	4,120
Additions:
Originated and purchased servicing	783		566
Subtractions
Paydowns:	(279)		(176)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(54)		(98)
Loan servicing asset revaluation	$	(333)	$	(274)
Balance, end of period	$	5,795	$	4,412

	Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	4,702	$	3,569
Additions:
Originated and purchased servicing	2,193		1,512
Subtractions
Paydowns:	(888)		(500)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(212)		(169)
Loan servicing asset revaluation	$	(1,100)	$	(669)
Balance, end of period	$	5,795	$	4,412

Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of September 30, 2022 and December 31, 2021 are shown in the table below.

(in thousands)	September 30, 2022		December 31, 2021
Loan portfolios serviced for:
SBA guaranteed loans	$	285,736	$	230,514
Total	$	285,736	$	230,514

Loan servicing revenue totaled $0.7 million and $1.9 million for the three and nine months ended September 30, 2022 and $0.5 million and $1.4 million for the three and nine months ended September 30, 2021, respectively. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.3 million and $1.1 million downward valuation for the three and nine months ended September 30, 2022, respectively, and a $0.3 million and $0.7 million downward valuation for the three and nine months ended September 30, 2021, respectively.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 11 - Fair Value of Financial Instruments for further details.

XML

Subordinated Debt

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Subordinated Debt

Subordinated Debt

In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially had a fixed interest rate of 6.0% per year to, but excluding September 30, 2021, and thereafter a floating rate equal to the then-current three-month LIBOR rate plus 485 basis points. All interest on the 2026 Notes was payable quarterly. The 2026 Notes were scheduled to mature on September 30, 2026. The 2026 Notes were unsecured subordinated obligations of the Company eligible to be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes were intended to qualify as Tier 2 capital under regulatory guidelines. The Company redeemed the 2026 Notes in full on September 30, 2021.

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate plus 4.11%). All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

In October 2020, the Company entered into a term loan in the principal amount of $10.0 million evidenced by a term note due 2030 (the “2030 Note”). The 2030 Note initially bears a fixed interest rate of 6.0% per year to, but excluding, November 1, 2025 and thereafter at a floating rate equal to the then-current benchmark rate (initially the then current three-month term secured overnight financing rate (“Term SOFR”) plus 5.795%). The 2030 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after November 1, 2025. The 2030 Note is intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2030 Note to redeem a subordinated term note that had been entered into in October 2015.

In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes initially bear a fixed interest rate of 3.75% per year to, but excluding, September 1, 2026, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR plus 3.11%). The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 1, 2026. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used a portion of the net proceeds from the issuance of the 2031 Notes to redeem the 2026 Notes. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. On December 30, 2021, we completed an exchange of $59.3 million principal amount of the unregistered 2031 Notes for registered 2031 Notes in satisfaction of our obligations under the registration rights agreement. Holders of $0.7 million of unregistered 2031 Notes did not participate in the exchange.

The following table presents the principal balance and unamortized debt issuance costs for the 2029 Notes, the 2030 Notes, and the 2031 Notes as of September 30, 2022 and December 31, 2021.

	September 30, 2022				December 31, 2021
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs
2029 Notes	$	37,000	$	(1,060)	$	37,000	$	(1,178)
2030 Notes	10,000		(190)		10,000		(208)
2031 Notes	60,000		(1,294)		60,000		(1,383)
Total	$	107,000	$	(2,544)	$	107,000	$	(2,769)

XML

Benefit Plans

9 Months Ended

Sep. 30, 2022

Retirement Benefits [Abstract]

Benefit Plans

Benefit Plans

Employment Agreements

The Company is party to certain employment agreements with each of its Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer. The employment agreements each provide for annual base salaries and annual bonuses, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonuses are to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee. The agreements also provide that each of the Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer, may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.

The agreements also provide for the continuation of salary and certain other benefits for a specified period of time upon termination of employment under certain circumstances, including resignation for “good reason” or termination by the Company without “cause” at any time or any termination of employment within twelve months following a “change in control,” along with other specific conditions.

2022 Equity Incentive Plan

The First Internet Bancorp 2022 Equity Incentive Plan (the “2022 Plan”) was approved by our Board of Directors and ratified by our shareholders on May 16, 2022. The plan permits awards of incentive and non-statutory stock options, stock appreciation rights, restricted stock awards, stock unit awards, performance awards and other stock-based awards. All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2022 Plan. The 2022 Plan initially authorized the issuance of 400,000 new shares of the Company’s common stock plus all shares of common stock that remained available for future grants under the First Internet Bancorp 2013 Equity Incentive Plan (the “2013 Plan”).

Award Activity Under 2022 Plan

The Company recorded less than $0.1 million of share-based compensation expense for both the three and nine months ended September 30, 2022, related to stock-based awards under the 2022 Plan.

The following table summarizes the stock-based award activity under the 2022 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	—	$	—	—	$	—	—	$	—
Granted	—	—		4,151	36.84		—	—
Unvested at September 30, 2022	—	$	—	4,151	$	36.84	—	$	—

At September 30, 2022, the total unrecognized compensation cost related to unvested stock-based awards was 0.1 million with a weighted-average expense recognition period of 0.6 years.

2013 Equity Incentive Plan

The 2013 Plan authorized the issuance of 750,000 shares of the Company’s common stock in the form of stock-based awards to employees, directors, and other eligible persons. Although outstanding stock-based awards under the 2013 Plan remain in place according to their terms, our authority to grant new awards under the 2013 Plan terminated upon shareholder approval of the 2022 Plan.

Award Activity Under 2013 Plan

The Company recorded $0.4 million and $2.0 million of share-based compensation expense for the three and nine months ended September 30, 2022, respectively, related to stock-based awards under the 2013 Plan. The Company recorded $0.6 million and $1.8 million of share-based compensation expense for the three and nine months ended September 30, 2021, related to stock-based awards under the 2013 Plan.

The following table summarizes the stock-based award activity under the 2013 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	112,822	$	28.18	—	$	—	—	$	—
Granted	41,662	46.67		9,954	52.64		3	41.87
Cancelled/Forfeited	(5,441)	36.68		(644)	52.64		—	—
Vested	(23,256)	24.62		(7,378)	52.64		(3)	41.87
Unvested at September 30, 2022	125,787	$	34.59	1,932	$	52.64	—	$	—

At September 30, 2022, the total unrecognized compensation cost related to unvested stock-based awards was $2.1 million with a weighted-average expense recognition period of 1.8 years.

Directors Deferred Stock Plan

Until January 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The Directors Deferred Stock Plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right.

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the nine months ended September 30, 2022.

	Deferred Stock Rights
Outstanding, beginning of period	84,536
Granted	322
Exercised	—
Outstanding, end of period	84,858

All deferred stock rights granted during the 2022 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.

XML

Commitments and Credit Risk

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Credit Risk

Commitments and Credit Risk

In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At September 30, 2022 and December 31, 2021, the Company had outstanding loan commitments totaling approximately $508.6 million and $324.3 million, respectively.

Capital Commitments

Capital expenditures contracted for at the balance sheet date but not yet recognized in the financial statements are associated with the construction of the building where our corporate headquarters is located, along with an attached parking garage. The Company has entered into construction-related contracts in the amount of $69.2 million. As of September 30, 2022, $6.1 million of such contract commitments had not yet been incurred. These commitments are due within one year.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1    Quoted prices in active markets for identical assets or liabilities

Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.

Available-for-Sale Securities

Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.

Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage- and asset-backed securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.

In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2022 or December 31, 2021.

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).

Servicing Asset

Fair value is based on a loan-by-loan basis taking into consideration the original maturity of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing assets begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).

Interest Rate Swap Agreements

The fair value of interest rate swap agreements is estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data (Level 2).

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).

Interest Rate Lock Commitments

The fair values of interest rate lock commitments (“IRLCs”) are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3).

The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at September 30, 2022 and December 31, 2021.

			September 30, 2022  Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	36,329	$	—	$	36,329	$	—
Municipal securities	63,537		—		63,537		—
Agency mortgage-backed securities - residential	219,191		—		219,191		—
Agency mortgage-backed securities - commercial	16,522		—		16,522		—
Private label mortgage-backed securities - residential	11,041		—		11,041		—
Asset-backed securities	4,884		—		4,884		—
Corporate securities	42,061		—		42,061		—
Total available-for-sale securities	$	393,565	$	—	$	393,565	$	—
Loans held-for-sale (mandatory pricing agreements)	9,677		—		9,677		—
Servicing asset	5,795		—		—		5,795
Interest rate swap assets	8,978		—		8,978		—
Forward contracts	1,006		1,006		—		—
IRLCs	(388)		—		—		(388)

			December 31, 2021 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	49,040	$	—	$	49,040	$	—
Municipal securities	77,033		—		77,033		—
Agency mortgage-backed securities - residential	373,236		—		373,236		—
Agency mortgage-backed securities - commercial	36,326		—		36,326		—
Private label mortgage-backed securities - residential	16,021		—		16,021		—
Asset-backed securities	5,004		—		5,004		—
Corporate securities	46,384		—		46,384		—
Total available-for-sale securities	$	603,044	$	—	$	603,044	$	—
Loans held-for-sale (mandatory pricing agreements)	23,233		—		23,233		—
Servicing asset	4,702		—		—		4,702
Interest rate swap agreements	(14,271)		—		(14,271)		—
Forward contracts	(30)		(30)		—		—
IRLCs	718		—		—		718

The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, July 1, 2022	$	5,345	$	462
Total realized gains
Additions:
Originated and purchased servicing	783		—
Subtractions:
Paydowns	(279)		—
Change in fair value	(54)		(850)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of July 1, 2021	$	4,120	$	818
Total realized gains
Additions:
Originated and purchased servicing	566		—
Subtractions:
Paydowns	(176)		—
Change in fair value	(98)		22
Balance, September 30, 2021	$	4,412	$	840

	Nine Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, January 1, 2022	$	4,702	$	718
Total realized gains
Additions:
Originated and purchased servicing	2,193		—
Subtractions:
Paydowns	(888)		—
Change in fair value	(212)		(1,106)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of January 1, 2021	$	3,569	$	3,361
Total realized gains
Additions:
Originated and purchased servicing	1,512		—
Subtractions:
Paydowns	(500)		—
Change in fair value	(169)		(2,521)
Balance, September 30, 2021	$	4,412	$	840

The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.

Impaired Loans (Collateral Dependent)

Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price.

If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment.

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at September 30, 2022 and December 31, 2021.

			September 30, 2022
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,134	$	—	$	—	$	1,134

			December 31, 2021
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,228	$	—	$	—	$	1,228

 Significant Unobservable (Level 3) Inputs

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)	Fair Value at September 30, 2022		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,134	Fair value of collateral	Discount for type of property and current market conditions	10%	10%
IRLCs	(388)		Discounted cash flow	Loan closing rates	25% - 100%	81%
Servicing asset	5,795		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 12%	14.6% 12%

(dollars in thousands)	Fair Value at December 31, 2021		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,228	Fair value of collateral	Discount for type of property and current market conditions	0% - 35%	10.1%
IRLCs	718		Discounted cash flow	Loan closing rates	42% - 100%	89%
Servicing asset	4,702		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 10%	12.5% 10%

The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.

Cash and Cash Equivalents

For these instruments, the carrying amount is a reasonable estimate of fair value.

Securities Held-to-Maturity

Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.

Level 2 securities include municipal securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for

specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.

In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2022 or December 31, 2021.

Loans Held-for-Sale (best efforts pricing agreements)

The fair value of these loans approximates carrying value.

Loans

The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.

Accrued Interest Receivable

The fair value of these financial instruments approximates carrying value.

Federal Home Loan Bank of Indianapolis Stock

The fair value approximates carrying value.

Deposits 

The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.

Advances from Federal Home Loan Bank

The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.

Subordinated Debt

The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.

 Accrued Interest Payable

The fair value of these financial instruments approximates carrying value.

Commitments

The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of September 30, 2022 and December 31, 2021.

The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021.

	September 30, 2022 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	221,052	$	221,052	$	221,052	$	—	$	—
Securities held-to-maturity	191,057		169,977		—		169,977		—
Loans held-for-sale (best efforts pricing agreements)	13,426		13,426		—		13,426		—
Net loans	3,226,040		3,027,916		—		—		3,027,916
Accrued interest receivable	16,918		16,918		16,918		—		—
Federal Home Loan Bank of Indianapolis stock	28,350		28,350		—		28,350		—
Deposits	3,192,644		3,056,730		1,910,715		—		1,146,015
Advances from Federal Home Loan Bank	589,926		545,824		—		545,824		—
Subordinated debt	104,456		104,544		34,425		70,119		—
Accrued interest payable	1,887		1,887		1,887		—		—

	December 31, 2021 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	442,960	$	442,960	$	442,960	$	—	$	—
Securities held-to-maturity	59,565		61,468		—		61,468		—
Loans held-for-sale (best efforts pricing agreements)	24,512		24,512		—		24,512		—
Net loans	2,859,821		2,880,024		—		—		2,880,024
Accrued interest receivable	16,037		16,037		16,037		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,178,959		3,190,000		1,909,432		—		1,280,568
Advances from Federal Home Loan Bank	514,922		526,143		—		526,143		—
Subordinated debt	104,231		108,788		38,643		70,145		—
Accrued interest payable	2,018		2,018		2,018		—		—

XML

Mortgage Banking Activities

9 Months Ended

Sep. 30, 2022

Mortgage Banking [Abstract]

Mortgage Banking Activities

Mortgage Banking ActivitiesThe Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income. Refer to Note 13 for further information on derivative financial instruments. 

During the three months ended September 30, 2022 and 2021, the Company originated mortgage loans held-for-sale of $85.1 million and $198.3 million, respectively, and sold $95.0 million and $186.1 million of mortgage loans, respectively, into the secondary market. During the nine months ended September 30, 2022 and 2021, the Company originated mortgage loans held-for-sale of $343.3 million and $585.5 million, respectively, and sold $365.3 million and $579.2 million of mortgage loans, respectively, into the secondary market.

The following table presents the components of income from mortgage banking activities for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Gain on loans sold	$	1,178	$	3,244	$	5,119	$	14,550
Gain (loss) resulting from the change in fair value of loans held-for-sale	(450)		110		(599)		(854)
Gain (loss) resulting from the change in fair value of derivatives	143		496		(66)		(1,422)
Net revenue from mortgage banking activities	$	871	$	3,850	$	4,454	$	12,274

Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.

The Company had various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of September 30, 2022 and December 31, 2021.  

(in thousands)	Carrying amount of the hedged asset				Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Securities available-for-sale (1)	$	69,050	$	75,156	$	(2,106)	$	1,729

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The designated hedged items were $50.0 million at both September 30, 2022 and December 31, 2021.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands) September 30, 2022	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%
Total at September 30, 2022	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%

(dollars in thousands) December 31, 2021	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%
Total at December 31, 2021	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%

In March 2021, the Company terminated the last layer of interest rate swaps associated with available-for-sale agency mortgage-backed securities - residential, which resulted in swap termination payments to counterparties totaling $1.9 million. The corresponding fair value hedging adjustment was allocated pro-rata to the underlying hedged securities and is being amortized over the remaining lives of the designated securities. During the three and nine months ended September 30, 2022, amortization expense totaling $0.1 million and $0.2 million, respectively, was recognized as a reduction to interest income on securities.

In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted average term to maturity of 11.5 years as of September 30, 2022. Amortization expense totaling $1.5 million and $3.6 million, for the three and nine months ended September 30 2022, respectively, and $1.5 million and $3.8 million, for the three and nine months ended September 30, 2021 respectively, related to these previously terminated fair value hedges was recognized as a reduction to interest income on loans.

The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021.

(dollars in thousands) September 30, 2022	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	4.34	$	5,242	3-month LIBOR	2.88	%
Interest rate swaps	60,000		0.89	730		1-month LIBOR	2.88	%
Interest rate swaps	40,000		1.67	912		Fed Funds Effective	2.78	%

(dollars in thousands) December 31, 2021	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	5.1	$	(8,560)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		2.0	(3,980)		1-month LIBOR	2.88	%

These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. As of September 30, 2022 the Company had no pledged cash collateral compared to $15.7 million, as of December 31, 2021. Cash collateral is pledged to counterparties on interest rate swap agreements as security for its obligations related to these agreements. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at September 30, 2022 and December 31, 2021.

	September 30, 2022				December 31, 2021
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	50,000	$	2,094	$	—	$	—
Interest rate swaps associated with variable-rate liabilities	210,000		6,884		—		—
Derivatives not designated as hedging instruments
IRLCs	—		—		62,789		718
Forward contracts	27,750		1,006		—		—
Total contracts	$	287,750	$	9,984	$	62,789	$	718
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	—	$	—	$	50,000	$	(1,731)
Interest rate swaps associated with variable-rate liabilities	—		—		210,000		(12,540)
Derivatives not designated as hedging instruments
Forward contracts	—		—		72,750		(30)
IRLCs	31,202		(388)		—		—
Total contracts	$	31,202	$	(388)	$	332,750	$	(14,301)

The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three and nine months ended September 30, 2022 and 2021.

	Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Three Months Ended				Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest rate swap agreements	$	6,058	$	1,439	$	19,424	$	7,665

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three and nine ended September 30, 2022 and 2021.

	Amount of Gain / (Loss) Recognized in the Three Months Ended				Amount of Gain / (Loss) Recognized in the Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	—	$	—	$	—	$	(2,519)
Forward contracts	993		—		1,036		—
Liability Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(850)	$	22	$	(1,102)	$	—
Forward contracts	—		474		—		1,097

The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three and nine months ended September 30, 2022 and 2021.

(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest income
Securities - taxable	$	—	$	—	$	—	$	(253)
Securities - non-taxable	(7)		(280)		(442)		(817)
Total interest income	(7)		(280)		(442)		(1,070)
Interest expense
Deposits	159		702		1,338		2,072
Other borrowed funds	168		774		1,355		2,258
Total interest expense	327		1,476		2,693		4,330
Net interest income	$	(334)	$	(1,756)	$	(3,135)	$	(5,400)

XML

Accumulated Other Comprehensive Loss

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive LossThe components of accumulated other comprehensive loss, included in shareholders' equity, for the nine months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, January 1, 2022	$	(2,555)	$	—	$	(8,484)	$	(11,039)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(51,682)		(5,402)		19,424		(37,660)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		608		—		608
Other comprehensive (loss) gain before tax	(51,682)		(4,794)		19,424		(37,052)
Income tax (benefit) provision	(13,384)		(1,203)		5,639		(8,948)
Other comprehensive (loss) income - net of tax	(38,298)		(3,591)		13,785		(28,104)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, January 1, 2021	$	468	$	—	$	(17,664)	$	(17,196)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(2,596)		—		7,665		5,069
Other comprehensive (loss) gain before tax	(2,596)		—		7,665		5,069
Income tax (benefit) provision	(616)		—		1,657		1,041
Other comprehensive (loss) income - net of tax	(1,980)		—		6,008		4,028
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, July 1, 2022	$	(27,568)	$	(3,818)	$	636	$	(30,750)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(18,406)		—		6,058		(12,348)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		296		—		296
Other comprehensive (loss) gain before tax	(18,406)		296		6,058		(12,052)
Income tax (benefit) provision	(5,121)		69		1,393		(3,659)
Other comprehensive (loss) income - net of tax	(13,285)		227		4,665		(8,393)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, July 1, 2021	$	(164)	$	—	$	(12,747)	$	(12,911)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(1,789)		—		1,439		(350)
Other comprehensive gain (loss) before tax	(1,789)		—		1,439		(350)
Income tax (benefit) provision	(441)		—		348		(93)
Other comprehensive income (loss) - net of tax	(1,348)		—		1,091		(257)
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

Details About Accumulated Other Comprehensive Income (Loss) Components	Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Affected Line Item in the Statements of Income
	Three Months Ended September 30, 2022		Three Months Ended September 30, 2021		Nine Months Ended September 30, 2022		Nine Months Ended September 30, 2021
Reclassifications from accumulated other comprehensive loss to earnings before tax	$	(296)	—		$	(608)	$	—	Interest income
Total amount reclassified before tax	(296)		—		(608)		—		Income before income taxes
Tax benefit	(68)		—		(139)		—		Income tax provision
Total reclassifications from accumulated other comprehensive loss	$	(228)	$	—	$	(469)	$	—	Net income

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2022

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

•Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

•Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

•In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

The Company expects to adopt this guidance on January 1, 2023 and is currently evaluating the impact of the amendments on the Company’s consolidated financial statements. The Company has a current expected credit losses (“CECL”) working group that has been meeting to discuss implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. Specific to the model, the CECL working group has discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation is expected to be completed in the fourth quarter 2022.

The Company expects to record a one-time cumulative effect adjustment to the ALLL in retained earnings on the consolidated balance sheet as of the beginning of the first reporting period in which the new standard is effective, as is required in the guidance. The Company believes there will be an increase in the ALLL as a result of the adoption of this new standard; however, it is waiting to provide an estimate until the completion of the model validation and analysis by the CECL working group. The Company will continue to evaluate and refine the ALLL throughout the remainder of 2022, considering changes in portfolio composition, economic conditions and the results from the model validation.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company adopted the temporary relief issued under the CARES Act, thereby suspending the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act specifies that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of January 1, 2022 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on     Financial Reporting (March 2020)

In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBORon financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2022. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the separate recognition and measurement guidance for Troubled Debt Restructurings ("TDRs") by creditors. The elimination of the TDR guidance may be adopted prospectively for loan modifications after adoption or on a modified retrospective basis, which would also apply to loans previously modified, resulting in a cumulative effect adjustment to retained earnings in the period of adoption for changes in the allowance for credit losses. The ASU requires an entity to disclose current-period gross write-offs by year of origination for financing receivables within the scope of Subtopic 326-20. This guidance is effective on January 1, 2023, with early adoption permitted. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

•Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

•Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

•In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

The Company expects to adopt this guidance on January 1, 2023 and is currently evaluating the impact of the amendments on the Company’s consolidated financial statements. The Company has a current expected credit losses (“CECL”) working group that has been meeting to discuss implementation matters related to the completeness and accuracy of historical data, model development and corporate governance documentation. Specific to the model, the CECL working group has discussed results from parallel model runs for each portfolio segment, assumptions related to unfunded commitments and economic forecast factors. Model validation is expected to be completed in the fourth quarter 2022.

The Company expects to record a one-time cumulative effect adjustment to the ALLL in retained earnings on the consolidated balance sheet as of the beginning of the first reporting period in which the new standard is effective, as is required in the guidance. The Company believes there will be an increase in the ALLL as a result of the adoption of this new standard; however, it is waiting to provide an estimate until the completion of the model validation and analysis by the CECL working group. The Company will continue to evaluate and refine the ALLL throughout the remainder of 2022, considering changes in portfolio composition, economic conditions and the results from the model validation.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company adopted the temporary relief issued under the CARES Act, thereby suspending the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act specifies that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of January 1, 2022 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates. See the “Non-TDR Loan Modifications due to COVID-19” section of Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information.

ASU 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on     Financial Reporting (March 2020)

In March 2020, FASB issued ASU 2020-04 to ease the potential burden in accounting for the transition away from the LIBORon financial reporting. The ASU provides optional expedients and exceptions for applying GAAP to contract modification and hedge accounting relationships. The guidance is effective March 12, 2020 through December 31, 2022. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

ASU 2022-02 - Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (March 2022)

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. This ASU eliminates the separate recognition and measurement guidance for Troubled Debt Restructurings ("TDRs") by creditors. The elimination of the TDR guidance may be adopted prospectively for loan modifications after adoption or on a modified retrospective basis, which would also apply to loans previously modified, resulting in a cumulative effect adjustment to retained earnings in the period of adoption for changes in the allowance for credit losses. The ASU requires an entity to disclose current-period gross write-offs by year of origination for financing receivables within the scope of Subtopic 326-20. This guidance is effective on January 1, 2023, with early adoption permitted. The Company believes the adoption of this guidance will not have a material impact on the condensed consolidated financial statements.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares

The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three and nine months ended September 30, 2022 and 2021. 

(dollars in thousands, except per share data)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Basic earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Basic earnings per common share	$	0.89	$	1.22	$	3.04	$	3.59
Diluted earnings per share
Net income	$	8,436	$	12,090	$	29,190	$	35,636
Weighted-average common shares	9,458,259		9,936,237		9,615,039		9,922,877
Dilutive effect of equity compensation	67,596		51,865		66,703		51,194
Weighted-average common and incremental shares	9,525,855		9,988,102		9,681,742		9,974,071
Diluted earnings per common share (1)	$	0.89	$	1.21	$	3.01	$	3.57

(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 426 and 1,616 for the three and nine months ended September 30, 2022, respectively. There were 0 and 28 weighted-average antidilutive shares for the three and nine months ended September 30, 2021, respectively.

XML

Securities (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-sale Securities Reconciliation

The following tables summarize securities available-for-sale and securities held-to-maturity as of September 30, 2022 and December 31, 2021.

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	38,197	$	—	$	(1,868)	$	36,329
Municipal securities	71,156		181		(7,800)		63,537
Agency mortgage-backed securities - residential	259,568		—		(40,377)		219,191
Agency mortgage-backed securities - commercial	17,825		—		(1,303)		16,522
Private label mortgage-backed securities - residential	12,320		—		(1,279)		11,041
Asset-backed securities	5,000		—		(116)		4,884
Corporate securities	44,644		25		(2,608)		42,061
Total available-for-sale	$	448,710	$	206	$	(55,351)	$	393,565

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities available-for-sale
U.S. Government-sponsored agencies	$	50,013	$	164	$	(1,137)	$	49,040
Municipal securities	75,158		1,940		(65)		77,033
Agency mortgage-backed securities - residential	377,928		960		(5,652)		373,236
Agency mortgage-backed securities - commercial	36,024		441		(139)		36,326
Private label mortgage-backed securities - residential	15,902		122		(3)		16,021
Asset-backed securities	5,000		4		—		5,004
Corporate securities	46,482		597		(695)		46,384
Total available-for-sale	$	606,507	$	4,228	$	(7,691)	$	603,044

Schedule Of Held-To-Maturity Securities Reconciliation

	September 30, 2022
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,957	$	—	$	(1,289)	$	12,668
Mortgage-backed securities - residential	123,718		—		(16,148)		107,570
Mortgage-backed securities - commercial	5,828		—		(1,142)		4,686
Corporate securities	47,554		9		(2,510)		45,053
Total held-to-maturity	$	191,057	$	9	$	(21,089)	$	169,977

	December 31, 2021
	Amortized		Gross Unrealized				Fair
(in thousands)	Cost		Gains		Losses		Value
Securities held-to-maturity
Municipal securities	$	13,992	$	717	$	—	$	14,709
Corporate securities	45,573		1,186		—		46,759
Total held-to-maturity	$	59,565	$	1,903	$	—	$	61,468

Available-for-sale Securities

The carrying value of securities at September 30, 2022 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

	Available-for-Sale
(in thousands)	Amortized Cost		Fair Value
One to five years	$	32,743	$	31,812
Five to ten years	50,888		48,261
After ten years	70,366		61,854
	153,997		141,927
Agency mortgage-backed securities - residential	259,568		219,191
Agency mortgage-backed securities - commercial	17,825		16,522
Private label mortgage-backed securities - residential	12,320		11,041
Asset-backed securities	5,000		4,884
Total	$	448,710	$	393,565

Held-to-maturity Securities

	Held-to-Maturity
(in thousands)	Amortized Cost		Fair Value
One to five years	$	11,163	$	10,915
Five to ten years	44,865		42,091
After ten years	5,483		4,715
	61,511		57,721
Agency mortgage-backed securities - residential	123,718		107,570
Agency mortgage-backed securities - commercial	5,828		4,686
Total	$	191,057	$	169,977

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at September 30, 2022 and December 31, 2021.

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	33,956	$	(1,092)	$	2,223	$	(776)	$	36,179	$	(1,868)
Municipal securities	52,815		(7,800)		—		—		52,815		(7,800)
Agency mortgage-backed securities- residential	186,134		(34,577)		30,061		(5,800)		216,195		(40,377)
Agency mortgage-backed securities- commercial	11,072		(849)		5,442		(454)		16,514		(1,303)
Private label mortgage-backed securities - residential	3,352		(418)		7,689		(861)		11,041		(1,279)
Asset-backed securities	4,884		(116)		—		—		4,884		(116)
Corporate securities	27,595		(1,478)		11,376		(1,130)		38,971		(2,608)
Total	$	319,808	$	(46,330)	$	56,791	$	(9,021)	$	376,599	$	(55,351)

	September 30, 2022
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities held-to-maturity
Municipal securities	$	12,167	$	(1,256)	$	388	$	(33)	$	12,555	$	(1,289)
Agency mortgage-backed securities - residential	75,251		(10,583)		32,319		(5,565)		107,570		(16,148)
Agency mortgage-backed securities - commercial	4,686		(1,142)		—		—		4,686		(1,142)
Corporate securities	33,712		(2,342)		5,831		(168)		39,543		(2,510)
Total	$	125,816	$	(15,323)	$	38,538	$	(5,766)	$	164,354	$	(21,089)

	December 31, 2021
	Less Than 12 Months				12 Months or Longer				Total
(in thousands)	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Securities available-for-sale
U.S. Government-sponsored agencies	$	2,921	$	(79)	$	40,305	$	(1,058)	$	43,226	$	(1,137)
Municipal securities	5,721		(65)		—		—		5,721		(65)
Agency mortgage-backed securities - residential	287,820		(3,694)		40,840		(1,958)		328,660		(5,652)
Agency mortgage-backed securities - commercial	3,944		(139)		—		—		3,944		(139)
Private label mortgage-backed securities	374		(3)		—		—		374		(3)
Asset-backed securities	—		—		—		—		—		—
Corporate securities	11,813		(187)		9,491		(508)		21,304		(695)
Total	$	312,593	$	(4,167)	$	90,636	$	(3,524)	$	403,229	$	(7,691)

Schedule of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive loss, included in shareholders' equity, for the nine months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, January 1, 2022	$	(2,555)	$	—	$	(8,484)	$	(11,039)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(51,682)		(5,402)		19,424		(37,660)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		608		—		608
Other comprehensive (loss) gain before tax	(51,682)		(4,794)		19,424		(37,052)
Income tax (benefit) provision	(13,384)		(1,203)		5,639		(8,948)
Other comprehensive (loss) income - net of tax	(38,298)		(3,591)		13,785		(28,104)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, January 1, 2021	$	468	$	—	$	(17,664)	$	(17,196)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(2,596)		—		7,665		5,069
Other comprehensive (loss) gain before tax	(2,596)		—		7,665		5,069
Income tax (benefit) provision	(616)		—		1,657		1,041
Other comprehensive (loss) income - net of tax	(1,980)		—		6,008		4,028
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, July 1, 2022	$	(27,568)	$	(3,818)	$	636	$	(30,750)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(18,406)		—		6,058		(12,348)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		296		—		296
Other comprehensive (loss) gain before tax	(18,406)		296		6,058		(12,052)
Income tax (benefit) provision	(5,121)		69		1,393		(3,659)
Other comprehensive (loss) income - net of tax	(13,285)		227		4,665		(8,393)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, July 1, 2021	$	(164)	$	—	$	(12,747)	$	(12,911)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(1,789)		—		1,439		(350)
Other comprehensive gain (loss) before tax	(1,789)		—		1,439		(350)
Income tax (benefit) provision	(441)		—		348		(93)
Other comprehensive income (loss) - net of tax	(1,348)		—		1,091		(257)
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

Details About Accumulated Other Comprehensive Income (Loss) Components	Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Affected Line Item in the Statements of Income
	Three Months Ended September 30, 2022		Three Months Ended September 30, 2021		Nine Months Ended September 30, 2022		Nine Months Ended September 30, 2021
Reclassifications from accumulated other comprehensive loss to earnings before tax	$	(296)	—		$	(608)	$	—	Interest income
Total amount reclassified before tax	(296)		—		(608)		—		Income before income taxes
Tax benefit	(68)		—		(139)		—		Income tax provision
Total reclassifications from accumulated other comprehensive loss	$	(228)	$	—	$	(469)	$	—	Net income

XML

Loans (Tables)

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

Loan balances as of September 30, 2022 and December 31, 2021 are summarized in the table below. Categories of loans include:

(in thousands)	September 30, 2022		December 31, 2021
Commercial loans
Commercial and industrial	$	104,780	$	96,008
Owner-occupied commercial real estate	58,615		66,732
Investor commercial real estate	91,021		28,019
Construction	139,509		136,619
Single tenant lease financing	895,302		865,854
Public finance	614,139		592,665
Healthcare finance	293,686		387,852
Small business lending	113,001		108,666
Franchise finance	225,012		81,448
Total commercial loans	2,535,065		2,363,863
Consumer loans
Residential mortgage	337,565		186,770
Home equity	22,114		17,665
Other consumer loans	312,512		265,478
Total consumer loans	672,191		469,913
Total commercial and consumer loans	3,207,256		2,833,776
Net deferred loan origination fees/costs and premiums/discounts on purchased loans and other(1)	48,650		53,886
Total loans	3,255,906		2,887,662
Allowance for loan losses	(29,866)		(27,841)
Net loans	$	3,226,040	$	2,859,821

(1) Includes carrying value adjustments of $33.9 million and $37.5 million related to terminated interest rate swaps associated with public finance loans as of September 30, 2022 and December 31, 2021, respectively.

Allowance for Credit Losses on Financing Receivables

The following tables present changes in the balance of the ALLL during the three and nine months ended September 30, 2022 and 2021. 

(in thousands)	Three Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	2,026	$	(301)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	703		(87)		—		—		616
Investor commercial real estate	621		453		—		—		1,074
Construction	1,707		(117)		—		—		1,590
Single tenant lease financing	9,712		315		—		—		10,027
Public finance	1,850		(61)		—		—		1,789
Healthcare finance	4,762		(1,150)		—		—		3,612
Small business lending	1,956		217		(130)		3		2,046
Franchise finance	2,281		734		—		—		3,015
Residential mortgage	1,138		231		—		1		1,370
Home equity	54		7		—		1		62
Other consumer loans	2,343		651		(106)		50		2,938
Total	$	29,153	$	892	$	(236)	$	57	$	29,866

	Nine Months Ended September 30, 2022
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,891	$	(166)	$	—	$	2	$	1,727
Owner-occupied commercial real estate	742		(126)		—		—		616
Investor commercial real estate	328		746		—		—		1,074
Construction	1,612		(22)		—		—		1,590
Single tenant lease financing	10,385		(1,589)		—		1,231		10,027
Public finance	1,776		13		—		—		1,789
Healthcare finance	5,940		(2,328)		—		—		3,612
Small business lending	1,387		847		(210)		22		2,046
Franchise finance	1,083		1,932		—		—		3,015
Residential mortgage	643		724		—		3		1,370
Home equity	64		(139)		—		137		62
Other consumer loans	1,990		1,116		(397)		229		2,938
Tax refund advance loans	—		1,860		(1,860)		—		—
Total	$	27,841	$	2,868	$	(2,467)	$	1,624	$	29,866

(in thousands)	Three Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,902	$	122	$	—	$	2	$	2,026
Owner-occupied commercial real estate	1,021		(28)		—		—		993
Investor commercial real estate	329		(4)		—		—		325
Construction	1,357		(30)		—		—		1,327
Single tenant lease financing	11,205		(152)		—		—		11,053
Public finance	1,700		32		—		—		1,732
Healthcare finance	6,938		(584)		—		—		6,354
Small business lending	783		415		(10)		26		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	594		19		—		3		616
Home equity	63		—		—		2		65
Other consumer loans	2,174		(129)		(110)		50		1,985
Total	$	28,066	$	(29)	$	(120)	$	83	$	28,000

	Nine Months Ended September 30, 2021
Allowance for loan losses:	Balance, Beginning of Period		(Credit) Provision Charged to Expense		Losses Charged Off		Recoveries		Balance, End of Period
Commercial and industrial	$	1,146	$	823	$	(28)	$	85	$	2,026
Owner-occupied commercial real estate	1,082		(89)		—		—		993
Investor commercial real estate	155		170		—		—		325
Construction	1,192		135		—		—		1,327
Single tenant lease financing	12,990		454		(2,391)		—		11,053
Public finance	1,732		—		—		—		1,732
Healthcare finance	7,485		(1,131)		—		—		6,354
Small business lending	628		776		(222)		32		1,214
Franchise finance	—		310		—		—		310
Residential mortgage	519		91		(6)		12		616
Home equity	48		63		(51)		5		65
Other consumer loans	2,507		(334)		(423)		235		1,985
Total	$	29,484	$	1,268	$	(3,121)	$	369	$	28,000

Allowance For Credit Losses On Financing Receivables Portfolio Segment

The following tables present the recorded investment in loans based on portfolio segment and impairment method as of September 30, 2022 and December 31, 2021. 

(in thousands)	Loans						Allowance for Loan Losses
September 30, 2022	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	94,617	$	10,163	$	104,780	$	1,377	$	350	$	1,727
Owner-occupied commercial real estate	56,993		1,622		58,615		616		—		616
Investor commercial real estate	91,021		—		91,021		1,074		—		1,074
Construction	139,509		—		139,509		1,590		—		1,590
Single tenant lease financing	895,302		—		895,302		10,027		—		10,027
Public finance	614,139		—		614,139		1,789		—		1,789
Healthcare finance	293,686		—		293,686		3,612		—		3,612
Small business lending(1)	105,129		7,872		113,001		1,368		678		2,046
Franchise finance	225,012		—		225,012		3,015		—		3,015
Residential mortgage	334,082		3,483		337,565		1,370		—		1,370
Home equity	22,114		—		22,114		62		—		62
Other consumer	312,509		3		312,512		2,938		—		2,938
Total	$	3,184,113	$	23,143	$	3,207,256	$	28,838	$	1,028	$	29,866

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

(in thousands)	Loans						Allowance for Loan Losses
December 31, 2021	Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance		Ending Balance:   Collectively Evaluated for Impairment		Ending Balance:   Individually Evaluated for Impairment		Ending Balance
Commercial and industrial	$	95,364	$	644	$	96,008	$	1,441	$	450	$	1,891
Owner-occupied commercial real estate	63,387		3,345		66,732		742		—		742
Investor commercial real estate	28,019		—		28,019		328		—		328
Construction	136,619		—		136,619		1,612		—		1,612
Single tenant lease financing	864,754		1,100		865,854		10,290		95		10,385
Public finance	592,665		—		592,665		1,776		—		1,776
Healthcare finance	386,926		926		387,852		5,417		523		5,940
Small business lending(1)	106,682		1,984		108,666		994		393		1,387
Franchise finance	81,448		—		81,448		1,083		—		1,083
Residential mortgage	183,852		2,918		186,770		643		—		643
Home equity	17,651		14		17,665		64		—		64
Other consumer	265,469		9		265,478		1,990		—		1,990
Total	$	2,822,836	$	10,940	$	2,833,776	$	26,380	$	1,461	$	27,841

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

Financing Receivable Credit Quality Indicators

The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	93,262	$	1,355	$	10,163	$	104,780
Owner-occupied commercial real estate	46,423		10,570		1,622		58,615
Investor commercial real estate	91,021		—		—		91,021
Construction	139,509		—		—		139,509
Single tenant lease financing	894,208		1,094		—		895,302
Public finance	611,709		2,430		—		614,139
Healthcare finance	292,280		1,406		—		293,686
Small business lending(1)	99,722		5,407		7,872		113,001
Franchise finance	224,721		291		—		225,012
Total commercial loans	$	2,492,855	$	22,553	$	19,657	$	2,535,065

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	September 30, 2022
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	336,492	$	1,073	$	337,565
Home equity	22,114		—		22,114
Other consumer	312,509		3		312,512
Total consumer loans	$	671,115	$	1,076	$	672,191

	December 31, 2021
(in thousands)	Pass		Special Mention		Substandard		Total
Commercial and industrial	$	82,412	$	12,952	$	644	$	96,008
Owner-occupied commercial real estate	59,369		4,018		3,345		66,732
Investor commercial real estate	28,019		—		—		28,019
Construction	124,578		12,041		—		136,619
Single tenant lease financing	859,612		5,142		1,100		865,854
Public finance	591,630		1,035		—		592,665
Healthcare finance	386,337		589		926		387,852
Small business lending(1)	99,250		7,433		1,983		108,666
Franchise finance	81,448		—		—		81,448
Total commercial loans	$	2,312,655	$	43,210	$	7,998	$	2,363,863

1 Balance in “Substandard” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	Performing		Nonaccrual		Total
Residential mortgage	$	185,544	$	1,226	$	186,770
Home equity	17,651		14		17,665
Other consumer	265,469		9		265,478
Total consumer loans	$	468,664	$	1,249	$	469,913

Past Due Financing Receivables

The following tables present the Company’s loan portfolio delinquency analysis as of September 30, 2022 and December 31, 2021. 

	September 30, 2022
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	350	$	350	$	104,430	$	104,780	$	350	$	—
Owner-occupied commercial real estate	—		—		—		—		58,615		58,615		1,622		—
Investor commercial real estate	—		—		—		—		91,021		91,021		—		—
Construction	—		—		—		—		139,509		139,509		—		—
Single tenant lease financing	—		—		—		—		895,302		895,302		—		—
Public finance	—		—		—		—		614,139		614,139		—		—
Healthcare finance	—		—		—		—		293,686		293,686		—		—
Small business lending(1)	—		356		488		844		112,157		113,001		2,958		—
Franchise finance	—		—		—		—		225,012		225,012		—		—
Residential mortgage	171		71		353		595		336,970		337,565		1,073		—
Home equity	—		—		—		—		22,114		22,114		—		—
Other consumer	30		20		—		50		312,462		312,512		3		—
Total	$	201	$	447	$	1,191	$	1,839	$	3,205,417	$	3,207,256	$	6,006	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

	December 31, 2021
(in thousands)	30-59 Days Past Due		60-89 Days Past Due		90 Days  or More Past Due		Total  Past Due		Current		Total Loans		Non- accrual Loans		Total Loans 90 Days or More Past Due and Accruing
Commercial and industrial	$	—	$	—	$	—	$	—	$	96,008	$	96,008	$	674	$	—
Owner-occupied commercial real estate	—		—		—		—		66,732		66,732		—		—
Investor commercial real estate	—		—		—		—		28,019		28,019		3,419		—
Construction	—		—		—		—		136,619		136,619		—		—
Single tenant lease financing	—		—		—		—		865,854		865,854		1,100		—
Public finance	—		—		—		—		592,665		592,665		—		—
Healthcare finance	—		—		—		—		387,852		387,852		—		—
Small business lending(1)	—		—		657		657		108,009		108,666		959		—
Franchising Finance	—		—		—		—		81,448		81,448		—		—
Residential mortgage	51		226		106		383		186,387		186,770		1,226		—
Home equity	—		—		—		—		17,665		17,665		14		—
Other consumer	68		18		—		86		265,392		265,478		9		—
Total	$	119	$	244	$	763	$	1,126	$	2,832,650	$	2,833,776	$	7,401	$	—

1 Balance in “Total Past Due” is partially guaranteed by the U.S. government.

Impaired Financing Receivables

The following table presents the Company’s impaired loans as of September 30, 2022 and December 31, 2021. 

	September 30, 2022						December 31, 2021
(in thousands)	Recorded Balance		Unpaid Principal Balance		Specific Allowance		Recorded Balance		Unpaid Principal Balance		Specific Allowance
Loans without a specific valuation allowance
Commercial and industrial	$	9,813	$	9,813	$	—	$	—	$	—	$	—
Owner-occupied commercial real estate	—		—		—		3,345		3,466		—
Small business lending(1)	5,838		6,087		—		959		1,193		—
Residential mortgage	3,483		3,634		—		2,918		3,063		—
Home equity	—		—		—		14		15		—
Other consumer loans	3		29		—		9		44		—
Total	19,137		19,563		—		7,245		7,781		—
Loans with a specific valuation allowance
Commercial and industrial	350		350		350		644		677		450
Owner-occupied commercial real estate	1,622		1,779		—		—		—		—
Single tenant lease financing	—		—		—		1,100		1,123		95
Healthcare finance	—		—		—		926		926		523
Small business lending(1)	2,034		2,034		678		1,025		1,025		393
Total	4,006		4,163		1,028		3,695		3,751		1,461
Total impaired loans	$	23,143	$	23,726	$	1,028	$	10,940	$	11,532	$	1,461

1 Balance of loans individually evaluated for impairment are partially guaranteed by the U.S. government.

The table below presents average balances and interest income recognized for impaired loans during the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended								Nine Months Ended
	September 30, 2022				September 30, 2021				September 30, 2022				September 30, 2021
(in thousands)	Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income		Average Balance		Interest Income
Loans without a specific valuation allowance
Commercial and industrial	$	4,906	$	—	$	—	$	—	$	1,636	$	—	$	259	$	9
Owner-occupied commercial real estate	1,645		—		3,457		—		2,471		—		3,297		—
Single tenant lease financing	—		—		1,315		—		—		—		100		5
Healthcare finance	—		—		—		—		—		—		336		—
Small business lending(1)	2,167		—		—		—		1,288		—		1,005		—
Residential mortgage	3,711		9		2,267		15		3,550		26		2,138		28
Home equity	15		—		14		—		14		—		13		—
Other consumer	8		—		23		—		9		—		27		—
Total	12,452		9		7,076		15		8,968		26		7,175		42
Loans with a specific valuation allowance
Commercial and industrial	350		—		690		—		456		—		677		—
Owner-occupied commercial real estate	—		—		—		—		—		—		473		—
Single tenant lease financing	—		—		2,048		—		547		—		4,875		—
Healthcare finance	660		—		956		37		826		45		809		73
Small business lending(1)	1,827		—		1,203		—		1,611		—		401		—
Other consumer	199		—		—		—		66		—		—		—
Total	3,036		—		4,897		37		3,506		45		7,235		73
Total impaired loans	$	15,488	$	9	$	11,973	$	52	$	12,474	$	71	$	14,410	$	115

1 Balance is partially guaranteed by the U.S. government.

XML

Premises and Equipment (Tables)

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

The following table summarizes premises and equipment at September 30, 2022 and December 31, 2021.

(in thousands)	September 30, 2022		December 31, 2021
Land	$	5,598	$	—
Construction in process	5		57,469
Right of use leased asset	244		208
Building and improvements	55,226		1,090
Furniture and equipment	19,424		7,800
Less: accumulated depreciation	(9,750)		(6,725)
Total	$	70,747	$	59,842

XML

Servicing Asset (Tables)

9 Months Ended

Sep. 30, 2022

Transfers and Servicing [Abstract]

Schedule of Servicing Assets at Fair Value

Activity for the servicing asset and the related changes in fair value for the three and nine months ended September 30, 2022 and 2021 are shown in the table below.

	Three Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	5,345	$	4,120
Additions:
Originated and purchased servicing	783		566
Subtractions
Paydowns:	(279)		(176)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(54)		(98)
Loan servicing asset revaluation	$	(333)	$	(274)
Balance, end of period	$	5,795	$	4,412

	Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021
Balance, beginning of period	$	4,702	$	3,569
Additions:
Originated and purchased servicing	2,193		1,512
Subtractions
Paydowns:	(888)		(500)
Changes in fair value due to changes in valuation inputs or assumptions used in       the valuation model	(212)		(169)
Loan servicing asset revaluation	$	(1,100)	$	(669)
Balance, end of period	$	5,795	$	4,412

Schedule Of Unpaid Principal Balances Of Loans Serviced For Others

The unpaid principal balances of these loans serviced for others as of September 30, 2022 and December 31, 2021 are shown in the table below.

(in thousands)	September 30, 2022		December 31, 2021
Loan portfolios serviced for:
SBA guaranteed loans	$	285,736	$	230,514
Total	$	285,736	$	230,514

XML

Subordinated Debt (Tables)

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Schedule of Subordinated Borrowing

	September 30, 2022				December 31, 2021
(in thousands)	Principal		Unamortized Debt Issuance Costs		Principal		Unamortized Debt Issuance Costs
2029 Notes	$	37,000	$	(1,060)	$	37,000	$	(1,178)
2030 Notes	10,000		(190)		10,000		(208)
2031 Notes	60,000		(1,294)		60,000		(1,383)
Total	$	107,000	$	(2,544)	$	107,000	$	(2,769)

XML

Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2022

Retirement Benefits [Abstract]

Nonvested Restricted Stock Shares Activity

The following table summarizes the stock-based award activity under the 2022 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	—	$	—	—	$	—	—	$	—
Granted	—	—		4,151	36.84		—	—
Unvested at September 30, 2022	—	$	—	4,151	$	36.84	—	$	—

The following table summarizes the stock-based award activity under the 2013 Plan for the nine months ended September 30, 2022.

	Restricted Stock Units	Weighted-Average Grant Date Fair Value Per Share		Restricted Stock Awards	Weighted-Average Grant Date Fair Value Per Share		Deferred Stock Units	Weighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2021	112,822	$	28.18	—	$	—	—	$	—
Granted	41,662	46.67		9,954	52.64		3	41.87
Cancelled/Forfeited	(5,441)	36.68		(644)	52.64		—	—
Vested	(23,256)	24.62		(7,378)	52.64		(3)	41.87
Unvested at September 30, 2022	125,787	$	34.59	1,932	$	52.64	—	$	—

Schedule Of Deferred Stock Option Plan

The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the nine months ended September 30, 2022.

	Deferred Stock Rights
Outstanding, beginning of period	84,536
Granted	322
Exercised	—
Outstanding, end of period	84,858

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value, Assets Measured on Recurring Basis

The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at September 30, 2022 and December 31, 2021.

			September 30, 2022  Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	36,329	$	—	$	36,329	$	—
Municipal securities	63,537		—		63,537		—
Agency mortgage-backed securities - residential	219,191		—		219,191		—
Agency mortgage-backed securities - commercial	16,522		—		16,522		—
Private label mortgage-backed securities - residential	11,041		—		11,041		—
Asset-backed securities	4,884		—		4,884		—
Corporate securities	42,061		—		42,061		—
Total available-for-sale securities	$	393,565	$	—	$	393,565	$	—
Loans held-for-sale (mandatory pricing agreements)	9,677		—		9,677		—
Servicing asset	5,795		—		—		5,795
Interest rate swap assets	8,978		—		8,978		—
Forward contracts	1,006		1,006		—		—
IRLCs	(388)		—		—		(388)

			December 31, 2021 Fair Value Measurements Using
(in thousands)	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Government-sponsored agencies	$	49,040	$	—	$	49,040	$	—
Municipal securities	77,033		—		77,033		—
Agency mortgage-backed securities - residential	373,236		—		373,236		—
Agency mortgage-backed securities - commercial	36,326		—		36,326		—
Private label mortgage-backed securities - residential	16,021		—		16,021		—
Asset-backed securities	5,004		—		5,004		—
Corporate securities	46,384		—		46,384		—
Total available-for-sale securities	$	603,044	$	—	$	603,044	$	—
Loans held-for-sale (mandatory pricing agreements)	23,233		—		23,233		—
Servicing asset	4,702		—		—		4,702
Interest rate swap agreements	(14,271)		—		(14,271)		—
Forward contracts	(30)		(30)		—		—
IRLCs	718		—		—		718

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, July 1, 2022	$	5,345	$	462
Total realized gains
Additions:
Originated and purchased servicing	783		—
Subtractions:
Paydowns	(279)		—
Change in fair value	(54)		(850)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of July 1, 2021	$	4,120	$	818
Total realized gains
Additions:
Originated and purchased servicing	566		—
Subtractions:
Paydowns	(176)		—
Change in fair value	(98)		22
Balance, September 30, 2021	$	4,412	$	840

	Nine Months Ended
(in thousands)	Servicing Asset		Interest Rate Lock Commitments
Balance, January 1, 2022	$	4,702	$	718
Total realized gains
Additions:
Originated and purchased servicing	2,193		—
Subtractions:
Paydowns	(888)		—
Change in fair value	(212)		(1,106)
Balance, September 30, 2022	$	5,795	$	(388)
Balance as of January 1, 2021	$	3,569	$	3,361
Total realized gains
Additions:
Originated and purchased servicing	1,512		—
Subtractions:
Paydowns	(500)		—
Change in fair value	(169)		(2,521)
Balance, September 30, 2021	$	4,412	$	840

Schedule Of Impaired Loans, Including Valuation Allowance, Fair Value, Unobservable Inputs Reconciliation

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at September 30, 2022 and December 31, 2021.

			September 30, 2022
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,134	$	—	$	—	$	1,134

			December 31, 2021
(in thousands)			Fair Value Measurements Using
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Impaired loans	$	1,228	$	—	$	—	$	1,228

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)	Fair Value at September 30, 2022		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,134	Fair value of collateral	Discount for type of property and current market conditions	10%	10%
IRLCs	(388)		Discounted cash flow	Loan closing rates	25% - 100%	81%
Servicing asset	5,795		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 12%	14.6% 12%

(dollars in thousands)	Fair Value at December 31, 2021		Valuation Technique	Significant Unobservable Inputs	Range	Weighted-Average Range
Impaired loans	$	1,228	Fair value of collateral	Discount for type of property and current market conditions	0% - 35%	10.1%
IRLCs	718		Discounted cash flow	Loan closing rates	42% - 100%	89%
Servicing asset	4,702		Discounted cash flow	Prepayment speeds Discount rate	0% - 25% 10%	12.5% 10%

Fair Value, by Balance Sheet Grouping

The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021.

	September 30, 2022 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	221,052	$	221,052	$	221,052	$	—	$	—
Securities held-to-maturity	191,057		169,977		—		169,977		—
Loans held-for-sale (best efforts pricing agreements)	13,426		13,426		—		13,426		—
Net loans	3,226,040		3,027,916		—		—		3,027,916
Accrued interest receivable	16,918		16,918		16,918		—		—
Federal Home Loan Bank of Indianapolis stock	28,350		28,350		—		28,350		—
Deposits	3,192,644		3,056,730		1,910,715		—		1,146,015
Advances from Federal Home Loan Bank	589,926		545,824		—		545,824		—
Subordinated debt	104,456		104,544		34,425		70,119		—
Accrued interest payable	1,887		1,887		1,887		—		—

	December 31, 2021 Fair Value Measurements Using
(in thousands)	Carrying Amount		Fair Value		Quoted Prices In Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	442,960	$	442,960	$	442,960	$	—	$	—
Securities held-to-maturity	59,565		61,468		—		61,468		—
Loans held-for-sale (best efforts pricing agreements)	24,512		24,512		—		24,512		—
Net loans	2,859,821		2,880,024		—		—		2,880,024
Accrued interest receivable	16,037		16,037		16,037		—		—
Federal Home Loan Bank of Indianapolis stock	25,650		25,650		—		25,650		—
Deposits	3,178,959		3,190,000		1,909,432		—		1,280,568
Advances from Federal Home Loan Bank	514,922		526,143		—		526,143		—
Subordinated debt	104,231		108,788		38,643		70,145		—
Accrued interest payable	2,018		2,018		2,018		—		—

XML

Mortgage Banking Activities (Tables)

9 Months Ended

Sep. 30, 2022

Mortgage Banking [Abstract]

Schedule of Participating Mortgage Loans

The following table presents the components of income from mortgage banking activities for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Gain on loans sold	$	1,178	$	3,244	$	5,119	$	14,550
Gain (loss) resulting from the change in fair value of loans held-for-sale	(450)		110		(599)		(854)
Gain (loss) resulting from the change in fair value of derivatives	143		496		(66)		(1,422)
Net revenue from mortgage banking activities	$	871	$	3,850	$	4,454	$	12,274

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule Of Derivative Instruments, Cumulative Basis Adjustments

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of September 30, 2022 and December 31, 2021.  

(in thousands)	Carrying amount of the hedged asset				Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Securities available-for-sale (1)	$	69,050	$	75,156	$	(2,106)	$	1,729

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The designated hedged items were $50.0 million at both September 30, 2022 and December 31, 2021.

Schedule Of Derivative Instruments Of Fixed Rate Receivables

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands) September 30, 2022	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%
Total at September 30, 2022	$	50,000	2.1	$	2,094	3-month LIBOR	2.33	%

(dollars in thousands) December 31, 2021	Notional Value		Weighted- Average Remaining Maturity (years)			Weighted-Average Ratio
Instruments Associated With				Fair Value		Receive	Pay
Securities available-for-sale	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%
Total at December 31, 2021	$	50,000	2.8	$	(1,731)	3-month LIBOR	2.33	%

Schedule Of Derivative Instruments Of Variable Rate Liabilities

The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at September 30, 2022 and December 31, 2021.

(dollars in thousands) September 30, 2022	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	4.34	$	5,242	3-month LIBOR	2.88	%
Interest rate swaps	60,000		0.89	730		1-month LIBOR	2.88	%
Interest rate swaps	40,000		1.67	912		Fed Funds Effective	2.78	%

(dollars in thousands) December 31, 2021	Notional		Weighted- Average Remaining Maturity			Weighted-Average Ratio
Cash Flow Hedges	Value		(years)	Fair Value		Receive	Pay
Interest rate swaps	$	110,000	5.1	$	(8,560)	3-month LIBOR	2.88	%
Interest rate swaps	100,000		2.0	(3,980)		1-month LIBOR	2.88	%

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at September 30, 2022 and December 31, 2021.

	September 30, 2022				December 31, 2021
(in thousands)	Notional Amount		Fair Value		Notional Amount		Fair Value
Asset Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	50,000	$	2,094	$	—	$	—
Interest rate swaps associated with variable-rate liabilities	210,000		6,884		—		—
Derivatives not designated as hedging instruments
IRLCs	—		—		62,789		718
Forward contracts	27,750		1,006		—		—
Total contracts	$	287,750	$	9,984	$	62,789	$	718
Liability Derivatives
Derivatives designated as hedging instruments
Interest rate swaps associated with securities available-for-sale	$	—	$	—	$	50,000	$	(1,731)
Interest rate swaps associated with variable-rate liabilities	—		—		210,000		(12,540)
Derivatives not designated as hedging instruments
Forward contracts	—		—		72,750		(30)
IRLCs	31,202		(388)		—		—
Total contracts	$	31,202	$	(388)	$	332,750	$	(14,301)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three and nine months ended September 30, 2022 and 2021.

	Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Three Months Ended				Amount of Gain Recognized in Other Comprehensive Income (Loss) in The Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest rate swap agreements	$	6,058	$	1,439	$	19,424	$	7,665

Schedule of Derivative Instruments in Statements of Income Fair Value

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three and nine ended September 30, 2022 and 2021.

	Amount of Gain / (Loss) Recognized in the Three Months Ended				Amount of Gain / (Loss) Recognized in the Nine Months Ended
(in thousands)	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Asset Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	—	$	—	$	—	$	(2,519)
Forward contracts	993		—		1,036		—
Liability Derivatives
Derivatives not designated as hedging instruments
IRLCs	$	(850)	$	22	$	(1,102)	$	—
Forward contracts	—		474		—		1,097

Schedule Of Effects Of Interest Rate Swap Agreements On Statements Of Income

The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three and nine months ended September 30, 2022 and 2021.

(in thousands) Line item in the condensed consolidated statements of income	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Interest income
Securities - taxable	$	—	$	—	$	—	$	(253)
Securities - non-taxable	(7)		(280)		(442)		(817)
Total interest income	(7)		(280)		(442)		(1,070)
Interest expense
Deposits	159		702		1,338		2,072
Other borrowed funds	168		774		1,355		2,258
Total interest expense	327		1,476		2,693		4,330
Net interest income	$	(334)	$	(1,756)	$	(3,135)	$	(5,400)

XML

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive loss, included in shareholders' equity, for the nine months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, January 1, 2022	$	(2,555)	$	—	$	(8,484)	$	(11,039)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(51,682)		(5,402)		19,424		(37,660)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		608		—		608
Other comprehensive (loss) gain before tax	(51,682)		(4,794)		19,424		(37,052)
Income tax (benefit) provision	(13,384)		(1,203)		5,639		(8,948)
Other comprehensive (loss) income - net of tax	(38,298)		(3,591)		13,785		(28,104)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, January 1, 2021	$	468	$	—	$	(17,664)	$	(17,196)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(2,596)		—		7,665		5,069
Other comprehensive (loss) gain before tax	(2,596)		—		7,665		5,069
Income tax (benefit) provision	(616)		—		1,657		1,041
Other comprehensive (loss) income - net of tax	(1,980)		—		6,008		4,028
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

The components of accumulated other comprehensive loss, included in stockholders' equity, for the three months ended September 30, 2022 and 2021, respectively, are presented in the table below.

(in thousands)	Unrealized Losses On Debt Securities		Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity		Cash Flow Hedges		Total
Balance, July 1, 2022	$	(27,568)	$	(3,818)	$	636	$	(30,750)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(18,406)		—		6,058		(12,348)
Reclassifications from accumulated other comprehensive (loss) income to earnings before tax	—		296		—		296
Other comprehensive (loss) gain before tax	(18,406)		296		6,058		(12,052)
Income tax (benefit) provision	(5,121)		69		1,393		(3,659)
Other comprehensive (loss) income - net of tax	(13,285)		227		4,665		(8,393)
Balance, September 30, 2022	$	(40,853)	$	(3,591)	$	5,301	$	(39,143)
Balance, July 1, 2021	$	(164)	$	—	$	(12,747)	$	(12,911)
Other comprehensive (loss) income before reclassifications from accumulated other comprehensive loss before tax	(1,789)		—		1,439		(350)
Other comprehensive gain (loss) before tax	(1,789)		—		1,439		(350)
Income tax (benefit) provision	(441)		—		348		(93)
Other comprehensive income (loss) - net of tax	(1,348)		—		1,091		(257)
Balance, September 30, 2021	$	(1,512)	$	—	$	(11,656)	$	(13,168)

Details About Accumulated Other Comprehensive Income (Loss) Components	Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) for the				Affected Line Item in the Statements of Income
	Three Months Ended September 30, 2022		Three Months Ended September 30, 2021		Nine Months Ended September 30, 2022		Nine Months Ended September 30, 2021
Reclassifications from accumulated other comprehensive loss to earnings before tax	$	(296)	—		$	(608)	$	—	Interest income
Total amount reclassified before tax	(296)		—		(608)		—		Income before income taxes
Tax benefit	(68)		—		(139)		—		Income tax provision
Total reclassifications from accumulated other comprehensive loss	$	(228)	$	—	$	(469)	$	—	Net income

XML

Basis of Presentation (Details)	Sep. 30, 2022 subsidiary
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of wholly-owned subsidiaries	3

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Basic earnings per share
Net income	$ 8,436	$ 12,090	$ 29,190	$ 35,636
Weighted-average common shares (in shares)	9,458,259,000	9,936,237,000	9,615,039,000	9,922,877
Basic earnings per common share ( in dollars per share)	$ 0.89	$ 1.22	$ 3.04	$ 3.59
Diluted earnings per share
Net income	$ 8,436	$ 12,090	$ 29,190	$ 35,636
Weighted-average common shares (in shares)	9,458,259,000	9,936,237,000	9,615,039,000	9,922,877
Dilutive effect of equity compensation (in shares)	67,596,000	51,865,000	66,703,000	51,194
Weighted-average common and incremental shares (in shares)	9,525,855,000	9,988,102,000	9,681,742,000	9,974,071
Diluted earnings per common share (in dollars per share)	$ 0.89	$ 1.21	$ 3.01	$ 3.57
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	426	0	1,616	28

XML

Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Available-for-sale Securities [Abstract]
Amortized cost	$ 448,710	$ 606,507
Gross Unrealized Gains	206	4,228
Gross Unrealized Losses	(55,351)	(7,691)
Fair Value	393,565	603,044
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	191,057	59,565
Held-to-maturity securities, Gross Unrealized Gains	9	1,903
Held-to-maturity securities, Gross Unrealized Losses	(21,089)	0
Held-to-maturity, at fair value	169,977	61,468
Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	393,565	603,044
U.S. Government-sponsored agencies
Available-for-sale Securities [Abstract]
Amortized cost	38,197	50,013
Gross Unrealized Gains	0	164
Gross Unrealized Losses	(1,868)	(1,137)
Fair Value	36,329	49,040
U.S. Government-sponsored agencies | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	36,329	49,040
Municipal securities
Available-for-sale Securities [Abstract]
Amortized cost	71,156	75,158
Gross Unrealized Gains	181	1,940
Gross Unrealized Losses	(7,800)	(65)
Fair Value	63,537	77,033
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	13,957	13,992
Held-to-maturity securities, Gross Unrealized Gains	0	717
Held-to-maturity securities, Gross Unrealized Losses	(1,289)	0
Held-to-maturity, at fair value	12,668	14,709
Municipal securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	63,537	77,033
Agency mortgage-backed securities - residential
Available-for-sale Securities [Abstract]
Amortized cost	259,568	377,928
Gross Unrealized Gains	0	960
Gross Unrealized Losses	(40,377)	(5,652)
Fair Value	219,191	373,236
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	123,718
Held-to-maturity, at fair value	107,570
Agency mortgage-backed securities - residential | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value		373,236
Agency mortgage-backed securities - commercial
Available-for-sale Securities [Abstract]
Amortized cost	17,825	36,024
Gross Unrealized Gains	0	441
Gross Unrealized Losses	(1,303)	(139)
Fair Value	16,522	36,326
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	5,828
Held-to-maturity securities, Gross Unrealized Gains	0
Held-to-maturity securities, Gross Unrealized Losses	(1,142)
Held-to-maturity, at fair value	4,686
Agency mortgage-backed securities - commercial | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	16,522	36,326
Private label mortgage-backed securities - residential
Available-for-sale Securities [Abstract]
Amortized cost	12,320	15,902
Gross Unrealized Gains	0	122
Gross Unrealized Losses	(1,279)	(3)
Fair Value	11,041	16,021
Asset-backed securities
Available-for-sale Securities [Abstract]
Amortized cost	5,000	5,000
Gross Unrealized Gains	0	4
Gross Unrealized Losses	(116)	0
Fair Value	4,884	5,004
Asset-backed securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	4,884	5,004
Corporate securities
Available-for-sale Securities [Abstract]
Amortized cost	44,644	46,482
Gross Unrealized Gains	25	597
Gross Unrealized Losses	(2,608)	(695)
Fair Value	42,061	46,384
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	47,554	45,573
Held-to-maturity securities, Gross Unrealized Gains	9	1,186
Held-to-maturity securities, Gross Unrealized Losses	(2,510)	0
Held-to-maturity, at fair value	45,053	46,759
Corporate securities | Significant Other Observable Inputs (Level 2)
Available-for-sale Securities [Abstract]
Fair Value	42,061	$ 46,384
Mortgage-backed securities - residential
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Held-to-maturity securities, amortized cost	123,718
Held-to-maturity securities, Gross Unrealized Gains	0
Held-to-maturity securities, Gross Unrealized Losses	(16,148)
Held-to-maturity, at fair value	$ 107,570

XML

Securities (Details Textual)	3 Months Ended	6 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($) security	Jun. 30, 2021	Sep. 30, 2022 USD ($) security	Dec. 31, 2021 USD ($)
Investments, Debt and Equity Securities [Abstract]
Available-for-sale securities, gross realized gain (loss) | $	$ 0		$ 0
Continuous unrealized loss position, fair value | $	$ 541,000,000		$ 541,000,000	$ 403,200,000
Continuous unrealized loss position, fair value (as a percent)		61.00%	96.00%
Number of securities in portfolio | security	447		447
Securities in unrealized loss position | security	438		438

XML

Securities - Carrying Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Amortized Cost
One to five years	$ 32,743
Five to ten years	50,888
After ten years	70,366
Amortized Cost	153,997
Amortized cost	448,710	$ 606,507
Held-to-maturity securities, One to five years	11,163
Held-to-maturity securities, Five to ten years	44,865
Held-to-maturity securities, After ten years	5,483
Held-to-maturity securities, Amortized Cost			$ 61,511
Debt Securities, Held-to-maturity	191,057	59,565
Fair Value
One to five years	31,812
Five to ten years	48,261
After ten years	61,854
Fair Value	141,927
Fair Value	393,565	603,044
Held-to-maturity securities, One to five years	10,915
Held-to-maturity securities, Five to ten years	42,091
Held-to-maturity securities, After ten years	4,715
Held-to-maturity securities, Fair Value			$ 57,721
Held-to-maturity, at fair value	169,977	61,468
Agency mortgage-backed securities - residential
Amortized Cost
Amortized cost	259,568	377,928
Debt Securities, Held-to-maturity	123,718
Fair Value
Fair Value	219,191	373,236
Held-to-maturity, at fair value	107,570
Private label mortgage-backed securities - residential
Amortized Cost
Amortized cost	12,320	15,902
Fair Value
Fair Value	11,041	16,021
Asset-backed securities
Amortized Cost
Amortized cost	5,000	5,000
Fair Value
Fair Value	$ 4,884	$ 5,004

XML

Securities - Gross Unrealized Losses and Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Less Than 12 Months, Fair Value	$ 319,808	$ 312,593
Less Than 12 Months, Unrealized Losses	(46,330)	(4,167)
12 Months or Longer, Fair Value	56,791	90,636
12 Months or Longer, Unrealized Losses	(9,021)	(3,524)
Total, Fair Value	376,599	403,229
Total, Unrealized Losses	(55,351)	(7,691)
Held-to-maturity securities, Less Than 12 Months, Fair Value	125,816
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(15,323)
Held-to-maturity securities, 12 Months or Longer, Fair Value	38,538
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	(5,766)
Held-to-maturity securities, Total, Fair Value	164,354
Held-to-maturity securities, Total, Unrealized Losses	(21,089)
U.S. Government-sponsored agencies
Less Than 12 Months, Fair Value	33,956	2,921
Less Than 12 Months, Unrealized Losses	(1,092)	(79)
12 Months or Longer, Fair Value	2,223	40,305
12 Months or Longer, Unrealized Losses	(776)	(1,058)
Total, Fair Value	36,179	43,226
Total, Unrealized Losses	(1,868)	(1,137)
Municipal securities
Less Than 12 Months, Fair Value	52,815	5,721
Less Than 12 Months, Unrealized Losses	(7,800)	(65)
12 Months or Longer, Fair Value	0	0
12 Months or Longer, Unrealized Losses	0	0
Total, Fair Value	52,815	5,721
Total, Unrealized Losses	(7,800)	(65)
Held-to-maturity securities, Less Than 12 Months, Fair Value	12,167
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(1,256)
Held-to-maturity securities, 12 Months or Longer, Fair Value	388
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	(33)
Held-to-maturity securities, Total, Fair Value	12,555
Held-to-maturity securities, Total, Unrealized Losses	(1,289)
Private label mortgage-backed securities - residential
Less Than 12 Months, Fair Value	3,352	374
Less Than 12 Months, Unrealized Losses	(418)	(3)
12 Months or Longer, Fair Value	7,689	0
12 Months or Longer, Unrealized Losses	(861)	0
Total, Fair Value	11,041	374
Total, Unrealized Losses	(1,279)	(3)
Asset-backed securities
Less Than 12 Months, Fair Value	4,884	0
Less Than 12 Months, Unrealized Losses	(116)	0
12 Months or Longer, Fair Value	0	0
12 Months or Longer, Unrealized Losses	0	0
Total, Fair Value	4,884	0
Total, Unrealized Losses	(116)	0
Corporate securities
Less Than 12 Months, Fair Value	27,595	11,813
Less Than 12 Months, Unrealized Losses	(1,478)	(187)
12 Months or Longer, Fair Value	11,376	9,491
12 Months or Longer, Unrealized Losses	(1,130)	(508)
Total, Fair Value	38,971	21,304
Total, Unrealized Losses	(2,608)	(695)
Held-to-maturity securities, Less Than 12 Months, Fair Value	33,712
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(2,342)
Held-to-maturity securities, 12 Months or Longer, Fair Value	5,831
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	(168)
Held-to-maturity securities, Total, Fair Value	39,543
Held-to-maturity securities, Total, Unrealized Losses	(2,510)
Mortgage-backed securities - residential
Less Than 12 Months, Fair Value	186,134	287,820
Less Than 12 Months, Unrealized Losses	(34,577)	(3,694)
12 Months or Longer, Fair Value	30,061	40,840
12 Months or Longer, Unrealized Losses	(5,800)	(1,958)
Total, Fair Value	216,195	328,660
Total, Unrealized Losses	(40,377)	(5,652)
Held-to-maturity securities, Less Than 12 Months, Fair Value	75,251
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(10,583)
Held-to-maturity securities, 12 Months or Longer, Fair Value	32,319
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	(5,565)
Held-to-maturity securities, Total, Fair Value	107,570
Held-to-maturity securities, Total, Unrealized Losses	(16,148)
Agency mortgage-backed securities - commercial
Less Than 12 Months, Fair Value	11,072	3,944
Less Than 12 Months, Unrealized Losses	(849)	(139)
12 Months or Longer, Fair Value	5,442	0
12 Months or Longer, Unrealized Losses	(454)	0
Total, Fair Value	16,514	3,944
Total, Unrealized Losses	(1,303)	$ (139)
Held-to-maturity securities, Less Than 12 Months, Fair Value	4,686
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses	(1,142)
Held-to-maturity securities, 12 Months or Longer, Fair Value	0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses	0
Held-to-maturity securities, Total, Fair Value	4,686
Held-to-maturity securities, Total, Unrealized Losses	$ (1,142)

XML

Loans - Categories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	$ 3,207,256		$ 2,833,776
Net deferred loan origination costs and premiums and discounts on purchased loans and other	48,650		53,886
Total loans	3,255,906		2,887,662
Allowance for loan losses	(29,866)	$ (29,153)	(27,841)	$ (28,000)	$ (28,066)	$ (29,484)
Net loans	3,226,040		2,859,821
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,727)	(2,026)	(1,891)	(2,026)	(1,902)	(1,146)
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(616)	(703)	(742)	(993)	(1,021)	(1,082)
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,074)	(621)	(328)	(325)	(329)	(155)
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,590)	(1,707)	(1,612)	(1,327)	(1,357)	(1,192)
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(10,027)	(9,712)	(10,385)	(11,053)	(11,205)	(12,990)
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,789)	(1,850)	(1,776)	(1,732)	(1,700)	(1,732)
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(3,612)	(4,762)	(5,940)	(6,354)	(6,938)	(7,485)
Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(3,015)	(2,281)	(1,083)	(310)	0	0
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(2,046)	(1,956)	(1,387)	(1,214)	(783)	(628)
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(1,370)	(1,138)	(643)	(616)	(594)	(519)
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(62)	(54)	(64)	(65)	(63)	(48)
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	(2,938)	$ (2,343)	(1,990)	$ (1,985)	$ (2,174)	$ (2,507)
Tax Refund Advance Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses	0		0
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	2,535,065		2,363,863
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	225,012		81,448
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans			108,666
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	672,191		469,913
Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	337,565		186,770
Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	22,114		17,665
Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	312,512		265,478
Interest rate swaps | Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total commercial loans	$ 33,900		$ 37,500

XML

Loans - Change in the Balances of the ALLL (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Allowance for loan losses:
Balance, beginning of period	$ 29,153	$ 28,066	$ 27,841	$ 29,484
Provision (credit) charged to expense	892	(29)	2,868	1,268
Losses charged off	(236)	(120)	(2,467)	(3,121)
Recoveries	57	83	1,624	369
Balance, end of period	29,866	28,000	29,866	28,000
Commercial and industrial
Allowance for loan losses:
Balance, beginning of period	2,026	1,902	1,891	1,146
Provision (credit) charged to expense	(301)	122	(166)	823
Losses charged off	0	0	0	(28)
Recoveries	2	2	2	85
Balance, end of period	1,727	2,026	1,727	2,026
Owner-occupied commercial real estate
Allowance for loan losses:
Balance, beginning of period	703	1,021	742	1,082
Provision (credit) charged to expense	(87)	(28)	(126)	(89)
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	616	993	616	993
Investor commercial real estate
Allowance for loan losses:
Balance, beginning of period	621	329	328	155
Provision (credit) charged to expense	453	(4)	746	170
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	1,074	325	1,074	325
Construction
Allowance for loan losses:
Balance, beginning of period	1,707	1,357	1,612	1,192
Provision (credit) charged to expense	(117)	(30)	(22)	135
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	1,590	1,327	1,590	1,327
Single tenant lease financing
Allowance for loan losses:
Balance, beginning of period	9,712	11,205	10,385	12,990
Provision (credit) charged to expense	315	(152)	(1,589)	454
Losses charged off	0	0	0	(2,391)
Recoveries	0	0	1,231	0
Balance, end of period	10,027	11,053	10,027	11,053
Public finance
Allowance for loan losses:
Balance, beginning of period	1,850	1,700	1,776	1,732
Provision (credit) charged to expense	(61)	32	13	0
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	1,789	1,732	1,789	1,732
Healthcare finance
Allowance for loan losses:
Balance, beginning of period	4,762	6,938	5,940	7,485
Provision (credit) charged to expense	(1,150)	(584)	(2,328)	(1,131)
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	3,612	6,354	3,612	6,354
Small business lending
Allowance for loan losses:
Balance, beginning of period	1,956	783	1,387	628
Provision (credit) charged to expense	217	415	847	776
Losses charged off	(130)	(10)	(210)	(222)
Recoveries	3	26	22	32
Balance, end of period	2,046	1,214	2,046	1,214
Franchise finance
Allowance for loan losses:
Balance, beginning of period	2,281	0	1,083	0
Provision (credit) charged to expense	734	310	1,932	310
Losses charged off	0	0	0	0
Recoveries	0	0	0	0
Balance, end of period	3,015	310	3,015	310
Residential mortgage
Allowance for loan losses:
Balance, beginning of period	1,138	594	643	519
Provision (credit) charged to expense	231	19	724	91
Losses charged off	0	0	0	(6)
Recoveries	1	3	3	12
Balance, end of period	1,370	616	1,370	616
Home equity
Allowance for loan losses:
Balance, beginning of period	54	63	64	48
Provision (credit) charged to expense	7	0	(139)	63
Losses charged off	0	0	0	(51)
Recoveries	1	2	137	5
Balance, end of period	62	65	62	65
Other consumer loans
Allowance for loan losses:
Balance, beginning of period	2,343	2,174	1,990	2,507
Provision (credit) charged to expense	651	(129)	1,116	(334)
Losses charged off	(106)	(110)	(397)	(423)
Recoveries	50	50	229	235
Balance, end of period	2,938	$ 1,985	2,938	$ 1,985
Tax Refund Advance Loans
Allowance for loan losses:
Balance, beginning of period			0
Provision (credit) charged to expense			1,860
Losses charged off			(1,860)
Recoveries			0
Balance, end of period	$ 0		$ 0

XML

Loans - Recorded Investments in Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Loans:
Ending balance: collectively evaluated for impairment	$ 3,184,113		$ 2,822,836
Ending balance: individually evaluated for impairment	23,143		10,940
Total Loans Receivable	3,207,256		2,833,776
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	28,838		26,380
Ending balance: individually evaluated for impairment	1,028		1,461
Ending balance	29,866	$ 29,153	27,841	$ 28,000	$ 28,066	$ 29,484
Commercial and industrial
Loans:
Ending balance: collectively evaluated for impairment	94,617		95,364
Ending balance: individually evaluated for impairment	10,163		644
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,377		1,441
Ending balance: individually evaluated for impairment	350		450
Ending balance	1,727	2,026	1,891	2,026	1,902	1,146
Owner-occupied commercial real estate
Loans:
Ending balance: collectively evaluated for impairment	56,993		63,387
Ending balance: individually evaluated for impairment	1,622		3,345
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	616		742
Ending balance: individually evaluated for impairment	0		0
Ending balance	616	703	742	993	1,021	1,082
Investor commercial real estate
Loans:
Ending balance: collectively evaluated for impairment	91,021		28,019
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,074		328
Ending balance: individually evaluated for impairment	0		0
Ending balance	1,074	621	328	325	329	155
Construction
Loans:
Ending balance: collectively evaluated for impairment	139,509		136,619
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,590		1,612
Ending balance: individually evaluated for impairment	0		0
Ending balance	1,590	1,707	1,612	1,327	1,357	1,192
Single tenant lease financing
Loans:
Ending balance: collectively evaluated for impairment	895,302		864,754
Ending balance: individually evaluated for impairment	0		1,100
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	10,027		10,290
Ending balance: individually evaluated for impairment	0		95
Ending balance	10,027	9,712	10,385	11,053	11,205	12,990
Public finance
Loans:
Ending balance: collectively evaluated for impairment	614,139		592,665
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,789		1,776
Ending balance: individually evaluated for impairment	0		0
Ending balance	1,789	1,850	1,776	1,732	1,700	1,732
Healthcare finance
Loans:
Ending balance: collectively evaluated for impairment	293,686		386,926
Ending balance: individually evaluated for impairment	0		926
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	3,612		5,417
Ending balance: individually evaluated for impairment	0		523
Ending balance	3,612	4,762	5,940	6,354	6,938	7,485
Small business lending
Loans:
Ending balance: collectively evaluated for impairment	105,129		106,682
Ending balance: individually evaluated for impairment	7,872		1,984
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,368		994
Ending balance: individually evaluated for impairment	678		393
Ending balance	2,046	1,956	1,387	1,214	783	628
Franchise finance
Loans:
Ending balance: collectively evaluated for impairment	225,012		81,448
Ending balance: individually evaluated for impairment	0		0
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	3,015		1,083
Ending balance: individually evaluated for impairment	0		0
Ending balance	3,015	2,281	1,083	310	0	0
Residential mortgage
Loans:
Ending balance: collectively evaluated for impairment	334,082		183,852
Ending balance: individually evaluated for impairment	3,483		2,918
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	1,370		643
Ending balance: individually evaluated for impairment	0		0
Ending balance	1,370	1,138	643	616	594	519
Home equity
Loans:
Ending balance: collectively evaluated for impairment	22,114		17,651
Ending balance: individually evaluated for impairment	0		14
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	62		64
Ending balance: individually evaluated for impairment	0		0
Ending balance	62	54	64	65	63	48
Other consumer loans
Loans:
Ending balance: collectively evaluated for impairment	312,509		265,469
Ending balance: individually evaluated for impairment	3		9
Allowance for loan losses:
Ending balance: collectively evaluated for impairment	2,938		1,990
Ending balance: individually evaluated for impairment	0		0
Ending balance	2,938	$ 2,343	1,990	$ 1,985	$ 2,174	$ 2,507
Tax Refund Advance Loans
Allowance for loan losses:
Ending balance	0		0
Commercial Portfolio Segment
Loans:
Total Loans Receivable	2,535,065		2,363,863
Commercial Portfolio Segment | Small business lending
Loans:
Total Loans Receivable			108,666
Commercial Portfolio Segment | Franchise finance
Loans:
Total Loans Receivable	225,012		81,448
Consumer Portfolio
Loans:
Total Loans Receivable	672,191		469,913
Consumer Portfolio | Residential mortgage
Loans:
Total Loans Receivable	337,565		186,770
Consumer Portfolio | Home equity
Loans:
Total Loans Receivable	22,114		17,665
Consumer Portfolio | Other consumer loans
Loans:
Total Loans Receivable	$ 312,512		$ 265,478

XML

Loans - Nonaccrual Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 3,207,256	$ 2,833,776
Loans serviced for others		2,833,776
Commercial Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,535,065	2,363,863
Commercial Portfolio Segment | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,492,855	2,312,655
Commercial Portfolio Segment | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	22,553	43,210
Commercial Portfolio Segment | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	19,657	7,998
Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	104,780	96,008
Commercial Portfolio Segment | Commercial and industrial | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	93,262	82,412
Commercial Portfolio Segment | Commercial and industrial | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,355	12,952
Commercial Portfolio Segment | Commercial and industrial | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	10,163	644
Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	58,615	66,732
Commercial Portfolio Segment | Owner-occupied commercial real estate | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	46,423	59,369
Commercial Portfolio Segment | Owner-occupied commercial real estate | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	10,570	4,018
Commercial Portfolio Segment | Owner-occupied commercial real estate | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,622	3,345
Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	91,021	28,019
Commercial Portfolio Segment | Investor commercial real estate | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	91,021	28,019
Commercial Portfolio Segment | Investor commercial real estate | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment | Investor commercial real estate | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	139,509	136,619
Commercial Portfolio Segment | Construction | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	139,509	124,578
Commercial Portfolio Segment | Construction | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	12,041
Commercial Portfolio Segment | Construction | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	895,302	865,854
Commercial Portfolio Segment | Single tenant lease financing | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	894,208	859,612
Commercial Portfolio Segment | Single tenant lease financing | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,094	5,142
Commercial Portfolio Segment | Single tenant lease financing | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	1,100
Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	614,139	592,665
Commercial Portfolio Segment | Public finance | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	611,709	591,630
Commercial Portfolio Segment | Public finance | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,430	1,035
Commercial Portfolio Segment | Public finance | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	0
Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	293,686	387,852
Commercial Portfolio Segment | Healthcare finance | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	292,280	386,337
Commercial Portfolio Segment | Healthcare finance | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,406	589
Commercial Portfolio Segment | Healthcare finance | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	0	926
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable		108,666
Loans serviced for others	113,001	108,666
Commercial Portfolio Segment | Small business lending | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	99,722	99,250
Commercial Portfolio Segment | Small business lending | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	5,407	7,433
Commercial Portfolio Segment | Small business lending | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	7,872	1,983
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	225,012	81,448
Loans serviced for others	225,012	81,448
Commercial Portfolio Segment | Franchise finance | Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	224,721	81,448
Commercial Portfolio Segment | Franchise finance | Special Mention
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	291	0
Commercial Portfolio Segment | Franchise finance | Substandard
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 0	$ 0

XML

Loans Loans - Internal Credit Assessment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	$ 3,207,256	$ 2,833,776
Consumer Portfolio
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	672,191	469,913
Consumer Portfolio | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	671,115	468,664
Consumer Portfolio | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	1,076	1,249
Consumer Portfolio | Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	337,565	186,770
Consumer Portfolio | Residential mortgage | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	336,492	185,544
Consumer Portfolio | Residential mortgage | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	1,073	1,226
Consumer Portfolio | Home equity
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	22,114	17,665
Consumer Portfolio | Home equity | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	22,114	17,651
Consumer Portfolio | Home equity | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	0	14
Consumer Portfolio | Other consumer loans
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	312,512	265,478
Consumer Portfolio | Other consumer loans | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	312,509	265,469
Consumer Portfolio | Other consumer loans | Nonaccrual
Financing Receivable, Credit Quality Indicator [Line Items]
Total Loans Receivable	$ 3	$ 9

XML

Loans - Loan Portfolio Aging (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	$ 0	$ 0
Loans serviced for others		2,833,776
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans 90 Days or More Past Due and Accruing	0	0
30-59 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others		119
60-89 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others		244
90 Days or More Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others		763
Financial Asset, Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others		1,126
Financial Asset, Not Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others		2,832,650
Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	104,780	96,008
Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	58,615	66,732
Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	91,021	28,019
Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	139,509	136,619
Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	895,302	865,854
Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	614,139	592,665
Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	293,686	387,852
Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	113,001	108,666
Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	225,012	81,448
Commercial Portfolio Segment | 30-59 Days Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 30-59 Days Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 60-89 Days Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	356	0
Commercial Portfolio Segment | 60-89 Days Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	350	0
Commercial Portfolio Segment | 90 Days or More Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | 90 Days or More Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	488	657
Commercial Portfolio Segment | 90 Days or More Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	350	0
Commercial Portfolio Segment | Financial Asset, Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	844	657
Commercial Portfolio Segment | Financial Asset, Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Commercial Portfolio Segment | Financial Asset, Not Past Due | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	104,430	96,008
Commercial Portfolio Segment | Financial Asset, Not Past Due | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	58,615	66,732
Commercial Portfolio Segment | Financial Asset, Not Past Due | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	91,021	28,019
Commercial Portfolio Segment | Financial Asset, Not Past Due | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	139,509	136,619
Commercial Portfolio Segment | Financial Asset, Not Past Due | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	895,302	865,854
Commercial Portfolio Segment | Financial Asset, Not Past Due | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	614,139	592,665
Commercial Portfolio Segment | Financial Asset, Not Past Due | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	293,686	387,852
Commercial Portfolio Segment | Financial Asset, Not Past Due | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	112,157	108,009
Commercial Portfolio Segment | Financial Asset, Not Past Due | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	225,012	81,448
Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	3,207,256
Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	337,565	186,770
Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	22,114	17,665
Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	312,512	265,478
Consumer Portfolio | 30-59 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	201
Consumer Portfolio | 30-59 Days Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	171	51
Consumer Portfolio | 30-59 Days Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Consumer Portfolio | 30-59 Days Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	30	68
Consumer Portfolio | 60-89 Days Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	447
Consumer Portfolio | 60-89 Days Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	71	226
Consumer Portfolio | 60-89 Days Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Consumer Portfolio | 60-89 Days Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	20	18
Consumer Portfolio | 90 Days or More Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	1,191
Consumer Portfolio | 90 Days or More Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	353	106
Consumer Portfolio | 90 Days or More Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Consumer Portfolio | 90 Days or More Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Consumer Portfolio | Financial Asset, Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	1,839
Consumer Portfolio | Financial Asset, Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	595	383
Consumer Portfolio | Financial Asset, Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	0	0
Consumer Portfolio | Financial Asset, Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	50	86
Consumer Portfolio | Financial Asset, Not Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	3,205,417
Consumer Portfolio | Financial Asset, Not Past Due | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	336,970	186,387
Consumer Portfolio | Financial Asset, Not Past Due | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	22,114	17,665
Consumer Portfolio | Financial Asset, Not Past Due | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans serviced for others	312,462	265,392
Nonaccrual
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual		7,401
Nonaccrual | Commercial Portfolio Segment | Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	350	674
Nonaccrual | Commercial Portfolio Segment | Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	1,622	0
Nonaccrual | Commercial Portfolio Segment | Investor commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	3,419
Nonaccrual | Commercial Portfolio Segment | Construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	0
Nonaccrual | Commercial Portfolio Segment | Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	1,100
Nonaccrual | Commercial Portfolio Segment | Public finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	0
Nonaccrual | Commercial Portfolio Segment | Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	0
Nonaccrual | Commercial Portfolio Segment | Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	2,958	959
Nonaccrual | Commercial Portfolio Segment | Franchise finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	0
Nonaccrual | Consumer Portfolio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	6,006
Nonaccrual | Consumer Portfolio | Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	1,073	1,226
Nonaccrual | Consumer Portfolio | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	0	14
Nonaccrual | Consumer Portfolio | Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Nonaccrual	$ 3	$ 9

XML

Loans - Impaired Loans (Details) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($) loan	Sep. 30, 2021 USD ($) security	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($) loan	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	$ 19,137			$ 19,137		$ 7,245
Loans without a specific valuation allowance - Unpaid Principal Balance	19,563			19,563		7,781
Loans without a specific valuation allowance	0			0		0
Impaired Financing Receivable, with Related Allowance, Recorded Investment	4,006			4,006		3,695
Loans with a specific valuation allowance - Unpaid Principal Balance	4,163			4,163		3,751
Loans with a specific valuation allowance	1,028			1,028		1,461
Impaired Financing Receivable, Recorded Investment	23,143			23,143		10,940
Impaired Financing Receivable, Unpaid Principal Balance	23,726			23,726
Loans without a specific valuation allowance - Average Balance	12,452	$ 7,076		8,968	$ 7,175
Loans without a specific valuation allowance - Interest Income	9	15		26	42
Loans with a specific valuation allowance - Average Balance	3,036	4,897		3,506	7,235
Loans with a specific valuation allowance - Interest Income	0	37		45	73
Impaired Financing Receivable, Average Recorded Investment	15,488	11,973	$ 11,532	12,474	14,410
Impaired Financing Receivable, Interest Income, Accrual Method	9	$ 52		71	115
Other real estate owned	$ 0			$ 0		$ 1,188
Mortgage loans in process of foreclosure, number of loans | loan	2			2		1,000,000
Mortgage loans in process of foreclosure, amount	$ 200			$ 200		$ 100
Number of contracts classified as TDRs | security		1
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	9,813			9,813		0
Loans without a specific valuation allowance - Unpaid Principal Balance	9,813			9,813		0
Loans without a specific valuation allowance	0			0		0
Impaired Financing Receivable, with Related Allowance, Recorded Investment	350			350		644
Loans with a specific valuation allowance - Unpaid Principal Balance	350			350		677
Loans with a specific valuation allowance	350			350		450
Loans without a specific valuation allowance - Average Balance	4,906	$ 0		1,636	259
Loans without a specific valuation allowance - Interest Income	0	0		0	9
Loans with a specific valuation allowance - Average Balance	350	690		456	677
Loans with a specific valuation allowance - Interest Income	0	0		0	0
Owner-occupied commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	0			0		3,345
Loans without a specific valuation allowance - Unpaid Principal Balance	0			0		3,466
Loans without a specific valuation allowance	0			0		0
Impaired Financing Receivable, with Related Allowance, Recorded Investment	1,622			1,622		0
Loans with a specific valuation allowance - Unpaid Principal Balance	1,779			1,779		0
Loans with a specific valuation allowance	0			0		0
Loans without a specific valuation allowance - Average Balance	1,645	3,457		2,471	3,297
Loans without a specific valuation allowance - Interest Income	0	0		0	0
Loans with a specific valuation allowance - Average Balance	0	0		0	473
Loans with a specific valuation allowance - Interest Income	0	0		0	0
Single tenant lease financing
Accounts, Notes, Loans and Financing Receivable [Line Items]
Impaired Financing Receivable, with Related Allowance, Recorded Investment	0			0		1,100
Loans with a specific valuation allowance - Unpaid Principal Balance	0			0		1,123
Loans with a specific valuation allowance	0			0		95
Loans without a specific valuation allowance - Average Balance	0	1,315		0	100
Loans without a specific valuation allowance - Interest Income	0	0		0	5
Loans with a specific valuation allowance - Average Balance	0	2,048		547	4,875
Loans with a specific valuation allowance - Interest Income	0	0		0	0
Healthcare finance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Impaired Financing Receivable, with Related Allowance, Recorded Investment	0			0		926
Loans with a specific valuation allowance - Unpaid Principal Balance	0			0		926
Loans with a specific valuation allowance	0			0		523
Loans without a specific valuation allowance - Average Balance	0	0		0	336
Loans without a specific valuation allowance - Interest Income	0	0		0	0
Loans with a specific valuation allowance - Average Balance	660	956		826	809
Loans with a specific valuation allowance - Interest Income	0	37		45	73
Small business lending
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	5,838			5,838		959
Loans without a specific valuation allowance - Unpaid Principal Balance	6,087			6,087		1,193
Loans without a specific valuation allowance	0			0		0
Impaired Financing Receivable, with Related Allowance, Recorded Investment	2,034			2,034		1,025
Loans with a specific valuation allowance - Unpaid Principal Balance	2,034			2,034		1,025
Loans with a specific valuation allowance	678			678		393
Loans without a specific valuation allowance - Average Balance	2,167	0		1,288	1,005
Loans without a specific valuation allowance - Interest Income	0			0	0
Loans with a specific valuation allowance - Average Balance	1,827	1,203		1,611	401
Loans with a specific valuation allowance - Interest Income	0	0		0	0
Residential mortgage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	3,483			3,483		2,918
Loans without a specific valuation allowance - Unpaid Principal Balance	3,634			3,634		3,063
Loans without a specific valuation allowance	0			0		0
Loans without a specific valuation allowance - Average Balance	3,711	2,267		3,550	2,138
Loans without a specific valuation allowance - Interest Income	9	15		$ 26	28
Number of contracts classified as TDRs | loan				1
Financing receivable, troubled debt restructuring	700	800		$ 700	800
Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	0			0		14
Loans without a specific valuation allowance - Unpaid Principal Balance	0			0		15
Loans without a specific valuation allowance	0			0		0
Loans without a specific valuation allowance - Average Balance	15	14		14	13
Loans without a specific valuation allowance - Interest Income	0	0		0	0
Other consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans without a specific valuation allowance - Recorded Balance	3			3		9
Loans without a specific valuation allowance - Unpaid Principal Balance	29			29		44
Loans without a specific valuation allowance	0			0		$ 0
Loans without a specific valuation allowance - Average Balance	8	23		9	27
Loans without a specific valuation allowance - Interest Income	0	0		0	0
Loans with a specific valuation allowance - Average Balance	199	0		66	0
Loans with a specific valuation allowance - Interest Income	$ 0	$ 0		$ 0	$ 0

XML

Premises and Equipment - Summary (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (9,750)	$ (6,725)
Premises and equipment, net	70,747	59,842
Land
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	5,598	0
Right of use leased asset
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	244	208
Construction in process
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	5	57,469
Building and improvements
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	55,226	1,090
Furniture and equipment
Property, Plant and Equipment [Line Items]
Premises and equipment, gross	$ 19,424	$ 7,800

XML

Premises and Equipment - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Apr. 16, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Gain on sale of headquarters and certain equipment	$ 2,500	$ 0	$ 0	$ 0	$ 2,523

XML

Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 4,687	$ 4,687

XML

Servicing Asset (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Servicing Asset at Fair Value, Amount [Roll Forward]
Balance, beginning of period	$ 5,345	$ 4,120	$ 4,702	$ 3,569
Originated and purchased servicing	783	566	2,193	1,512
Paydowns:	(279)	(176)	(888)	(500)
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	(54)	(98)	(212)	(169)
Loan servicing asset revaluation	(333)	(274)	(1,100)	(669)
Balance, end of period	$ 5,795	$ 4,412	$ 5,795	$ 4,412

XML

Servicing Asset - Unpaid principal balance (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Servicing Assets at Fair Value [Line Items]
Loans serviced for others		$ 2,833,776
Loan servicing
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 285,736	230,514
Loan servicing | SBA guaranteed loans
Servicing Assets at Fair Value [Line Items]
Loans serviced for others	$ 285,736	$ 230,514

XML

Servicing Asset - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Servicing Assets at Fair Value [Line Items]
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	$ 54	$ 98	$ 212	$ 169
Loan servicing
Servicing Assets at Fair Value [Line Items]
Loan servicing revenue	653	511	1,858	1,390
Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model	$ 300	$ 300	$ 1,100	$ 700

XML

Subordinated Debt (Details Textual) - Subordinated Debt - USD ($)	1 Months Ended
	Aug. 31, 2021	Oct. 31, 2020	Jun. 30, 2019	Sep. 30, 2016	Dec. 30, 2021
2031 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount			$ 37,000,000
Fixed annual interest rate (as a percent)			6.00%
2030 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount		$ 10,000,000
Fixed annual interest rate (as a percent)		6.00%
2031 Notes
Debt Instrument [Line Items]
Subordinated debenture, principal amount	$ 60,000,000
Fixed annual interest rate (as a percent)	3.75%
Unregistered 2031 Notes
Debt Instrument [Line Items]
Debt Instrument, Principal Amount Exchanged					$ 59,300,000
Debt Instrument, Principal Amount Remaining					$ 700,000
6.0% Fixed To Floating Rate Subordinated Notes Due 2026
Debt Instrument [Line Items]
Subordinated debenture, principal amount				$ 25,000,000
Fixed annual interest rate (as a percent)				6.00%
LIBOR | 2031 Notes
Debt Instrument [Line Items]
Basis spread on variable rate			4.11%
LIBOR | 6.0% Fixed To Floating Rate Subordinated Notes Due 2026
Debt Instrument [Line Items]
Basis spread on variable rate				4.85%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | 2030 Notes
Debt Instrument [Line Items]
Basis spread on variable rate		5.795%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | 2031 Notes
Debt Instrument [Line Items]
Basis spread on variable rate	3.11%

XML

Subordinated Debt - Schedule of Subordinated Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 589,926	$ 514,922
Unamortized Debt Issuance Costs	(2,619)	(2,769)
Subordinated Debt
Debt Instrument [Line Items]
Principal	107,000	107,000
Unamortized Debt Issuance Costs	(2,544)	(2,769)
Subordinated Debt | 2029 Notes
Debt Instrument [Line Items]
Principal	37,000	37,000
Unamortized Debt Issuance Costs	(1,060)	(1,178)
Subordinated Debt | 2030 Notes
Debt Instrument [Line Items]
Principal	10,000	10,000
Unamortized Debt Issuance Costs	(190)	(208)
Subordinated Debt | 2031 Notes
Debt Instrument [Line Items]
Principal	60,000	60,000
Unamortized Debt Issuance Costs	$ (1,294)	$ (1,383)

XML

Benefit Plans - Activity (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Restricted Stock Awards
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	9,954
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 52.64
Cancelled/Forfeited (in shares) | shares	(644)
Vested (in shares) | shares	(7,378)
Balance at end of period (in shares) | shares	1,932
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	52.64
Vested (in dollars per share) | $ / shares	52.64
Balance at end of period (in dollars per share) | $ / shares	$ 52.64
Restricted Stock Awards | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	4,151
Balance at end of period (in shares) | shares	4,151
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	36.84
Balance at end of period (in dollars per share) | $ / shares	$ 36.84
Deferred Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	3
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 0
Cancelled/Forfeited (in shares) | shares	0
Vested (in shares) | shares	(3)
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	41.87
Vested (in dollars per share) | $ / shares	41.87
Balance at end of period (in dollars per share) | $ / shares	$ 0
Deferred Stock Units | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	0
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 0
Restricted Stock Units
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	112,822
Granted (in shares) | shares	41,662
Cancelled/Forfeited (in dollars per share) | $ / shares	$ 36.68
Cancelled/Forfeited (in shares) | shares	(5,441)
Vested (in shares) | shares	(23,256)
Balance at end of period (in shares) | shares	125,787
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 28.18
Granted (in dollars per share) | $ / shares	46.67
Vested (in dollars per share) | $ / shares	24.62
Balance at end of period (in dollars per share) | $ / shares	$ 34.59
Restricted Stock Units | Plan 2022
Awards/Units Outstanding (in shares)
Balance at beginning of period (in shares) | shares	0
Granted (in shares) | shares	0
Balance at end of period (in shares) | shares	0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)
Balance at beginning of period (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	0
Balance at end of period (in dollars per share) | $ / shares	$ 0

XML

Benefit Plans - Deferred Stock Rights (Details)	9 Months Ended
	Sep. 30, 2022 shares
Deferred Stock Rights
Outstanding, beginning of period (in shares)	84,536,000
Granted (in shares)	322,000
Exercised (in shares)	0
Outstanding, end of period (in shares)	84,858,000

XML

Benefit Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	May 16, 2022
Allocated share-based compensation expense	$ 434	$ 568	$ 1,967	$ 1,830
Compensation cost not yet recognized	$ 2,100		$ 2,100
Period for recognition			1 year 9 months 18 days
Percentage of annual retainer received in either common stock or deferred stock rights			100.00%
Plan 2013
Number of shares authorized (in shares)	750,000		750,000
Plan 2022
Number of shares authorized (in shares)					400,000
Share-based Payment Arrangement, Expense	$ 100		$ 100
Director
Common stock shares reserved for future grants (in shares)			180,000
Plan 2022 | Restricted Stock Units
Compensation cost not yet recognized	100		$ 100
Period for recognition			7 months 6 days
Voting and Nonvoting Common Stock | Voting and Nonvoting Common Stock
Allocated share-based compensation expense	$ 434	$ 568	$ 1,967	$ 1,830

XML

Commitments and Credit Risk (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Other Commitments [Line Items]
Loan commitments	$ 508.6	$ 324.3
Construction related contract commitment, term	1 year
Capital Addition Purchase Commitments
Other Commitments [Line Items]
Other contract commitment	$ 69.2
Construction related contract commitment, not yet incurred	$ 6.1

XML

Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Total available-for-sale securities	$ 393,565	$ 603,044
Loans held-for-sale (mandatory pricing agreements)	17,072	23,233
Servicing asset	5,795	4,702
Derivative, fair value	(388)	(14,301)
Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	9,677	23,233
Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Servicing asset	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	0	0
Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	393,565	603,044
Servicing asset	0	0
Significant Other Observable Inputs (Level 2) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	9,677	23,233
Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Servicing asset	5,795	4,702
Significant Unobservable Inputs (Level 3) | Loans Held For Sale
Loans held-for-sale (mandatory pricing agreements)	0	0
U.S. Government-sponsored agencies
Total available-for-sale securities	36,329	49,040
U.S. Government-sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
U.S. Government-sponsored agencies | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	36,329	49,040
U.S. Government-sponsored agencies | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Municipal securities
Total available-for-sale securities	63,537	77,033
Municipal securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Municipal securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	63,537	77,033
Municipal securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - residential
Total available-for-sale securities	219,191	373,236
Agency mortgage-backed securities - residential | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - residential | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities		373,236
Agency mortgage-backed securities - residential | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Private label mortgage-backed securities - residential
Total available-for-sale securities	11,041	16,021
Private label mortgage-backed securities - residential | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Private label mortgage-backed securities - residential | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Asset-backed securities
Total available-for-sale securities	4,884	5,004
Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Asset-backed securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	4,884	5,004
Asset-backed securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Corporate securities
Total available-for-sale securities	42,061	46,384
Corporate securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Corporate securities | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	42,061	46,384
Corporate securities | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
IRLCs
Derivative, fair value	(388)	718
IRLCs | Quoted Prices in Active Markets for Identical Assets (Level 1)
Derivative, fair value	0	0
IRLCs | Significant Other Observable Inputs (Level 2)
Derivative, fair value	0	0
IRLCs | Significant Unobservable Inputs (Level 3)
Derivative, fair value	(388)	718
Agency mortgage-backed securities - commercial
Total available-for-sale securities	16,522	36,326
Agency mortgage-backed securities - commercial | Quoted Prices in Active Markets for Identical Assets (Level 1)
Total available-for-sale securities	0	0
Agency mortgage-backed securities - commercial | Significant Other Observable Inputs (Level 2)
Total available-for-sale securities	16,522	36,326
Agency mortgage-backed securities - commercial | Significant Unobservable Inputs (Level 3)
Total available-for-sale securities	0	0
Interest rate swaps | Interest rate swaps
Derivative liability, fair value	8,978	(14,271)
Interest rate swaps | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swaps
Derivative liability, fair value	0	0
Interest rate swaps | Significant Other Observable Inputs (Level 2) | Interest rate swaps
Derivative liability, fair value	8,978	(14,271)
Interest rate swaps | Significant Unobservable Inputs (Level 3) | Interest rate swaps
Derivative liability, fair value	0	0
Forward contracts | Forward contracts
Derivative, fair value	1,006	(30)
Forward contracts | Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward contracts
Derivative, fair value	1,006	(30)
Forward contracts | Significant Other Observable Inputs (Level 2) | Forward contracts
Derivative, fair value	0	0
Forward contracts | Significant Unobservable Inputs (Level 3) | Forward contracts
Derivative, fair value	0	0
Derivatives designated as hedging instruments | Interest rate swaps
Derivative, fair value	$ 2,094	$ (1,731)

XML

Fair Value of Financial Instruments - Fair Value Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest Rate Lock Commitments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 462	$ 818	$ 718	$ 3,361
Additions:	0	0	0	0
Paydowns	0	0	0	0
Included in net income	(850)	22	(1,106)	(2,521)
Ending balance	(388)	840	(388)	840
Servicing asset
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5,345	4,120	4,702	3,569
Additions:	783	566	2,193	1,512
Paydowns	(279)	(176)	(888)	(500)
Included in net income	(54)	(98)	(212)	(169)
Ending balance	$ 5,795	$ 4,412	$ 5,795	$ 4,412

XML

Fair Value of Financial Instruments - Quantitative Information About Unobservable Inputs (Details) - USD ($) $ in Thousands	6 Months Ended	9 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Impaired Financing Receivable, with Related Allowance, Recorded Investment		$ 4,006	$ 3,695
Servicing asset		5,795	4,702
Quoted Prices in Active Markets for Identical Assets (Level 1)
Servicing asset		0	0
Significant Other Observable Inputs (Level 2)
Servicing asset		0	0
Significant Unobservable Inputs (Level 3)
Servicing asset		5,795	4,702
IRLCs | Significant Unobservable Inputs (Level 3)
IRLCs Fair Value		(388)	718
Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset		5,795	4,702
Impaired Loans | Significant Unobservable Inputs (Level 3)
Impaired Financing Receivable, with Related Allowance, Recorded Investment		$ 1,134	$ 1,228
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Minimum
IRLC - Loan closing rates	42.00%	25.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Maximum
IRLC - Loan closing rates	100.00%	100.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
IRLC - Loan closing rates	89.00%	81.00%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Minimum
Servicing asset, discount rate	0.00%	0.00%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Maximum
Servicing asset, discount rate	25.00%	25.00%
Measurement Input, Prepayment Rate [Member] | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Servicing asset, discount rate	12.50%	14.60%
Measurement Input, Discount Rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3)
Servicing asset, discount rate	10.00%	12.00%
Measurement Input, Discount Rate | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Servicing asset, discount rate	10.00%	12.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3)
Impaired Financing Receivable, Measurement Input		10.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Minimum
Impaired Financing Receivable, Measurement Input			0.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Maximum
Impaired Financing Receivable, Measurement Input			35.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Weighted-Average Range
Impaired Financing Receivable, Measurement Input		10.00%	10.10%

XML

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Cash and cash equivalents, Carrying Amount	$ 221,052	$ 442,960
Debt Securities, Held-to-maturity	191,057	59,565
Held-to-maturity, at fair value	169,977	61,468
Loans Held-For-Sale	13,426	24,512
Loans held for sale, Fair Value	17,072	23,233
Loans receivable	3,226,040	2,859,821
Accrued interest receivable, Carrying Amount	16,918	16,037
FHLB stock, Carrying Amount	28,350	25,650
Deposits, Carrying Amount	3,192,644	3,178,959
FHLB Advances, Carrying Amount	589,926	514,922
Accrued interest payable	1,887	2,018
Subordinated debt, Carrying Value	104,456	104,231
Reported Value Measurement
Cash and cash equivalents, Carrying Amount	221,052	442,960
Debt Securities, Held-to-maturity	191,057	59,565
Loans receivable	3,226,040	2,859,821
Accrued interest receivable, Carrying Amount	16,918	16,037
FHLB stock, Carrying Amount	28,350	25,650
Deposits, Carrying Amount	3,192,644	3,178,959
Fair Value
Cash and cash equivalents, Fair Value	221,052	442,960
Held-to-maturity, at fair value	169,977	61,468
Loans held for sale, Fair Value	13,426	24,512
Loans receivable, fair value	3,027,916	2,880,024
Accrued interest receivable, Fair Value	16,918	16,037
FHLB stock, Fair Value	28,350	25,650
Deposits, Fair Value	3,056,730	3,190,000
FHLB Advances, Fair Value	545,824	526,143
Subordinated debt, Fair Value	104,544	108,788
Accrued interest payable, Fair Value	1,887	2,018
Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)
Cash and cash equivalents, Fair Value	221,052	442,960
Held-to-maturity, at fair value	0	0
Loans held for sale, Fair Value	0	0
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	16,918	16,037
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,910,715	1,909,432
FHLB Advances, Fair Value	0	0
Subordinated debt, Fair Value	34,425	38,643
Accrued interest payable, Fair Value	1,887	2,018
Fair Value | Significant Other Observable Inputs (Level 2)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	169,977	61,468
Loans held for sale, Fair Value	13,426	24,512
Loans receivable, fair value	0	0
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	28,350	25,650
Deposits, Fair Value	0	0
FHLB Advances, Fair Value	545,824	526,143
Subordinated debt, Fair Value	70,119	70,145
Accrued interest payable, Fair Value	0	0
Fair Value | Significant Unobservable Inputs (Level 3)
Cash and cash equivalents, Fair Value	0	0
Held-to-maturity, at fair value	0	0
Loans held for sale, Fair Value	0	0
Loans receivable, fair value	3,027,916	2,880,024
Accrued interest receivable, Fair Value	0	0
FHLB stock, Fair Value	0	0
Deposits, Fair Value	1,146,015	1,280,568
FHLB Advances, Fair Value	0	0
Subordinated debt, Fair Value	0	0
Accrued interest payable, Fair Value	$ 0	$ 0

XML

Mortgage Banking Activities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Principal Transaction Revenue [Line Items]
Loans originated for sale	$ 85,100	$ 198,300	$ 343,300	$ 585,500
Proceeds from sale of loans	95,000	186,100	365,300	579,200
Mortgage banking activities
Principal Transaction Revenue [Line Items]
Gain on loans sold	1,178	3,244	5,119	14,550
Gain (loss) resulting from the change in fair value of loans held-for-sale	(450)	110	(599)	(854)
Gain (loss) resulting from the change in fair value of derivatives	143	496	(66)	(1,422)
Net revenue from mortgage banking activities	$ 871	$ 3,850	$ 4,454	$ 12,274

XML

Derivative Financial Instruments - Carrying Amount and Adjustment (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended	9 Months Ended
	Mar. 31, 2021	Jun. 30, 2020	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost			$ 448,710,000			$ 448,710,000		$ 606,507,000
Payments for swap termination payments		$ 46,100,000
Cash Pledged As Collateral			0			0		15,700,000
Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortized cost			50,000,000			50,000,000
Securities available-for-sale | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying amount of the hedged assets			69,050,000			69,050,000		$ 75,156,000
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets					$ 1,729,000	(2,106,000)
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Payments for swap termination payments	$ 1,900,000
Amortization Expense			100,000			200,000
Loans | Derivatives designated as hedging instruments | Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amortization Expense			$ 1,500,000	$ 1,500,000		$ 3,600,000	$ 3,800,000

XML

Derivative Financial Instruments - Interest Swap Derivatives (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2021	Jun. 30, 2020	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 31,202			$ 31,202		$ 332,750
Fair Value			(388)			(388)		(14,301)
Interest expense			15,105	$ 12,115		35,815	$ 36,640
Payments for swap termination payments		$ 46,100
Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			50,000			$ 50,000		$ 50,000
Weighted Average Remaining Maturity (years)						2 years 1 month 6 days		2 years 9 months 18 days
Fair Value			$ 2,094			$ 2,094		$ (1,731)
Weighted-Average Rate			2.33%			2.33%		2.33%
Loans | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Weighted Average Remaining Maturity (years)						11 years 6 months
Securities available-for-sale | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fair value hedging adjustment					$ 1,729	$ (2,106)
Securities available-for-sale | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 50,000			$ 50,000		$ 50,000
Weighted Average Remaining Maturity (years)						2 years 1 month 6 days		2 years 9 months 18 days
Fair Value			$ 2,094			$ 2,094		$ (1,731)
Weighted-Average Rate			2.33%			2.33%		2.33%
Payments for swap termination payments	$ 1,900
3-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 110,000			$ 110,000		$ 110,000
Weighted Average Remaining Maturity (years)						4 years 4 months 2 days		5 years 1 month 6 days
Fair Value			$ 5,242			$ 5,242		$ (8,560)
Derivative, variable interest rate			2.88%			2.88%		2.88%
1-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 60,000			$ 60,000		$ 100,000
Weighted Average Remaining Maturity (years)						10 months 20 days		2 years
Fair Value			$ 730			$ 730		$ (3,980)
Derivative, variable interest rate			2.88%			2.88%		2.88%
Fed Funds Effective | Interest rate swaps | Derivatives designated as hedging instruments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Value			$ 40,000			$ 40,000
Weighted Average Remaining Maturity (years)						1 year 8 months 1 day
Fair Value			$ 912			$ 912
Derivative, variable interest rate			2.78%			2.78%

XML

Derivative Financial Instruments - Notional Amounts and Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Asset Derivatives
Notional Amount	$ 287,750	$ 62,789
Fair Value	9,984	718
Derivative Liability [Abstract]
Notional Amount	31,202	332,750
Derivative, fair value	(388)	(14,301)
Interest Rate Lock Commitments
Derivative Liability [Abstract]
Derivative, fair value	(388)	718
Derivatives designated as hedging instruments | Interest rate swaps
Derivative Liability [Abstract]
Notional Amount	50,000	50,000
Derivative, fair value	2,094	(1,731)
Derivatives not designated as hedging instruments | Interest Rate Lock Commitments
Asset Derivatives
Notional Amount	0	62,789
Fair Value	0	718
Derivatives not designated as hedging instruments | Forward contracts
Asset Derivatives
Notional Amount	27,750	0
Fair Value	1,006	0
Derivatives not designated as hedging instruments | Forward contracts
Derivative Liability [Abstract]
Notional Amount	0	72,750
Fair Value	0	(30)
Derivatives not designated as hedging instruments | Interest Rate Lock Commitments
Derivative Liability [Abstract]
Notional Amount	31,202	0
Fair Value	(388)	0
Loans | Derivatives designated as hedging instruments | Interest rate swaps
Asset Derivatives
Notional Amount	50,000	0
Fair Value	2,094	0
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps
Asset Derivatives
Notional Amount	210,000	0
Fair Value	6,884	0
Derivative Liability [Abstract]
Notional Amount	50,000	50,000
Derivative, fair value	2,094	(1,731)
Securities available-for-sale | Derivatives designated as hedging instruments | Forward contracts
Derivative Liability [Abstract]
Notional Amount	0	50,000
Fair Value	0	(1,731)
Liability | Derivatives designated as hedging instruments | Forward contracts
Derivative Liability [Abstract]
Notional Amount	0	210,000
Fair Value	$ 0	$ (12,540)

XML

Derivative Financial Instruments - Gain (Loss) Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Asset Derivatives | Interest Rate Lock Commitments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	$ 0	$ 0	$ 0	$ (2,519)
Asset Derivatives | Forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	993	0	1,036	0
Forward contracts | Liability Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	0	474	0	1,097
Interest Rate Lock Commitments | Liability Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments	$ (850)	$ 22	$ (1,102)	$ 0

XML

Derivative Financial Instruments - Effect Of Derivatives on Income (Details) - Interest rate swaps - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Other Comprehensive Income	$ 6,058	$ 1,439	$ 19,424	$ 7,665
Securities - taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	0		0
Gain (loss) recognized on the condensed consolidated statements of income		0		(253)
Securities - non-taxable
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(7)		(442)
Gain (loss) recognized on the condensed consolidated statements of income		(280)		(817)
Total interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	(7)		(442)
Gain (loss) recognized on the condensed consolidated statements of income		(280)		(1,070)
Deposits
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	159		1,338
Gain (loss) recognized on the condensed consolidated statements of income		702		2,072
Other borrowed funds
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	168		1,355
Gain (loss) recognized on the condensed consolidated statements of income		774		2,258
Total interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	327		2,693
Gain (loss) recognized on the condensed consolidated statements of income		1,476		4,330
Net interest income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized on the condensed consolidated statements of income	$ (334)		$ (3,135)
Gain (loss) recognized on the condensed consolidated statements of income		$ (1,756)		$ (5,400)

XML

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	$ 365,332	$ 358,641	$ 380,338	$ 330,944
Net change in unrealized gain	(12,348)	(350)	(37,660)	5,069
Reclassification of net loss realized and included in earnings	296		608
Other comprehensive (loss) gain before tax	(12,052)	(350)	(37,052)	5,069
Income tax provision (benefit)	(3,659)	(93)	(8,948)	1,041
Other comprehensive (loss) income - net of tax	(8,393)	(257)	(28,104)	4,028
Balance, end of period	360,857	370,442	360,857	370,442
Reclassifications from accumulated other comprehensive loss to earnings before tax	(296)	0	(608)	0
Tax benefit	(68)	0	(139)	0
Total reclassifications from accumulated other comprehensive loss	(228)	0	(469)	0
Available-For-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(27,568)	(164)	(2,555)	468
Net change in unrealized gain	(18,406)	(1,789)	(51,682)	(2,596)
Reclassification of net loss realized and included in earnings	0		0
Other comprehensive (loss) gain before tax	(18,406)	(1,789)	(51,682)	(2,596)
Income tax provision (benefit)	(5,121)	(441)	(13,384)	(616)
Other comprehensive (loss) income - net of tax	(13,285)	(1,348)	(38,298)	(1,980)
Balance, end of period	(40,853)	(1,512)	(40,853)	(1,512)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	636	(12,747)	(8,484)	(17,664)
Net change in unrealized gain	6,058	1,439	19,424	7,665
Reclassification of net loss realized and included in earnings	0		0
Other comprehensive (loss) gain before tax	6,058	1,439	19,424	7,665
Income tax provision (benefit)	1,393	348	5,639	1,657
Other comprehensive (loss) income - net of tax	4,665	1,091	13,785	6,008
Balance, end of period	5,301	(11,656)	5,301	(11,656)
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(30,750)	(12,911)	(11,039)	(17,196)
Other comprehensive (loss) income - net of tax	(8,393)	(257)	(28,104)	4,028
Balance, end of period	(39,143)	$ (13,168)	(39,143)	$ (13,168)
AOCI, Accumulated Gain (Loss), Debt Securities, Held-To-Maturity, Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance, beginning of period	(3,818)		0
Net change in unrealized gain	0		(5,402)
Reclassification of net loss realized and included in earnings	296		608
Other comprehensive (loss) gain before tax	296		(4,794)
Income tax provision (benefit)	69		(1,203)
Other comprehensive (loss) income - net of tax	227		(3,591)
Balance, end of period	$ (3,591)		$ (3,591)